Drug Description in Trials / DrugBank / KEGG DRUG


Search results


No. 薬物名(臨床試験情報から抽出) DrugBank KEGG DRUG KEGG GENES KEGG PATHWAY 指定難病告示番号
1(11C)PE2I----1件: 6 💬
2(2-chloro-5-[11C]methoxy-N-(((3s,5s,7s)-3,5,7-trifluoroadamantan-1-yl)methyl) benzamide)----1件: 6 💬
3(3aR,8aS)-1,2,3,3a,8,8a-hexahydro-1,3a,8-trimethylpyrrolo[2,3-b] indol-5-ol----1件: 6 💬
4(3aR,8aS)-1,2,3,3a,8,8a-hexahydro-1,3a,8-trimethylpyrrolo[2,3-b] indol-5-ol phenylcarbamate, (2S,3S)-2,3-dihydroxybutanedioate (1:1)----1件: 6 💬
5(3beta, 5beta, 25R)-spirostan-3-ol----1件: 6 💬
6(3ß, 5ß, 25R)-spirostan-3-ol----1件: 6 💬
7(6S)-6-{propyl-[2-[2-thienyl]ethyl]amino}-5,6,7,8-tetrahydro-1-naphtalenol----1件: 6 💬
8(minus)-L-alpha-hydrazino-3,4-dihydroxy-alpha-methylbenzenepropanoic acid monohydrate----1件: 6 💬
9(R)-troloxamide quinone----1件: 6 💬
10(S)- 2- Amino- 4,5,6,7- tetrahydro- 6- (propylamino)benzothiazol----1件: 6 💬
11(S)-(+)-2-(4-(3-fluorobenzyl)oxybenzyl)aminopropanamide methanesulfonate----1件: 6 💬
120 mg tropicamide1件: Tropicamide1件: Tropicamide 💬 5件: CHRM1,
CHRM2,
CHRM3,
CHRM4,
CHRM5 💬
14件: Alzheimer disease, Calcium signaling pathway, Cholinergic synapse, Gastric acid secretion, Insulin secretion, Neuroactive ligand signaling, Neuroactive ligand-receptor interaction, PI3K-Akt signaling pathway, Pancreatic secretion, Pathways of neurodegeneration - multiple diseases, Regulation of actin cytoskeleton, Salivary secretion, Taste transduction, cAMP signaling pathway 💬1件: 6 💬
130.04 mg Lu AE04621----1件: 6 💬
140.08 mg Lu AE04621----1件: 6 💬
150.2 mg Lu AE04621----1件: 6 💬
160.3 mg tropicamide1件: Tropicamide1件: Tropicamide 💬 5件: CHRM1,
CHRM2,
CHRM3,
CHRM4,
CHRM5 💬
14件: Alzheimer disease, Calcium signaling pathway, Cholinergic synapse, Gastric acid secretion, Insulin secretion, Neuroactive ligand signaling, Neuroactive ligand-receptor interaction, PI3K-Akt signaling pathway, Pancreatic secretion, Pathways of neurodegeneration - multiple diseases, Regulation of actin cytoskeleton, Salivary secretion, Taste transduction, cAMP signaling pathway 💬1件: 6 💬
170.4 mg Lu AE04621----1件: 6 💬
180.5~1ug/kg/min remifentanil combined with 0.2~0.5mg/kg/h esketamine for the physiological testing phase of DBS surgery.2件: Esketamine,
Remifentanil
4件: Remifentanil hydrochloride ,
Esketamine ,
Remifentanil ,
Esketamine hydrochloride 💬
6件: GRIN1,
GRIN2A,
GRIN2B,
GRIN2C,
GRIN2D,
OPRM1 💬
24件: Alcoholism, Alzheimer disease, Amphetamine addiction, Amyotrophic lateral sclerosis, Calcium signaling pathway, Circadian entrainment, Cocaine addiction, Dopaminergic synapse, Estrogen signaling pathway, Glutamatergic synapse, Hormone signaling, Huntington disease, Long-term potentiation, Morphine addiction, Neuroactive ligand signaling, Neuroactive ligand-receptor interaction, Nicotine addiction, Pathways of neurodegeneration - multiple diseases, Prion disease, Rap1 signaling pathway, Ras signaling pathway, Spinocerebellar ataxia, Systemic lupus erythematosus, cAMP signaling pathway 💬1件: 6 💬
190.6 mg Lu AE04621----1件: 6 💬
200.8 mg Lu AE04621----1件: 6 💬
210.9% saline----2件: 6, 70 💬
220.9% sodium chloride1件: Sodium chloride1件: Sodium chloride 💬 --5件: 6, 14, 51, 53, 96 💬
230.9% sodium chloride (normal saline)1件: Sodium chloride1件: Sodium chloride 💬 --2件: 6, 85 💬
2400000----2件: 6, 96 💬
25000000----1件: 6 💬
26009-0----1件: 6 💬
27009-1----1件: 6 💬
28009-2----1件: 6 💬
29009-3----1件: 6 💬
30009-4----1件: 6 💬
31009-5----1件: 6 💬
32009-A0----1件: 6 💬
33009-A1----1件: 6 💬
34009-A2----1件: 6 💬
35009-A3----1件: 6 💬
361 mg QD to 15 mg QD PF-06649751----1件: 6 💬
371 mg QD to 7 mg QD PF-06649751 (if de-escalated in parent study)----1件: 6 💬
381 mg tropicamide1件: Tropicamide1件: Tropicamide 💬 5件: CHRM1,
CHRM2,
CHRM3,
CHRM4,
CHRM5 💬
14件: Alzheimer disease, Calcium signaling pathway, Cholinergic synapse, Gastric acid secretion, Insulin secretion, Neuroactive ligand signaling, Neuroactive ligand-receptor interaction, PI3K-Akt signaling pathway, Pancreatic secretion, Pathways of neurodegeneration - multiple diseases, Regulation of actin cytoskeleton, Salivary secretion, Taste transduction, cAMP signaling pathway 💬1件: 6 💬
391. Tesofensine (NS 2330)1件: Tesofensine---1件: 6 💬
401.0 mg Lu AE04621----1件: 6 💬
411.0 mg rasagiline mesylate1件: Rasagiline3件: Rasagiline mesylate ,
Rasagiline ,
Rasagiline tartrate 💬
1件: MAOB 💬 13件: Alcoholism, Amphetamine addiction, Arginine and proline metabolism, Cocaine addiction, Dopaminergic synapse, Drug metabolism - cytochrome P450, Glycine, serine and threonine metabolism, Histidine metabolism, Parkinson disease, Phenylalanine metabolism, Serotonergic synapse, Tryptophan metabolism, Tyrosine metabolism 💬1件: 6 💬
421.2 mg Lu AE04621----1件: 6 💬
43100----2件: 6, 97 💬
4411C-MC1----2件: 6, 13 💬
4511C-Methylreboxetine (11C-MRB)----2件: 6, 17 💬
4611C-PBR28----2件: 6, 13 💬
4711C-PiB----2件: 6, 13 💬
4811C-PS13----2件: 6, 13 💬
4911C-Raclopride1件: Raclopride---1件: 6 💬
50125----1件: 6 💬
5113N-Ammonia1件: Ammonia1件: Ammonia solution, strong 💬 --2件: 6, 17 💬
5215 mg QD de-escalated to 7 mg QD PF-06649751 in parent study remain at 7 mg QD----1件: 6 💬
5315 mg QD PF-06649751----1件: 6 💬
5415-0 H20----2件: 6, 19 💬
55150% of their routine home dopaminergic medications dose right in the clinic----1件: 6 💬
5615O H2O----1件: 6 💬
5718-FDTBZ----1件: 6 💬
5818F florbetaben----1件: 6 💬
5918F- DTBZ----1件: 6 💬
6018F-AV-133----1件: 6 💬
6118F-AV-45----2件: 6, 127 💬
6218F-DOPA----3件: 6, 17, 75 💬
6318F-DOPA PET----1件: 6 💬
6418F-Dopamine1件: Dopamine2件: Dopamine hydrochloride ,
Dopamine 💬
5件: DRD1,
DRD2,
DRD3,
DRD4,
DRD5 💬
13件: Alcoholism, Amphetamine addiction, Calcium signaling pathway, Cocaine addiction, Dopaminergic synapse, Gap junction, Hormone signaling, Morphine addiction, Neuroactive ligand signaling, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, cAMP signaling pathway 💬2件: 6, 17 💬
6518F-DTBZ----1件: 6 💬
6618F-DTBZ AV-133----1件: 6 💬
6718F-FDG----3件: 6, 127, 300 💬
6818f-florbetaben----1件: 6 💬
6918F-Fluoro-L-dopa----1件: 6 💬
7018F-MFBG----1件: 6 💬
7118F-OP-801----3件: 2, 6, 13 💬
7218F-SMBT-1----1件: 6 💬
731[(6- Allyl- 8beta- erg----1件: 6 💬
741[(6- Allyl- 8beta- ergolinyl)carbonyl]- 1- [3- (dimethylamino)propyl]-----1件: 6 💬
751[(6- Allyl- 8beta- ergolinyl)carbonyl]- 1- [3- (dimethylamino)propyl]- 3- ethylurea----1件: 6 💬
761[(6- Allyl- 8ß- erg----1件: 6 💬
771[(6- Allyl- 8ß- ergolinyl)carbonyl]- 1- [3- (dimethylamino)propyl]-----1件: 6 💬
781[(6- Allyl- 8ß- ergolinyl)carbonyl]- 1- [3- (dimethylamino)propyl]- 3- ethylurea----1件: 6 💬
792 mg perampanel1件: Perampanel2件: Perampanel ,
Perampanel hydrate 💬
4件: GRIA1,
GRIA2,
GRIA3,
GRIA4 💬
17件: Amphetamine addiction, Amyotrophic lateral sclerosis, Circadian entrainment, Cocaine addiction, Dopaminergic synapse, Glutamatergic synapse, Huntington disease, Long-term depression, Long-term potentiation, Neuroactive ligand signaling, Neuroactive ligand-receptor interaction, Nicotine addiction, Pathways of neurodegeneration - multiple diseases, Retrograde endocannabinoid signaling, Spinocerebellar ataxia, Transcriptional misregulation in cancer, cAMP signaling pathway 💬1件: 6 💬
802,5-Dichloro-3-(5-(3,4-dihydroxy-5-nitrophenyl)-1,2,4-oxadiazol-3-yl)-4,6-dimethylpyridine-1-oxide----1件: 6 💬
812-[[[(2R)-1-[1-[(4-CHLORO-3-METHYLPHENYL)METHYL]-4- PIPERIDINYL]-5-OXO-2-PYRROLIDINYL]CARBONYL]AMINO]- N,N,6-TRIMETHYL-4-PYRIDINECARBOXAMIDE,DIHYDROCHLORIDE----2件: 6, 162 💬
82200 mg BIA 6-5121件: BIA---1件: 6 💬
83207-3120----1件: 6 💬
84240mg Amantadine HCl ER tablets1件: Amantadine2件: Amantadine hydrochloride ,
Amantadine 💬
5件: GRIN1,
GRIN2A,
GRIN2B,
GRIN2C,
GRIN2D 💬
21件: Alcoholism, Alzheimer disease, Amphetamine addiction, Amyotrophic lateral sclerosis, Calcium signaling pathway, Circadian entrainment, Cocaine addiction, Dopaminergic synapse, Glutamatergic synapse, Huntington disease, Long-term potentiation, Neuroactive ligand signaling, Neuroactive ligand-receptor interaction, Nicotine addiction, Pathways of neurodegeneration - multiple diseases, Prion disease, Rap1 signaling pathway, Ras signaling pathway, Spinocerebellar ataxia, Systemic lupus erythematosus, cAMP signaling pathway 💬1件: 6 💬
8525 mg BIA9 1067----1件: 6 💬
8625 mg Ongentys----1件: 6 💬
8725330----1件: 6 💬
883 mg QD to 15 mg QD PF-06649751----1件: 6 💬
893 mg QD to 7 mg QD PF-06649751 (de-escalated in parent study)----1件: 6 💬
903 mg tropicamide1件: Tropicamide1件: Tropicamide 💬 5件: CHRM1,
CHRM2,
CHRM3,
CHRM4,
CHRM5 💬
14件: Alzheimer disease, Calcium signaling pathway, Cholinergic synapse, Gastric acid secretion, Insulin secretion, Neuroactive ligand signaling, Neuroactive ligand-receptor interaction, PI3K-Akt signaling pathway, Pancreatic secretion, Pathways of neurodegeneration - multiple diseases, Regulation of actin cytoskeleton, Salivary secretion, Taste transduction, cAMP signaling pathway 💬1件: 6 💬
913- (9,10- Didehydro- 6- methyl- 8?- ergolinyl)-1,1- diethylurea hydrogenmaleate----1件: 6 💬
923-(3,4-Dihydroxyphenyl)-L-alanine1件: Alanine1件: Alanine 💬 --1件: 6 💬
93320mg Amantadine HCl ER tablets1件: Amantadine2件: Amantadine hydrochloride ,
Amantadine 💬
5件: GRIN1,
GRIN2A,
GRIN2B,
GRIN2C,
GRIN2D 💬
21件: Alcoholism, Alzheimer disease, Amphetamine addiction, Amyotrophic lateral sclerosis, Calcium signaling pathway, Circadian entrainment, Cocaine addiction, Dopaminergic synapse, Glutamatergic synapse, Huntington disease, Long-term potentiation, Neuroactive ligand signaling, Neuroactive ligand-receptor interaction, Nicotine addiction, Pathways of neurodegeneration - multiple diseases, Prion disease, Rap1 signaling pathway, Ras signaling pathway, Spinocerebellar ataxia, Systemic lupus erythematosus, cAMP signaling pathway 💬1件: 6 💬
944 mg perampanel1件: Perampanel2件: Perampanel ,
Perampanel hydrate 💬
4件: GRIA1,
GRIA2,
GRIA3,
GRIA4 💬
17件: Amphetamine addiction, Amyotrophic lateral sclerosis, Circadian entrainment, Cocaine addiction, Dopaminergic synapse, Glutamatergic synapse, Huntington disease, Long-term depression, Long-term potentiation, Neuroactive ligand signaling, Neuroactive ligand-receptor interaction, Nicotine addiction, Pathways of neurodegeneration - multiple diseases, Retrograde endocannabinoid signaling, Spinocerebellar ataxia, Transcriptional misregulation in cancer, cAMP signaling pathway 💬1件: 6 💬
955-year Follow-up DPA-714-PET/MRI----1件: 6 💬
9650 mg BIA 9 10671件: BIA---1件: 6 💬
9750 mg Ongentys----1件: 6 💬
986-[18F]Fluorodopa----1件: 6 💬
996-[18F]Fluorodopamine----1件: 6 💬
1006abeta - apomorphine-10,11-diol hydrochloride hemihydrate1件: Apomorphine2件: Apomorphine hydrochloride ,
Apomorphine 💬
2件: DRD1,
DRD2 💬
13件: Alcoholism, Amphetamine addiction, Calcium signaling pathway, Cocaine addiction, Dopaminergic synapse, Gap junction, Hormone signaling, Morphine addiction, Neuroactive ligand signaling, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, cAMP signaling pathway 💬1件: 6 💬
1016aß - apomorphine-10,11-diol hydrochloride hemihydrate1件: Apomorphine2件: Apomorphine hydrochloride ,
Apomorphine 💬
2件: DRD1,
DRD2 💬
13件: Alcoholism, Amphetamine addiction, Calcium signaling pathway, Cocaine addiction, Dopaminergic synapse, Gap junction, Hormone signaling, Morphine addiction, Neuroactive ligand signaling, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, cAMP signaling pathway 💬1件: 6 💬
1027 mg QD to 15 mg QD PF-06649751----1件: 6 💬
1037 mg QD to 7 mg QD PF-06649751 (de-escalated in parent study)----1件: 6 💬
1047-beta-Hydroxyepiandrosterone1件: 7-beta-Hydroxyepiandrosterone---1件: 6 💬
10575----1件: 6 💬
106[023145028]----1件: 6 💬
107[043906039]----1件: 6 💬
108[11C]-CS1P1----1件: 6 💬
109[11C]-PIB----1件: 6 💬
110[11C]MODAG-005----2件: 6, 17 💬
111[11C]PBR28----1件: 6 💬
112[11C]PXT012253----1件: 6 💬
113[11C]SMW139----1件: 6 💬
114[123I] 5-IA----1件: 6 💬
115[123I] IBVM and SPECT imaging----1件: 6 💬
116[123I] mZINT injection and serial dynamic SPECT imaging----1件: 6 💬
117[123I]-IBVM----1件: 6 💬
118[123I]-IBZM imaging----1件: 6 💬
119[123I]B-CIT----1件: 6 💬
120[123I]B-CIT SPECT imaging----1件: 6 💬
121[123I]beta CIT----1件: 6 💬
122[123I]beta CIT and SPECT imaging----1件: 6 💬
123[123I]beta-CIT----1件: 6 💬
124[123I]beta-CIT and SPECT imaging----1件: 6 💬
125[123I]CLINDE----2件: 6, 13 💬
126[123I]MNI-420----2件: 6, 8 💬
127[123I]ß CIT----1件: 6 💬
128[123I]ß CIT and SPECT imaging----1件: 6 💬
129[123I]ß-CIT----1件: 6 💬
130[123I]ß-CIT and SPECT imaging----1件: 6 💬
131[14C]-BIA 9-10671件: BIA---1件: 6 💬
132[15O]H2O----1件: 6 💬
133[18683-91-5]----1件: 6 💬
134[18F] AV-133 PET Imaging----1件: 6 💬
135[18F] CFPyPB----1件: 6 💬
136[18F] LBT-999----1件: 6 💬
137[18F] LBT-999 PET----1件: 6 💬
138[18F] PBR06----2件: 6, 13 💬
139[18F] PI-2620----1件: 6 💬
140[18F]-(E)-N-(3-iodoprop-2-enyl)-2b-carbofluoroethoxy-3b-(4'-methylphenyl)nortropane----1件: 6 💬
141[18F]-FEPPA----2件: 6, 13 💬
142[18F]DPA-714 PET scan----1件: 6 💬
143[18F]FDOPA----2件: 6, 17 💬
144[18F]FDOPA PET/CT----1件: 6 💬
145[18F]FE-PE2I----1件: 6 💬
146[18F]FPEB----3件: 6, 8, 206 💬
147[18F]MC225----1件: 6 💬
148[18F]MK-0947----1件: 6 💬
149[18F]MK-9470----1件: 6 💬
150[18F]MNI-1126----1件: 6 💬
151[18F]MNI-1216----1件: 6 💬
152[18F]MPPF----1件: 6 💬
153[18F]NOS----1件: 6 💬
154[18F]P17-059----1件: 6 💬
155[18F]PI-2620----2件: 6, 127 💬
156[18F]T807 ([18F]MNI-777)----2件: 5, 6 💬
157[18F]UCB-2897----1件: 6 💬
158[21CFR640.30] Plasma from 18 - 25 year old volunteer donors----1件: 6 💬
159[6036937.00.01]----1件: 6 💬
160[ABBV-951]----1件: 6 💬
161[ANVS401]----1件: 6 💬
162[APL-130277]----1件: 6 💬
163[BIA 9-1067]1件: BIA---1件: 6 💬
164[BIIB054]----1件: 6 💬
165[citicolin]----1件: 6 💬
166[CVL-751]----1件: 6 💬
167[DaTSCAN]----1件: 6 💬
168[DNL151, DN0001575, DN1575]----1件: 6 💬
169[DNL151]----1件: 6 💬
170[F-18] Fluorodopa Positron Emission Tomography----1件: 6 💬
171[F-18]DPA714 administration IV----1件: 6 💬
172[IPX203]----1件: 6 💬
173[IR CD-LD]----1件: 6 💬
174[IRL790]----1件: 6 💬
175[JM-010]----1件: 6 💬
176[JNJ31-31001074]----1件: 6 💬
177[N04BA]----1件: 6 💬
178[N06AX26]----1件: 6 💬
179[NA]----34件: 3, 6, 11, 13, 14, 19, 28, 35, 41, 46, 49, 50, 53, 57, 62, 63, 65, 75, 79, 85, 90, 96, 97, 98, 113, 127, 162, 195, 223, 229, 251, 294, 299, 302 💬
180[ND0612]----1件: 6 💬
181[RO7046015]----1件: 6 💬
182[TD-9855]----2件: 6, 17 💬
183[UCB0599]----1件: 6 💬
184[¹8F]MODAG-009 PET imaging----2件: 6, 17 💬
185A-DOPAMINE1件: Dopamine2件: Dopamine hydrochloride ,
Dopamine 💬
5件: DRD1,
DRD2,
DRD3,
DRD4,
DRD5 💬
13件: Alcoholism, Amphetamine addiction, Calcium signaling pathway, Cocaine addiction, Dopaminergic synapse, Gap junction, Hormone signaling, Morphine addiction, Neuroactive ligand signaling, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, cAMP signaling pathway 💬1件: 6 💬
186Aadipose-Derived Mesenchymal Stem Cells----1件: 6 💬
187AAV2-GDNF----1件: 6 💬
188AAV2-GDNF gene therapy----2件: 6, 17 💬
189AAV2-hAADC----1件: 6 💬
190AB-1005----1件: 6 💬
191AB1010----6件: 2, 5, 6, 13, 46, 96 💬
192ABBV-0805----1件: 6 💬
193ABBV-951----1件: 6 💬
194Abdominal compression----2件: 6, 17 💬
195ABT-SLV187----1件: 6 💬
196Acamprosate1件: Acamprosate2件: Acamprosate calcium ,
Acamprosate 💬
5件: GRIN1,
GRIN2A,
GRIN2B,
GRIN2C,
GRIN2D 💬
21件: Alcoholism, Alzheimer disease, Amphetamine addiction, Amyotrophic lateral sclerosis, Calcium signaling pathway, Circadian entrainment, Cocaine addiction, Dopaminergic synapse, Glutamatergic synapse, Huntington disease, Long-term potentiation, Neuroactive ligand signaling, Neuroactive ligand-receptor interaction, Nicotine addiction, Pathways of neurodegeneration - multiple diseases, Prion disease, Rap1 signaling pathway, Ras signaling pathway, Spinocerebellar ataxia, Systemic lupus erythematosus, cAMP signaling pathway 💬3件: 2, 6, 206 💬
197Accordion Pill Carbidopa/Levodopa2件: Carbidopa,
Levodopa
2件: Levodopa ,
Carbidopa 💬
6件: DDC,
DRD1,
DRD2,
DRD3,
DRD4,
DRD5 💬
17件: Alcoholism, Amphetamine addiction, Calcium signaling pathway, Cocaine addiction, Dopaminergic synapse, Gap junction, Hormone signaling, Morphine addiction, Neuroactive ligand signaling, Neuroactive ligand-receptor interaction, Parkinson disease, Phenylalanine metabolism, Rap1 signaling pathway, Serotonergic synapse, Tryptophan metabolism, Tyrosine metabolism, cAMP signaling pathway 💬1件: 6 💬
198Accordion Pill ¿ Carbidopa/Levodopa 50/400 mg2件: Carbidopa,
Levodopa
2件: Levodopa ,
Carbidopa 💬
6件: DDC,
DRD1,
DRD2,
DRD3,
DRD4,
DRD5 💬
17件: Alcoholism, Amphetamine addiction, Calcium signaling pathway, Cocaine addiction, Dopaminergic synapse, Gap junction, Hormone signaling, Morphine addiction, Neuroactive ligand signaling, Neuroactive ligand-receptor interaction, Parkinson disease, Phenylalanine metabolism, Rap1 signaling pathway, Serotonergic synapse, Tryptophan metabolism, Tyrosine metabolism, cAMP signaling pathway 💬1件: 6 💬
199Accordion Pill ¿ Carbidopa/Levodopa 50/500 mg2件: Carbidopa,
Levodopa
2件: Levodopa ,
Carbidopa 💬
6件: DDC,
DRD1,
DRD2,
DRD3,
DRD4,
DRD5 💬
17件: Alcoholism, Amphetamine addiction, Calcium signaling pathway, Cocaine addiction, Dopaminergic synapse, Gap junction, Hormone signaling, Morphine addiction, Neuroactive ligand signaling, Neuroactive ligand-receptor interaction, Parkinson disease, Phenylalanine metabolism, Rap1 signaling pathway, Serotonergic synapse, Tryptophan metabolism, Tyrosine metabolism, cAMP signaling pathway 💬1件: 6 💬
200Accordion Pill? Carbidopa/Levodopa 50/400 mg2件: Carbidopa,
Levodopa
2件: Levodopa ,
Carbidopa 💬
6件: DDC,
DRD1,
DRD2,
DRD3,
DRD4,
DRD5 💬
17件: Alcoholism, Amphetamine addiction, Calcium signaling pathway, Cocaine addiction, Dopaminergic synapse, Gap junction, Hormone signaling, Morphine addiction, Neuroactive ligand signaling, Neuroactive ligand-receptor interaction, Parkinson disease, Phenylalanine metabolism, Rap1 signaling pathway, Serotonergic synapse, Tryptophan metabolism, Tyrosine metabolism, cAMP signaling pathway 💬1件: 6 💬
201Accordion Pill? Carbidopa/Levodopa 50/500 mg2件: Carbidopa,
Levodopa
2件: Levodopa ,
Carbidopa 💬
6件: DDC,
DRD1,
DRD2,
DRD3,
DRD4,
DRD5 💬
17件: Alcoholism, Amphetamine addiction, Calcium signaling pathway, Cocaine addiction, Dopaminergic synapse, Gap junction, Hormone signaling, Morphine addiction, Neuroactive ligand signaling, Neuroactive ligand-receptor interaction, Parkinson disease, Phenylalanine metabolism, Rap1 signaling pathway, Serotonergic synapse, Tryptophan metabolism, Tyrosine metabolism, cAMP signaling pathway 💬1件: 6 💬
202Accordion Pill¿ Carbidopa/levodopa2件: Carbidopa,
Levodopa
2件: Levodopa ,
Carbidopa 💬
6件: DDC,
DRD1,
DRD2,
DRD3,
DRD4,
DRD5 💬
17件: Alcoholism, Amphetamine addiction, Calcium signaling pathway, Cocaine addiction, Dopaminergic synapse, Gap junction, Hormone signaling, Morphine addiction, Neuroactive ligand signaling, Neuroactive ligand-receptor interaction, Parkinson disease, Phenylalanine metabolism, Rap1 signaling pathway, Serotonergic synapse, Tryptophan metabolism, Tyrosine metabolism, cAMP signaling pathway 💬1件: 6 💬
203Accordion Pill™ Carbidopa/Levodopa2件: Carbidopa,
Levodopa
2件: Levodopa ,
Carbidopa 💬
6件: DDC,
DRD1,
DRD2,
DRD3,
DRD4,
DRD5 💬
17件: Alcoholism, Amphetamine addiction, Calcium signaling pathway, Cocaine addiction, Dopaminergic synapse, Gap junction, Hormone signaling, Morphine addiction, Neuroactive ligand signaling, Neuroactive ligand-receptor interaction, Parkinson disease, Phenylalanine metabolism, Rap1 signaling pathway, Serotonergic synapse, Tryptophan metabolism, Tyrosine metabolism, cAMP signaling pathway 💬1件: 6 💬
204Accordion Pill™ Carbidopa/Levodopa 50/400 mg2件: Carbidopa,
Levodopa
2件: Levodopa ,
Carbidopa 💬
6件: DDC,
DRD1,
DRD2,
DRD3,
DRD4,
DRD5 💬
17件: Alcoholism, Amphetamine addiction, Calcium signaling pathway, Cocaine addiction, Dopaminergic synapse, Gap junction, Hormone signaling, Morphine addiction, Neuroactive ligand signaling, Neuroactive ligand-receptor interaction, Parkinson disease, Phenylalanine metabolism, Rap1 signaling pathway, Serotonergic synapse, Tryptophan metabolism, Tyrosine metabolism, cAMP signaling pathway 💬1件: 6 💬
205Accordion Pill™ Carbidopa/Levodopa 50/500 mg2件: Carbidopa,
Levodopa
2件: Levodopa ,
Carbidopa 💬
6件: DDC,
DRD1,
DRD2,
DRD3,
DRD4,
DRD5 💬
17件: Alcoholism, Amphetamine addiction, Calcium signaling pathway, Cocaine addiction, Dopaminergic synapse, Gap junction, Hormone signaling, Morphine addiction, Neuroactive ligand signaling, Neuroactive ligand-receptor interaction, Parkinson disease, Phenylalanine metabolism, Rap1 signaling pathway, Serotonergic synapse, Tryptophan metabolism, Tyrosine metabolism, cAMP signaling pathway 💬1件: 6 💬
206Acetate1件: Acetate---52件: 1, 2, 6, 10, 11, 13, 22, 35, 40, 46, 49, 51, 60, 63, 64, 65, 66, 67, 70, 71, 73, 75, 76, 77, 78, 79, 81, 83, 85, 86, 88, 89, 90, 96, 97, 113, 145, 156, 158, 162, 171, 206, 222, 223, 224, 225, 227, 235, 251, 265, 298, 299 💬
207Acetylcysteine1件: Acetylcysteine1件: Acetylcysteine 💬 --25件: 2, 6, 13, 19, 20, 21, 34, 49, 51, 53, 58, 63, 85, 90, 94, 97, 111, 164, 193, 233, 296, 298, 299, 303, 337 💬
208ACI-7104.056 at Dose A----1件: 6 💬
209ACI-7104.056 at Dose B (optional)----1件: 6 💬
210ACI-7104.056 at Dose C (optional)----1件: 6 💬
211ACP-103----1件: 6 💬
212ACR325----1件: 6 💬
213ActiMyo recording----1件: 6 💬
214Active comparator----3件: 6, 46, 96 💬
215Active drug (BIIB014) at 10, 30, 100, or 300 mg once daily.----1件: 6 💬
216Active drug: pimavanserin 17mg (2 strength tablets)1件: Pimavanserin1件: Pimavanserin tartrate 💬 2件: HTR2A,
HTR2C 💬
6件: Calcium signaling pathway, Gap junction, Inflammatory mediator regulation of TRP channels, Neuroactive ligand signaling, Neuroactive ligand-receptor interaction, Serotonergic synapse 💬1件: 6 💬
217Active Investigational Treatment ENT-01----1件: 6 💬
218Active tDCS----1件: 6 💬
219Active tPCS----1件: 6 💬
220Active Transcranial Direct Current Stimulation----1件: 6 💬
221Adaptor: Hakko Adaptor----1件: 6 💬
222Adjuvant without active component----2件: 6, 17 💬
223Administration of Carbidopa/levodopa2件: Carbidopa,
Levodopa
2件: Levodopa ,
Carbidopa 💬
6件: DDC,
DRD1,
DRD2,
DRD3,
DRD4,
DRD5 💬
17件: Alcoholism, Amphetamine addiction, Calcium signaling pathway, Cocaine addiction, Dopaminergic synapse, Gap junction, Hormone signaling, Morphine addiction, Neuroactive ligand signaling, Neuroactive ligand-receptor interaction, Parkinson disease, Phenylalanine metabolism, Rap1 signaling pathway, Serotonergic synapse, Tryptophan metabolism, Tyrosine metabolism, cAMP signaling pathway 💬2件: 6, 17 💬
224Administration of stable isotope-labelled leucine-1件: Leucine1件: Leucine 💬 --1件: 6 💬
225ADS-5102----2件: 6, 13 💬
226ADS-5102 (extended release amantadine HCl)1件: Amantadine2件: Amantadine hydrochloride ,
Amantadine 💬
5件: GRIN1,
GRIN2A,
GRIN2B,
GRIN2C,
GRIN2D 💬
21件: Alcoholism, Alzheimer disease, Amphetamine addiction, Amyotrophic lateral sclerosis, Calcium signaling pathway, Circadian entrainment, Cocaine addiction, Dopaminergic synapse, Glutamatergic synapse, Huntington disease, Long-term potentiation, Neuroactive ligand signaling, Neuroactive ligand-receptor interaction, Nicotine addiction, Pathways of neurodegeneration - multiple diseases, Prion disease, Rap1 signaling pathway, Ras signaling pathway, Spinocerebellar ataxia, Systemic lupus erythematosus, cAMP signaling pathway 💬1件: 6 💬
227ADX48621----1件: 6 💬
228AFFITOPE® PD01A----1件: 6 💬
229AFFITOPE® PD01A + Adjuvant----2件: 6, 17 💬
230AFQ056----3件: 6, 8, 206 💬
231AFQ056 with L-dopa----1件: 6 💬
232AFQ065----1件: 6 💬
233AGB101----1件: 6 💬
234Agomelatine1件: Agomelatine1件: Agomelatine 💬 3件: HTR2C,
MTNR1A,
MTNR1B 💬
7件: Calcium signaling pathway, Circadian entrainment, Gap junction, Inflammatory mediator regulation of TRP channels, Neuroactive ligand signaling, Neuroactive ligand-receptor interaction, Serotonergic synapse 💬1件: 6 💬
235Agomelatine or PIacebo1件: Agomelatine1件: Agomelatine 💬 3件: HTR2C,
MTNR1A,
MTNR1B 💬
7件: Calcium signaling pathway, Circadian entrainment, Gap junction, Inflammatory mediator regulation of TRP channels, Neuroactive ligand signaling, Neuroactive ligand-receptor interaction, Serotonergic synapse 💬1件: 6 💬
236AKST4290----2件: 6, 162 💬
237Alanine1件: Alanine1件: Alanine 💬 --8件: 6, 13, 70, 94, 97, 251, 298, 299 💬
238ALC01 therapy----1件: 6 💬
239Alcoholic drink----1件: 6 💬
240AlloEx----1件: 6 💬
241Allogeneic bone marrow-derived mesenchymal stem cells----1件: 6 💬
242Allogeneic bone marrow-derived MSCs (1 x 10 6 MSC/kg)----1件: 6 💬
243Allogeneic bone marrow-derived MSCs (10 x 10 6 MSC/kg)----1件: 6 💬
244Allogeneic bone marrow-derived MSCs (3 x 10 6 MSC/kg)----1件: 6 💬
245Allogeneic bone marrow-derived MSCs (6 x 10 6 MSC/kg)----1件: 6 💬
246Allogeneic dopaminergic neural precursor cell(iDAP)----1件: 6 💬
247Allogeneic dopaminergic neural precursor cell(NCR201)----1件: 6 💬
248Allogeneic embryonic stem cell-derived ventral midbrain dopaminergic progenitor cells----1件: 6 💬
249Allogenic embryonic stem cell-derived A9 dopamine progenitor cell (A9-DPC) High Dose1件: Dopamine2件: Dopamine hydrochloride ,
Dopamine 💬
5件: DRD1,
DRD2,
DRD3,
DRD4,
DRD5 💬
13件: Alcoholism, Amphetamine addiction, Calcium signaling pathway, Cocaine addiction, Dopaminergic synapse, Gap junction, Hormone signaling, Morphine addiction, Neuroactive ligand signaling, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, cAMP signaling pathway 💬1件: 6 💬
250Allogenic embryonic stem cell-derived A9 dopamine progenitor cell (A9-DPC) Low Dose1件: Dopamine2件: Dopamine hydrochloride ,
Dopamine 💬
5件: DRD1,
DRD2,
DRD3,
DRD4,
DRD5 💬
13件: Alcoholism, Amphetamine addiction, Calcium signaling pathway, Cocaine addiction, Dopaminergic synapse, Gap junction, Hormone signaling, Morphine addiction, Neuroactive ligand signaling, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, cAMP signaling pathway 💬1件: 6 💬
251Allogenic embryonic stem cellderived A9 dopamine progenitor cell (A9-DPC)_High Dose1件: Dopamine2件: Dopamine hydrochloride ,
Dopamine 💬
5件: DRD1,
DRD2,
DRD3,
DRD4,
DRD5 💬
13件: Alcoholism, Amphetamine addiction, Calcium signaling pathway, Cocaine addiction, Dopaminergic synapse, Gap junction, Hormone signaling, Morphine addiction, Neuroactive ligand signaling, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, cAMP signaling pathway 💬1件: 6 💬
252Allogenic embryonic stem cellderived A9 dopamine progenitor cell (A9-DPC)_Low Dose1件: Dopamine2件: Dopamine hydrochloride ,
Dopamine 💬
5件: DRD1,
DRD2,
DRD3,
DRD4,
DRD5 💬
13件: Alcoholism, Amphetamine addiction, Calcium signaling pathway, Cocaine addiction, Dopaminergic synapse, Gap junction, Hormone signaling, Morphine addiction, Neuroactive ligand signaling, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, cAMP signaling pathway 💬1件: 6 💬
253Allopregnanolone----2件: 6, 205 💬
254Allopurinol1件: Allopurinol2件: Allopurinol ,
Allopurinol sodium 💬
1件: XDH 💬 4件: Caffeine metabolism, Drug metabolism - other enzymes, Peroxisome, Purine metabolism 💬7件: 6, 46, 57, 60, 66, 96, 97 💬
255ALN-SNCA----1件: 6 💬
256Alovudine1件: Alovudine1件: Alovudine 💬 --1件: 6 💬
257Altanserin1件: Altanserin---1件: 6 💬
258Alternating, 10 sec High-Frequency, 10 sec Low-Frequency Stimulation----1件: 6 💬
259Alternating, 10 sec High-Frequency, 50 sec Low-Frequency Stimulation----1件: 6 💬
260Alternating, 50 sec High-Frequency, 10 sec Low-Frequency Stimulation----1件: 6 💬
261Alternating, 50 sec High-Frequency, 50 sec Low-Frequency Stimulation----1件: 6 💬
262Altropane1件: Altropane---1件: 6 💬
263Altropane (123I) Injection1件: Altropane---1件: 6 💬
264ALTROPANE®1件: Altropane---1件: 6 💬
265Amantadin-ratiopharm 100mg----1件: 6 💬
266Amantadine1件: Amantadine2件: Amantadine hydrochloride ,
Amantadine 💬
5件: GRIN1,
GRIN2A,
GRIN2B,
GRIN2C,
GRIN2D 💬
21件: Alcoholism, Alzheimer disease, Amphetamine addiction, Amyotrophic lateral sclerosis, Calcium signaling pathway, Circadian entrainment, Cocaine addiction, Dopaminergic synapse, Glutamatergic synapse, Huntington disease, Long-term potentiation, Neuroactive ligand signaling, Neuroactive ligand-receptor interaction, Nicotine addiction, Pathways of neurodegeneration - multiple diseases, Prion disease, Rap1 signaling pathway, Ras signaling pathway, Spinocerebellar ataxia, Systemic lupus erythematosus, cAMP signaling pathway 💬5件: 2, 6, 8, 13, 127 💬
267Amantadine (100mg) as add on therapy.1件: Amantadine2件: Amantadine hydrochloride ,
Amantadine 💬
5件: GRIN1,
GRIN2A,
GRIN2B,
GRIN2C,
GRIN2D 💬
21件: Alcoholism, Alzheimer disease, Amphetamine addiction, Amyotrophic lateral sclerosis, Calcium signaling pathway, Circadian entrainment, Cocaine addiction, Dopaminergic synapse, Glutamatergic synapse, Huntington disease, Long-term potentiation, Neuroactive ligand signaling, Neuroactive ligand-receptor interaction, Nicotine addiction, Pathways of neurodegeneration - multiple diseases, Prion disease, Rap1 signaling pathway, Ras signaling pathway, Spinocerebellar ataxia, Systemic lupus erythematosus, cAMP signaling pathway 💬1件: 6 💬
268Amantadine 300 mg1件: Amantadine2件: Amantadine hydrochloride ,
Amantadine 💬
5件: GRIN1,
GRIN2A,
GRIN2B,
GRIN2C,
GRIN2D 💬
21件: Alcoholism, Alzheimer disease, Amphetamine addiction, Amyotrophic lateral sclerosis, Calcium signaling pathway, Circadian entrainment, Cocaine addiction, Dopaminergic synapse, Glutamatergic synapse, Huntington disease, Long-term potentiation, Neuroactive ligand signaling, Neuroactive ligand-receptor interaction, Nicotine addiction, Pathways of neurodegeneration - multiple diseases, Prion disease, Rap1 signaling pathway, Ras signaling pathway, Spinocerebellar ataxia, Systemic lupus erythematosus, cAMP signaling pathway 💬1件: 6 💬
269Amantadine HCl ER1件: Amantadine2件: Amantadine hydrochloride ,
Amantadine 💬
5件: GRIN1,
GRIN2A,
GRIN2B,
GRIN2C,
GRIN2D 💬
21件: Alcoholism, Alzheimer disease, Amphetamine addiction, Amyotrophic lateral sclerosis, Calcium signaling pathway, Circadian entrainment, Cocaine addiction, Dopaminergic synapse, Glutamatergic synapse, Huntington disease, Long-term potentiation, Neuroactive ligand signaling, Neuroactive ligand-receptor interaction, Nicotine addiction, Pathways of neurodegeneration - multiple diseases, Prion disease, Rap1 signaling pathway, Ras signaling pathway, Spinocerebellar ataxia, Systemic lupus erythematosus, cAMP signaling pathway 💬1件: 6 💬
270Amantadine HCl Extended Release1件: Amantadine2件: Amantadine hydrochloride ,
Amantadine 💬
5件: GRIN1,
GRIN2A,
GRIN2B,
GRIN2C,
GRIN2D 💬
21件: Alcoholism, Alzheimer disease, Amphetamine addiction, Amyotrophic lateral sclerosis, Calcium signaling pathway, Circadian entrainment, Cocaine addiction, Dopaminergic synapse, Glutamatergic synapse, Huntington disease, Long-term potentiation, Neuroactive ligand signaling, Neuroactive ligand-receptor interaction, Nicotine addiction, Pathways of neurodegeneration - multiple diseases, Prion disease, Rap1 signaling pathway, Ras signaling pathway, Spinocerebellar ataxia, Systemic lupus erythematosus, cAMP signaling pathway 💬1件: 6 💬
271Amantadine HCl Extended Release Capsule1件: Amantadine2件: Amantadine hydrochloride ,
Amantadine 💬
5件: GRIN1,
GRIN2A,
GRIN2B,
GRIN2C,
GRIN2D 💬
21件: Alcoholism, Alzheimer disease, Amphetamine addiction, Amyotrophic lateral sclerosis, Calcium signaling pathway, Circadian entrainment, Cocaine addiction, Dopaminergic synapse, Glutamatergic synapse, Huntington disease, Long-term potentiation, Neuroactive ligand signaling, Neuroactive ligand-receptor interaction, Nicotine addiction, Pathways of neurodegeneration - multiple diseases, Prion disease, Rap1 signaling pathway, Ras signaling pathway, Spinocerebellar ataxia, Systemic lupus erythematosus, cAMP signaling pathway 💬1件: 6 💬
272AMANTADINE HYDROCHLORIDE1件: Amantadine2件: Amantadine hydrochloride ,
Amantadine 💬
5件: GRIN1,
GRIN2A,
GRIN2B,
GRIN2C,
GRIN2D 💬
21件: Alcoholism, Alzheimer disease, Amphetamine addiction, Amyotrophic lateral sclerosis, Calcium signaling pathway, Circadian entrainment, Cocaine addiction, Dopaminergic synapse, Glutamatergic synapse, Huntington disease, Long-term potentiation, Neuroactive ligand signaling, Neuroactive ligand-receptor interaction, Nicotine addiction, Pathways of neurodegeneration - multiple diseases, Prion disease, Rap1 signaling pathway, Ras signaling pathway, Spinocerebellar ataxia, Systemic lupus erythematosus, cAMP signaling pathway 💬2件: 6, 13 💬
273Amantadine hydrochloride (HCl)1件: Amantadine2件: Amantadine hydrochloride ,
Amantadine 💬
5件: GRIN1,
GRIN2A,
GRIN2B,
GRIN2C,
GRIN2D 💬
21件: Alcoholism, Alzheimer disease, Amphetamine addiction, Amyotrophic lateral sclerosis, Calcium signaling pathway, Circadian entrainment, Cocaine addiction, Dopaminergic synapse, Glutamatergic synapse, Huntington disease, Long-term potentiation, Neuroactive ligand signaling, Neuroactive ligand-receptor interaction, Nicotine addiction, Pathways of neurodegeneration - multiple diseases, Prion disease, Rap1 signaling pathway, Ras signaling pathway, Spinocerebellar ataxia, Systemic lupus erythematosus, cAMP signaling pathway 💬1件: 6 💬
274Amantadine sulfate1件: Amantadine2件: Amantadine hydrochloride ,
Amantadine 💬
5件: GRIN1,
GRIN2A,
GRIN2B,
GRIN2C,
GRIN2D 💬
21件: Alcoholism, Alzheimer disease, Amphetamine addiction, Amyotrophic lateral sclerosis, Calcium signaling pathway, Circadian entrainment, Cocaine addiction, Dopaminergic synapse, Glutamatergic synapse, Huntington disease, Long-term potentiation, Neuroactive ligand signaling, Neuroactive ligand-receptor interaction, Nicotine addiction, Pathways of neurodegeneration - multiple diseases, Prion disease, Rap1 signaling pathway, Ras signaling pathway, Spinocerebellar ataxia, Systemic lupus erythematosus, cAMP signaling pathway 💬1件: 6 💬
275AMBROSAN 60mg Tablets----1件: 6 💬
276Ambroxol1件: Ambroxol2件: Ambroxol hydrochloride ,
Ambroxol 💬
--3件: 2, 6, 19 💬
277AMBROXOL CLORIDRATO1件: Ambroxol2件: Ambroxol hydrochloride ,
Ambroxol 💬
--1件: 6 💬
278Ambroxol Hydrochloride1件: Ambroxol2件: Ambroxol hydrochloride ,
Ambroxol 💬
--2件: 6, 19 💬
279Ambroxol Hydrochloride (420mg)1件: Ambroxol2件: Ambroxol hydrochloride ,
Ambroxol 💬
--1件: 6 💬
280AMDX2011P----2件: 2, 6 💬
281Amino acid supplement----2件: 6, 46 💬
282Amino acids1件: Amino acids---6件: 6, 70, 90, 113, 240, 298 💬
283Ammonia1件: Ammonia1件: Ammonia solution, strong 💬 --6件: 6, 17, 86, 88, 251, 296 💬
284Amoxicillin1件: Amoxicillin3件: Amoxicillin ,
Amoxicillin sodium ,
Amoxicillin 💬
--9件: 6, 46, 63, 94, 96, 97, 222, 223, 299 💬
285Ampreloxetine1件: Ampreloxetine1件: Ampreloxetine 💬 2件: SLC6A2,
SLC6A4 💬
3件: Neuroactive ligand signaling, Serotonergic synapse, Synaptic vesicle cycle 💬2件: 6, 17 💬
286Ampreloxetine chydrochloride1件: Ampreloxetine1件: Ampreloxetine 💬 2件: SLC6A2,
SLC6A4 💬
3件: Neuroactive ligand signaling, Serotonergic synapse, Synaptic vesicle cycle 💬2件: 6, 17 💬
287Ampreloxetine hydrochloride1件: Ampreloxetine1件: Ampreloxetine 💬 2件: SLC6A2,
SLC6A4 💬
3件: Neuroactive ligand signaling, Serotonergic synapse, Synaptic vesicle cycle 💬2件: 6, 17 💬
288Ampyra first,----1件: 6 💬
289AMS2434 (amino acids)1件: Amino acids---1件: 6 💬
290ANAVEX2-731件: Blarcamesine2件: Blarcamesine ,
Blarcamesine hydrochloride 💬
6件: CHRM1,
CHRM2,
CHRM3,
CHRM4,
CHRM5,
SIGMAR1 💬
15件: Alzheimer disease, Amyotrophic lateral sclerosis, Calcium signaling pathway, Cholinergic synapse, Gastric acid secretion, Insulin secretion, Neuroactive ligand signaling, Neuroactive ligand-receptor interaction, PI3K-Akt signaling pathway, Pancreatic secretion, Pathways of neurodegeneration - multiple diseases, Regulation of actin cytoskeleton, Salivary secretion, Taste transduction, cAMP signaling pathway 💬2件: 6, 156 💬
291ANHYDROUS CARBIDOPA1件: Carbidopa1件: Carbidopa 💬 1件: DDC 💬 8件: Alcoholism, Amphetamine addiction, Cocaine addiction, Dopaminergic synapse, Phenylalanine metabolism, Serotonergic synapse, Tryptophan metabolism, Tyrosine metabolism 💬1件: 6 💬
292Anle138b----1件: 6 💬
293ANPD001----1件: 6 💬
294Anti-Parkinson medication----5件: 5, 6, 7, 8, 17 💬
295Anti-Parkinsonian Drugs----1件: 6 💬
296Antiparkinsonian Agent(s)----1件: 6 💬
297ANVS401----1件: 6 💬
298AP-472----1件: 6 💬
299AP-CD/LD----1件: 6 💬
300AP09004----1件: 6 💬
301Apigenin1件: Apigenin---3件: 6, 46, 97 💬
302APL-130277----1件: 6 💬
303Aplindore1件: Aplindore1件: Aplindore fumarate 💬 2件: DRD2,
DRD3 💬
10件: Alcoholism, Cocaine addiction, Dopaminergic synapse, Gap junction, Hormone signaling, Neuroactive ligand signaling, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, cAMP signaling pathway 💬1件: 6 💬
304Aplindore MR tablets1件: Aplindore1件: Aplindore fumarate 💬 2件: DRD2,
DRD3 💬
10件: Alcoholism, Cocaine addiction, Dopaminergic synapse, Gap junction, Hormone signaling, Neuroactive ligand signaling, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, cAMP signaling pathway 💬1件: 6 💬
305APO-go----1件: 6 💬
306APO-go®----1件: 6 💬
307APOKINON----1件: 6 💬
308APOKYN----1件: 6 💬
309Apomor----1件: 6 💬
310APOMORFINA CLORIDRATO1件: Apomorphine2件: Apomorphine hydrochloride ,
Apomorphine 💬
2件: DRD1,
DRD2 💬
13件: Alcoholism, Amphetamine addiction, Calcium signaling pathway, Cocaine addiction, Dopaminergic synapse, Gap junction, Hormone signaling, Morphine addiction, Neuroactive ligand signaling, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, cAMP signaling pathway 💬1件: 6 💬
311Apomorp----1件: 6 💬
312Apomorphine1件: Apomorphine2件: Apomorphine hydrochloride ,
Apomorphine 💬
2件: DRD1,
DRD2 💬
13件: Alcoholism, Amphetamine addiction, Calcium signaling pathway, Cocaine addiction, Dopaminergic synapse, Gap junction, Hormone signaling, Morphine addiction, Neuroactive ligand signaling, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, cAMP signaling pathway 💬3件: 5, 6, 7 💬
313Apomorphine 0.25% (2.5mg/ml)1件: Apomorphine2件: Apomorphine hydrochloride ,
Apomorphine 💬
2件: DRD1,
DRD2 💬
13件: Alcoholism, Amphetamine addiction, Calcium signaling pathway, Cocaine addiction, Dopaminergic synapse, Gap junction, Hormone signaling, Morphine addiction, Neuroactive ligand signaling, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, cAMP signaling pathway 💬1件: 6 💬
314Apomorphine Cartridge1件: Apomorphine2件: Apomorphine hydrochloride ,
Apomorphine 💬
2件: DRD1,
DRD2 💬
13件: Alcoholism, Amphetamine addiction, Calcium signaling pathway, Cocaine addiction, Dopaminergic synapse, Gap junction, Hormone signaling, Morphine addiction, Neuroactive ligand signaling, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, cAMP signaling pathway 💬1件: 6 💬
315Apomorphine HCl injection1件: Apomorphine2件: Apomorphine hydrochloride ,
Apomorphine 💬
2件: DRD1,
DRD2 💬
13件: Alcoholism, Amphetamine addiction, Calcium signaling pathway, Cocaine addiction, Dopaminergic synapse, Gap junction, Hormone signaling, Morphine addiction, Neuroactive ligand signaling, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, cAMP signaling pathway 💬1件: 6 💬
316APOMORPHINE HYDROCHLORIDE1件: Apomorphine2件: Apomorphine hydrochloride ,
Apomorphine 💬
2件: DRD1,
DRD2 💬
13件: Alcoholism, Amphetamine addiction, Calcium signaling pathway, Cocaine addiction, Dopaminergic synapse, Gap junction, Hormone signaling, Morphine addiction, Neuroactive ligand signaling, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, cAMP signaling pathway 💬1件: 6 💬
317Apomorphine hydrochloride 1.8mg inhalation powder, pre-dispensed1件: Apomorphine2件: Apomorphine hydrochloride ,
Apomorphine 💬
2件: DRD1,
DRD2 💬
13件: Alcoholism, Amphetamine addiction, Calcium signaling pathway, Cocaine addiction, Dopaminergic synapse, Gap junction, Hormone signaling, Morphine addiction, Neuroactive ligand signaling, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, cAMP signaling pathway 💬1件: 6 💬
318Apomorphine hydrochloride 2.8mg inhalation powder, pre-dispensed1件: Apomorphine2件: Apomorphine hydrochloride ,
Apomorphine 💬
2件: DRD1,
DRD2 💬
13件: Alcoholism, Amphetamine addiction, Calcium signaling pathway, Cocaine addiction, Dopaminergic synapse, Gap junction, Hormone signaling, Morphine addiction, Neuroactive ligand signaling, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, cAMP signaling pathway 💬1件: 6 💬
319Apomorphine hydrochloride 4.0 mg inhalation powder, pre-dispensed1件: Apomorphine2件: Apomorphine hydrochloride ,
Apomorphine 💬
2件: DRD1,
DRD2 💬
13件: Alcoholism, Amphetamine addiction, Calcium signaling pathway, Cocaine addiction, Dopaminergic synapse, Gap junction, Hormone signaling, Morphine addiction, Neuroactive ligand signaling, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, cAMP signaling pathway 💬1件: 6 💬
320Apomorphine hydrochloride 5.8 mg inhalation powder, pre-dispensed1件: Apomorphine2件: Apomorphine hydrochloride ,
Apomorphine 💬
2件: DRD1,
DRD2 💬
13件: Alcoholism, Amphetamine addiction, Calcium signaling pathway, Cocaine addiction, Dopaminergic synapse, Gap junction, Hormone signaling, Morphine addiction, Neuroactive ligand signaling, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, cAMP signaling pathway 💬1件: 6 💬
321APOMORPHINE HYDROCHLORIDE HEMIHYDRATE1件: Apomorphine2件: Apomorphine hydrochloride ,
Apomorphine 💬
2件: DRD1,
DRD2 💬
13件: Alcoholism, Amphetamine addiction, Calcium signaling pathway, Cocaine addiction, Dopaminergic synapse, Gap junction, Hormone signaling, Morphine addiction, Neuroactive ligand signaling, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, cAMP signaling pathway 💬1件: 6 💬
322Apomorphine Hydrocloride1件: Apomorphine2件: Apomorphine hydrochloride ,
Apomorphine 💬
2件: DRD1,
DRD2 💬
13件: Alcoholism, Amphetamine addiction, Calcium signaling pathway, Cocaine addiction, Dopaminergic synapse, Gap junction, Hormone signaling, Morphine addiction, Neuroactive ligand signaling, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, cAMP signaling pathway 💬1件: 6 💬
323Apomorphine Hydrocloride Hemihydrate1件: Apomorphine2件: Apomorphine hydrochloride ,
Apomorphine 💬
2件: DRD1,
DRD2 💬
13件: Alcoholism, Amphetamine addiction, Calcium signaling pathway, Cocaine addiction, Dopaminergic synapse, Gap junction, Hormone signaling, Morphine addiction, Neuroactive ligand signaling, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, cAMP signaling pathway 💬1件: 6 💬
324Apomorphine infusion1件: Apomorphine2件: Apomorphine hydrochloride ,
Apomorphine 💬
2件: DRD1,
DRD2 💬
13件: Alcoholism, Amphetamine addiction, Calcium signaling pathway, Cocaine addiction, Dopaminergic synapse, Gap junction, Hormone signaling, Morphine addiction, Neuroactive ligand signaling, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, cAMP signaling pathway 💬1件: 6 💬
325Apomorphine Injectable Solution1件: Apomorphine2件: Apomorphine hydrochloride ,
Apomorphine 💬
2件: DRD1,
DRD2 💬
13件: Alcoholism, Amphetamine addiction, Calcium signaling pathway, Cocaine addiction, Dopaminergic synapse, Gap junction, Hormone signaling, Morphine addiction, Neuroactive ligand signaling, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, cAMP signaling pathway 💬1件: 6 💬
326Apomorphine Nasal Powder1件: Apomorphine2件: Apomorphine hydrochloride ,
Apomorphine 💬
2件: DRD1,
DRD2 💬
13件: Alcoholism, Amphetamine addiction, Calcium signaling pathway, Cocaine addiction, Dopaminergic synapse, Gap junction, Hormone signaling, Morphine addiction, Neuroactive ligand signaling, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, cAMP signaling pathway 💬1件: 6 💬
327Apomorphine pump1件: Apomorphine2件: Apomorphine hydrochloride ,
Apomorphine 💬
2件: DRD1,
DRD2 💬
13件: Alcoholism, Amphetamine addiction, Calcium signaling pathway, Cocaine addiction, Dopaminergic synapse, Gap junction, Hormone signaling, Morphine addiction, Neuroactive ligand signaling, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, cAMP signaling pathway 💬1件: 6 💬
328APORON----1件: 6 💬
329AQW051----1件: 6 💬
330ARICEPT----3件: 6, 13, 124 💬
331Aricept 5 mg-Filmtabletten----1件: 6 💬
332Aricept 5mg-Filmtabletten----1件: 6 💬
333Aripiprazole1件: Aripiprazole1件: Aripiprazole 💬 4件: DRD2,
DRD3,
HTR1A,
HTR2A 💬
14件: Alcoholism, Calcium signaling pathway, Cocaine addiction, Dopaminergic synapse, Gap junction, Hormone signaling, Inflammatory mediator regulation of TRP channels, Neuroactive ligand signaling, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, Serotonergic synapse, Taste transduction, cAMP signaling pathway 💬3件: 6, 74, 206 💬
334Armodafinil1件: Armodafinil1件: Armodafinil 💬 1件: SLC6A3 💬 8件: Alcoholism, Amphetamine addiction, Cocaine addiction, Dopaminergic synapse, Neuroactive ligand signaling, Parkinson disease, Pathways of neurodegeneration - multiple diseases, Synaptic vesicle cycle 💬3件: 6, 13, 84 💬
335AS2----1件: 6 💬
336ASK Nr. 21972----2件: 5, 6 💬
337ASyn Mab----1件: 6 💬
338ATH-1017----1件: 6 💬
339ATM FOG in PD----1件: 6 💬
340Atomoxetine1件: Atomoxetine2件: Atomoxetine hydrochloride ,
Atomoxetine 💬
1件: SLC6A2 💬 2件: Neuroactive ligand signaling, Synaptic vesicle cycle 💬4件: 6, 8, 13, 17 💬
341Atypical Antipsychotics----1件: 6 💬
342Autologous dopaminergic cell implantation----1件: 6 💬
343Autologous induced neural stem cell-derived DA precursor cells----1件: 6 💬
344Autologous mesenchymal stem cells----5件: 2, 6, 13, 17, 46 💬
345Autologous midbrain dopamine neurons1件: Dopamine2件: Dopamine hydrochloride ,
Dopamine 💬
5件: DRD1,
DRD2,
DRD3,
DRD4,
DRD5 💬
13件: Alcoholism, Amphetamine addiction, Calcium signaling pathway, Cocaine addiction, Dopaminergic synapse, Gap junction, Hormone signaling, Morphine addiction, Neuroactive ligand signaling, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, cAMP signaling pathway 💬1件: 6 💬
346Autonomic testing on and off levodopa1件: Levodopa1件: Levodopa 💬 5件: DRD1,
DRD2,
DRD3,
DRD4,
DRD5 💬
13件: Alcoholism, Amphetamine addiction, Calcium signaling pathway, Cocaine addiction, Dopaminergic synapse, Gap junction, Hormone signaling, Morphine addiction, Neuroactive ligand signaling, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, cAMP signaling pathway 💬1件: 6 💬
347AV-1011件: AV-101---2件: 6, 86 💬
348AV1451 Tau----3件: 6, 17, 127 💬
349AVALOX - 400----1件: 6 💬
350AVE8112----1件: 6 💬
351AVP-923----3件: 2, 6, 13 💬
352AVP-923-45----1件: 6 💬
353Azathioprine1件: Azathioprine2件: Azathioprine ,
Azathioprine sodium 💬
--26件: 6, 11, 13, 19, 35, 42, 43, 44, 45, 46, 49, 55, 57, 63, 65, 66, 84, 85, 93, 94, 95, 96, 97, 162, 223, 300 💬
354AZD0328----1件: 6 💬
355AZD3241----2件: 6, 17 💬
356AZD3241 300 mg BID----1件: 6 💬
357AZD3241 600 mg BID----1件: 6 💬
358AZD3241 Alternative titration scheme with formulation 1 or 2----1件: 6 💬
359AZD3241 ER formulation 1----1件: 6 💬
360AZD3241 Extended release tablets 100 mg----1件: 6 💬
361AZD3241 Extended release tablets 25 mg----1件: 6 💬
362Azilect----3件: 5, 6, 17 💬
363AZILECT 1 mg comprimidos----2件: 6, 17 💬
364Azilect 1mg----1件: 6 💬
365AZILECT®----1件: 6 💬
366B-STN DBS----1件: 6 💬
367B6, B12, L-methylfolate----1件: 6 💬
368Bacillus coagulans1件: Bacillus coagulans---1件: 6 💬
369Bacillus licheniformis1件: Bacillus licheniformis---1件: 6 💬
370Bacillus Subtilis1件: Bacillus subtilis---3件: 6, 28, 96 💬
371Barium1件: Barium---5件: 2, 6, 19, 97, 98 💬
372Bavisant1件: Bavisant1件: Bavisant 💬 1件: HRH3 💬 2件: Neuroactive ligand signaling, Neuroactive ligand-receptor interaction 💬1件: 6 💬
373Bavisant dihydrochloride monohydrate1件: Bavisant1件: Bavisant 💬 1件: HRH3 💬 2件: Neuroactive ligand signaling, Neuroactive ligand-receptor interaction 💬1件: 6 💬
374BAVISANT HYDROCHLORIDE MONOHYDRATE1件: Bavisant1件: Bavisant 💬 1件: HRH3 💬 2件: Neuroactive ligand signaling, Neuroactive ligand-receptor interaction 💬1件: 6 💬
375BBM-P002----1件: 6 💬
376Bee venom----1件: 6 💬
377BEFIRADOL1件: Befiradol---1件: 6 💬
378Behavioral: assessment during the transition between OFF-levodopa (i.e. withdrawal of levodopa phase) and ON-levodopa (i.e. effect of Levodopa phase)states1件: Levodopa1件: Levodopa 💬 5件: DRD1,
DRD2,
DRD3,
DRD4,
DRD5 💬
13件: Alcoholism, Amphetamine addiction, Calcium signaling pathway, Cocaine addiction, Dopaminergic synapse, Gap junction, Hormone signaling, Morphine addiction, Neuroactive ligand signaling, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, cAMP signaling pathway 💬1件: 6 💬
379Behavioral: Assessment of cognition----1件: 6 💬
380Behavioral: Assessment of depression----1件: 6 💬
381Behavioral: Assessment of motor and non-motors symptoms of PD Evaluation of hyper- and hypodopaminergic behaviors----1件: 6 💬
382Behavioral: Assessment of quality of life----2件: 6, 97 💬
383Behavioral: Assessment of severity of ICD (impulse control disorders)----1件: 6 💬
384Behavioral: Assessment of severity of Parkinson Disease----1件: 6 💬
385Behavioral: Assessments in ON and OFF levodopa state1件: Levodopa1件: Levodopa 💬 5件: DRD1,
DRD2,
DRD3,
DRD4,
DRD5 💬
13件: Alcoholism, Amphetamine addiction, Calcium signaling pathway, Cocaine addiction, Dopaminergic synapse, Gap junction, Hormone signaling, Morphine addiction, Neuroactive ligand signaling, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, cAMP signaling pathway 💬1件: 6 💬
386Behavioral: Balance & Strengthening Exercises----1件: 6 💬
387Behavioral: Balance Training----3件: 6, 13, 18 💬
388Behavioral: Brisk walking and balance training----1件: 6 💬
389Behavioral: CBT and sleep hygiene----1件: 6 💬
390Behavioral: Clinical Assessment----1件: 6 💬
391Behavioral: Combined balance and brisk walking training----1件: 6 💬
392Behavioral: Complex task practice----1件: 6 💬
393Behavioral: Comprehensive rehabilitation----1件: 6 💬
394Behavioral: Conservative Measures for Orthostatic Hypotension----2件: 6, 17 💬
395Behavioral: Conventional Balance exercise----1件: 6 💬
396Behavioral: Cycling Intervention----1件: 6 💬
397Behavioral: Dexterity----1件: 6 💬
398Behavioral: Exercise----6件: 6, 46, 113, 265, 299, 344 💬
399Behavioral: Exercise-based behavioral therapy----1件: 6 💬
400Behavioral: Flexibility and strengthening exercise----1件: 6 💬
401Behavioral: Gait and balance----1件: 6 💬
402Behavioral: gait and balance training program----1件: 6 💬
403Behavioral: Gait and balance training with dual-task (six weeks)----1件: 6 💬
404Behavioral: Gait and balance training with dual-task (twelve weeks: 6 +6)----1件: 6 💬
405Behavioral: Gait and balance training with dual-task + action observation and motor imagery (six weeks)----1件: 6 💬
406Behavioral: Gait and balance training with dual-task + action observation and motor imagery (twelve weeks: 6 + 6)----1件: 6 💬
407Behavioral: Healthy age-matched controls----1件: 6 💬
408Behavioral: Levodopa or acupuncture1件: Levodopa1件: Levodopa 💬 5件: DRD1,
DRD2,
DRD3,
DRD4,
DRD5 💬
13件: Alcoholism, Amphetamine addiction, Calcium signaling pathway, Cocaine addiction, Dopaminergic synapse, Gap junction, Hormone signaling, Morphine addiction, Neuroactive ligand signaling, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, cAMP signaling pathway 💬1件: 6 💬
409Behavioral: Low-load resistance training with blood flow restriction----1件: 6 💬
410Behavioral: Mediterranean-Ketogenic Diet----1件: 6 💬
411Behavioral: Memory----1件: 6 💬
412Behavioral: OM Meditation----1件: 6 💬
413Behavioral: Participant open-response writing----1件: 6 💬
414Behavioral: Participant self-assessment surveys----1件: 6 💬
415Behavioral: Pelvic floor muscle exercise-based behavioral therapy----1件: 6 💬
416Behavioral: Phonation----1件: 6 💬
417Behavioral: Physical Therapy----2件: 6, 13 💬
418Behavioral: Psychosocial intervention----1件: 6 💬
419Behavioral: Questionnaires and Clinical Assessments----1件: 6 💬
420Behavioral: Rehabilitation therapy----1件: 6 💬
421Behavioral: Resistance Training----1件: 6 💬
422Behavioral: Role of dopamine1件: Dopamine2件: Dopamine hydrochloride ,
Dopamine 💬
5件: DRD1,
DRD2,
DRD3,
DRD4,
DRD5 💬
13件: Alcoholism, Amphetamine addiction, Calcium signaling pathway, Cocaine addiction, Dopaminergic synapse, Gap junction, Hormone signaling, Morphine addiction, Neuroactive ligand signaling, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, cAMP signaling pathway 💬1件: 6 💬
423Behavioral: Split-belt treadmill training----1件: 6 💬
424Behavioral: Static balance exercise----1件: 6 💬
425Behavioral: stretching----2件: 6, 13 💬
426Behavioral: Structured wellness care----1件: 6 💬
427Behavioral: Upper limb exercise----1件: 6 💬
428Behavioral: Voice, Speech and Language Analysis----1件: 6 💬
429Bemdaneprocel----1件: 6 💬
430BEN-2001----1件: 6 💬
431BENSERAZIDE1件: Benserazide2件: Benserazide hydrochloride ,
Benserazide 💬
1件: DDC 💬 8件: Alcoholism, Amphetamine addiction, Cocaine addiction, Dopaminergic synapse, Phenylalanine metabolism, Serotonergic synapse, Tryptophan metabolism, Tyrosine metabolism 💬1件: 6 💬
432BENSERAZIDE HYDROCHLORIDE1件: Benserazide2件: Benserazide hydrochloride ,
Benserazide 💬
1件: DDC 💬 8件: Alcoholism, Amphetamine addiction, Cocaine addiction, Dopaminergic synapse, Phenylalanine metabolism, Serotonergic synapse, Tryptophan metabolism, Tyrosine metabolism 💬1件: 6 💬
433Benzofuran1件: Benzofuran---1件: 6 💬
434Berachin----1件: 6 💬
435Best Medical Treatment----1件: 6 💬
436Best medical treatment (BMT): Adjustment of the dopaminergic medication and non-dopaminergic therapy customized for each patient according to the latest published Consensus Group Recommendations----1件: 6 💬
437Best medical treatment for management of impulse control in Parkinson´s disease according to widely accepted expert consensus paper----1件: 6 💬
438Best médical treatment----1件: 6 💬
439Best oral medication----1件: 6 💬
440Betaquik MCT supplement----1件: 6 💬
441BF 2.649----1件: 6 💬
442BF 2.649 10 mg----1件: 6 💬
443BF 2.649 20 mg----1件: 6 💬
444BF 2.649 40 mg----1件: 6 💬
445BF 2.649 5 mg----1件: 6 💬
446BF2.649----1件: 6 💬
447BF2.649 (Pitolisant)1件: Pitolisant2件: Pitolisant ,
Pitolisant hydrochloride 💬
1件: HRH3 💬 2件: Neuroactive ligand signaling, Neuroactive ligand-receptor interaction 💬1件: 6 💬
448BHV-8000----1件: 6 💬
449BI-Sifrol®----1件: 6 💬
450BIA1件: BIA---4件: 6, 86, 96, 299 💬
451BIA 28-61561件: BIA---1件: 6 💬
452BIA 28-6156 10 mg1件: BIA---1件: 6 💬
453BIA 28-6156 60 mg1件: BIA---1件: 6 💬
454BIA 3-2021件: BIA---1件: 6 💬
455BIA 3-202 (200 mg)1件: BIA---1件: 6 💬
456BIA 6-5121件: BIA---1件: 6 💬
457BIA 6-512 100 mg1件: BIA---1件: 6 💬
458BIA 6-512 100 mg dose1件: BIA---1件: 6 💬
459BIA 6-512 200 mg dose1件: BIA---1件: 6 💬
460BIA 6-512 25 mg1件: BIA---1件: 6 💬
461BIA 6-512 25 mg dose1件: BIA---1件: 6 💬
462BIA 6-512 400 mg1件: BIA---1件: 6 💬
463BIA 6-512 50 mg dose1件: BIA---1件: 6 💬
464BIA 9-10671件: BIA---1件: 6 💬
465BIA 9-1067 (test)1件: BIA---1件: 6 💬
466BIA 9-1067 15 mg1件: BIA---1件: 6 💬
467BIA 9-1067 25 mg1件: BIA---1件: 6 💬
468BIA 9-1067 30 mg1件: BIA---1件: 6 💬
469BIA 9-1067 5 mg1件: BIA---1件: 6 💬
470BIA 9-1067 micronized1件: BIA---1件: 6 💬
471BIA 9-1067 non-micronized1件: BIA---1件: 6 💬
472BIIB014----1件: 6 💬
473BIIB054----1件: 6 💬
474BIIB094----1件: 6 💬
475BIIB122----1件: 6 💬
476BIIB122 225 mg----1件: 6 💬
477Bilateral high frequency deep brain stimulation of the subthalamic neucleus combined with best medical treatment according to widely accepted expert consensus paper----1件: 6 💬
478Bilateral high frequency deep brainstimulation of the subthalamic nucleus combined with best medical treatment----1件: 6 💬
479Bioactivated GRA for adult patients----2件: 6, 13 💬
480Bioactivated GRA for pediatric patients----2件: 6, 13 💬
481Biofluid samplings----1件: 6 💬
482Biological/Vaccine: Allogeneic HB-adMSCs----1件: 6 💬
483Bisphosphonates----2件: 6, 274 💬
484Blood analysis----1件: 6 💬
485Blood Brain Barrier Disruption - Functional----1件: 6 💬
486Blood draw----16件: 3, 6, 13, 19, 46, 48, 49, 51, 58, 65, 67, 193, 215, 231, 298, 299 💬
487Blood flow restriction (BFR) and aerobic exercise via recumbent stepping (Nu-Step)----1件: 6 💬
488Blood pressure measurement----1件: 6 💬
489Blood sample----33件: 2, 3, 6, 8, 10, 13, 14, 19, 34, 46, 48, 49, 51, 53, 61, 63, 65, 66, 67, 77, 79, 84, 88, 96, 97, 107, 113, 127, 195, 206, 235, 274, 299 💬
490Blood test----19件: 2, 6, 13, 36, 46, 49, 51, 74, 79, 83, 96, 113, 127, 162, 227, 256, 280, 299, 300 💬
491BMS-9894923----1件: 6 💬
492Bone marrow derived mesenchymal stem cells----2件: 6, 60 💬
493BoNT-A----1件: 6 💬
494BOTOX----5件: 6, 13, 36, 149, 226 💬
495Botulinum Toxin----3件: 6, 13, 149 💬
496BOTULINUM TOXIN TYPE A1件: Botulinum toxin type A4件: Botulinum toxin type A ,
OnabotulinumtoxinA ,
AbobotulinumtoxinA ,
Incobotulinumtoxin A 💬
1件: SNAP25 💬 2件: Insulin secretion, Synaptic vesicle cycle 💬13件: 2, 5, 6, 7, 13, 15, 17, 47, 70, 113, 149, 171, 226 💬
497Botulinum toxin type A injection1件: Botulinum toxin type A4件: Botulinum toxin type A ,
OnabotulinumtoxinA ,
AbobotulinumtoxinA ,
Incobotulinumtoxin A 💬
1件: SNAP25 💬 2件: Insulin secretion, Synaptic vesicle cycle 💬1件: 6 💬
498Botulinum toxin type B1件: Botulinum toxin type B1件: RimabotulinumtoxinB 💬 1件: SNAP25 💬 2件: Insulin secretion, Synaptic vesicle cycle 💬3件: 2, 6, 51 💬
499Botulinum toxin type B (Myobloc)1件: Botulinum toxin type B1件: RimabotulinumtoxinB 💬 1件: SNAP25 💬 2件: Insulin secretion, Synaptic vesicle cycle 💬2件: 2, 6 💬
500Botulinum Toxin: Xeomin----1件: 6 💬
501Brintellix----1件: 6 💬
502BRINTELLIX - 20 MG/ML - GOCCE ORALI, SOLUZIONE - USO ORALE - FLACONE (VETRO) 15 ML - 1 FLACONE----1件: 6 💬
503BROMOCRIPTINE1件: Bromocriptine2件: Bromocriptine mesylate ,
Bromocriptine 💬
2件: DRD2,
PRL 💬
14件: Alcoholism, Cocaine addiction, Cytokine-cytokine receptor interaction, Dopaminergic synapse, Gap junction, Hormone signaling, JAK-STAT signaling pathway, Neuroactive ligand signaling, Neuroactive ligand-receptor interaction, PI3K-Akt signaling pathway, Parkinson disease, Prolactin signaling pathway, Rap1 signaling pathway, cAMP signaling pathway 💬3件: 6, 57, 74 💬
504Bromocriptine and other dopamine agonists2件: Bromocriptine,
Dopamine
4件: Dopamine hydrochloride ,
Bromocriptine mesylate ,
Bromocriptine ,
Dopamine 💬
6件: DRD1,
DRD2,
DRD3,
DRD4,
DRD5,
PRL 💬
17件: Alcoholism, Amphetamine addiction, Calcium signaling pathway, Cocaine addiction, Cytokine-cytokine receptor interaction, Dopaminergic synapse, Gap junction, Hormone signaling, JAK-STAT signaling pathway, Morphine addiction, Neuroactive ligand signaling, Neuroactive ligand-receptor interaction, PI3K-Akt signaling pathway, Parkinson disease, Prolactin signaling pathway, Rap1 signaling pathway, cAMP signaling pathway 💬1件: 6 💬
505BTRX-2460401件: BTRX-246040---1件: 6 💬
506Bumetanide1件: Bumetanide1件: Bumetanide 💬 1件: SLC12A2 💬 3件: Pancreatic secretion, Salivary secretion, Vibrio cholerae infection 💬4件: 6, 57, 115, 158 💬
507Bumetanide white, oblong, scored tablet1件: Bumetanide1件: Bumetanide 💬 1件: SLC12A2 💬 3件: Pancreatic secretion, Salivary secretion, Vibrio cholerae infection 💬1件: 6 💬
508Buntanetap----1件: 6 💬
509Buntanetap Tartrate [(+)-phenserine D-tartrate]1件: Phenserine---1件: 6 💬
510Buntanetap/posiphen1件: Posiphen1件: Buntanetap 💬 1件: ACHE 💬 3件: Cholinergic synapse, Glycerophospholipid metabolism, Neuroactive ligand signaling 💬1件: 6 💬
511Bupleurum+Ginkgo----1件: 6 💬
512Buspirone1件: Buspirone2件: Buspirone hydrochloride ,
Buspirone 💬
2件: DRD2,
HTR1A 💬
12件: Alcoholism, Cocaine addiction, Dopaminergic synapse, Gap junction, Hormone signaling, Neuroactive ligand signaling, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, Serotonergic synapse, Taste transduction, cAMP signaling pathway 💬3件: 6, 51, 179 💬
513BUSPIRONE CLORIDRATO1件: Buspirone2件: Buspirone hydrochloride ,
Buspirone 💬
2件: DRD2,
HTR1A 💬
12件: Alcoholism, Cocaine addiction, Dopaminergic synapse, Gap junction, Hormone signaling, Neuroactive ligand signaling, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, Serotonergic synapse, Taste transduction, cAMP signaling pathway 💬1件: 6 💬
514Buspirone Hydrochloride1件: Buspirone2件: Buspirone hydrochloride ,
Buspirone 💬
2件: DRD2,
HTR1A 💬
12件: Alcoholism, Cocaine addiction, Dopaminergic synapse, Gap junction, Hormone signaling, Neuroactive ligand signaling, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, Serotonergic synapse, Taste transduction, cAMP signaling pathway 💬1件: 6 💬
515Butylphthalide1件: Butylphthalide---4件: 2, 6, 17, 22 💬
516BYDUREON----2件: 6, 17 💬
517Bydureon 2 mg powder and solvent for prolonged-release suspension----1件: 6 💬
518Byetta 5 micrograms----1件: 6 💬
519C-11 ER176----3件: 6, 17, 127 💬
520C-11 PiB----3件: 6, 17, 127 💬
521C11-SY08----2件: 6, 17 💬
522Cabaser----2件: 6, 77 💬
523Cabaseril----1件: 6 💬
524Cabaseril, 1,0 mg Tablette----1件: 6 💬
525Cabaseril, 2,0 mg Tablette----1件: 6 💬
526CABERGOLINA1件: Cabergoline1件: Cabergoline 💬 2件: DRD2,
PRL 💬
14件: Alcoholism, Cocaine addiction, Cytokine-cytokine receptor interaction, Dopaminergic synapse, Gap junction, Hormone signaling, JAK-STAT signaling pathway, Neuroactive ligand signaling, Neuroactive ligand-receptor interaction, PI3K-Akt signaling pathway, Parkinson disease, Prolactin signaling pathway, Rap1 signaling pathway, cAMP signaling pathway 💬2件: 6, 75 💬
527Cabergoline1件: Cabergoline1件: Cabergoline 💬 2件: DRD2,
PRL 💬
14件: Alcoholism, Cocaine addiction, Cytokine-cytokine receptor interaction, Dopaminergic synapse, Gap junction, Hormone signaling, JAK-STAT signaling pathway, Neuroactive ligand signaling, Neuroactive ligand-receptor interaction, PI3K-Akt signaling pathway, Parkinson disease, Prolactin signaling pathway, Rap1 signaling pathway, cAMP signaling pathway 💬4件: 6, 74, 75, 77 💬
528CADD-Legacy ambulatory infusion pump----1件: 6 💬
529CADD-Legacy® 1400 ambulatory infusion pump----1件: 6 💬
530Caffeine1件: Caffeine2件: Caffeine ,
Caffeine citrate 💬
11件: ADORA1,
ADORA2A,
PDE1B,
PDE2A,
PDE3A,
PDE3B,
PDE4A,
PDE4B,
PDE4C,
PDE4D,
PDE5A 💬
22件: Alcoholism, Aldosterone synthesis and secretion, Apelin signaling pathway, Calcium signaling pathway, Glucagon signaling pathway, Insulin signaling pathway, Morphine addiction, Neuroactive ligand signaling, Neuroactive ligand-receptor interaction, Olfactory transduction, Parathyroid hormone synthesis, secretion and action, Parkinson disease, Progesterone-mediated oocyte maturation, Purine metabolism, Rap1 signaling pathway, Regulation of lipolysis in adipocytes, Renin secretion, Sphingolipid signaling pathway, Taste transduction, Vascular smooth muscle contraction, cAMP signaling pathway, cGMP-PKG signaling pathway 💬8件: 2, 6, 13, 21, 46, 96, 97, 265 💬
531Caffeine 100-200 mg BID1件: Caffeine2件: Caffeine ,
Caffeine citrate 💬
11件: ADORA1,
ADORA2A,
PDE1B,
PDE2A,
PDE3A,
PDE3B,
PDE4A,
PDE4B,
PDE4C,
PDE4D,
PDE5A 💬
22件: Alcoholism, Aldosterone synthesis and secretion, Apelin signaling pathway, Calcium signaling pathway, Glucagon signaling pathway, Insulin signaling pathway, Morphine addiction, Neuroactive ligand signaling, Neuroactive ligand-receptor interaction, Olfactory transduction, Parathyroid hormone synthesis, secretion and action, Parkinson disease, Progesterone-mediated oocyte maturation, Purine metabolism, Rap1 signaling pathway, Regulation of lipolysis in adipocytes, Renin secretion, Sphingolipid signaling pathway, Taste transduction, Vascular smooth muscle contraction, cAMP signaling pathway, cGMP-PKG signaling pathway 💬1件: 6 💬
532Caffeine alkaloid1件: Caffeine2件: Caffeine ,
Caffeine citrate 💬
11件: ADORA1,
ADORA2A,
PDE1B,
PDE2A,
PDE3A,
PDE3B,
PDE4A,
PDE4B,
PDE4C,
PDE4D,
PDE5A 💬
22件: Alcoholism, Aldosterone synthesis and secretion, Apelin signaling pathway, Calcium signaling pathway, Glucagon signaling pathway, Insulin signaling pathway, Morphine addiction, Neuroactive ligand signaling, Neuroactive ligand-receptor interaction, Olfactory transduction, Parathyroid hormone synthesis, secretion and action, Parkinson disease, Progesterone-mediated oocyte maturation, Purine metabolism, Rap1 signaling pathway, Regulation of lipolysis in adipocytes, Renin secretion, Sphingolipid signaling pathway, Taste transduction, Vascular smooth muscle contraction, cAMP signaling pathway, cGMP-PKG signaling pathway 💬1件: 6 💬
533Calcium1件: Calcium---39件: 2, 3, 6, 13, 15, 19, 46, 48, 49, 51, 53, 56, 62, 67, 68, 71, 74, 75, 79, 84, 90, 93, 94, 95, 96, 97, 156, 186, 214, 215, 222, 224, 235, 256, 265, 271, 274, 298, 299 💬
534Cannabidiol1件: Cannabidiol1件: Cannabidiol 💬 2件: CNR1,
CNR2 💬
4件: Neuroactive ligand-receptor interaction, Rap1 signaling pathway, Retrograde endocannabinoid signaling, Thermogenesis 💬20件: 6, 8, 13, 19, 36, 46, 51, 95, 96, 97, 140, 144, 145, 156, 157, 158, 193, 206, 226, 271 💬
535Cannabidiol (CBD)1件: Cannabidiol1件: Cannabidiol 💬 2件: CNR1,
CNR2 💬
4件: Neuroactive ligand-receptor interaction, Rap1 signaling pathway, Retrograde endocannabinoid signaling, Thermogenesis 💬7件: 6, 13, 140, 144, 145, 156, 158 💬
536Cannabidiol 100 mg/ml1件: Cannabidiol1件: Cannabidiol 💬 2件: CNR1,
CNR2 💬
4件: Neuroactive ligand-receptor interaction, Rap1 signaling pathway, Retrograde endocannabinoid signaling, Thermogenesis 💬1件: 6 💬
537Cannabidiol 300 mg/ml1件: Cannabidiol1件: Cannabidiol 💬 2件: CNR1,
CNR2 💬
4件: Neuroactive ligand-receptor interaction, Rap1 signaling pathway, Retrograde endocannabinoid signaling, Thermogenesis 💬1件: 6 💬
538Cannabidiol 400 mg/ml1件: Cannabidiol1件: Cannabidiol 💬 2件: CNR1,
CNR2 💬
4件: Neuroactive ligand-receptor interaction, Rap1 signaling pathway, Retrograde endocannabinoid signaling, Thermogenesis 💬1件: 6 💬
539Cannabis Oil----1件: 6 💬
540Cannabis, Medical----5件: 2, 6, 13, 96, 97 💬
541Capsaicin1件: Capsaicin1件: Capsaicin 💬 1件: TRPV1 💬 2件: Inflammatory mediator regulation of TRP channels, Neuroactive ligand-receptor interaction 💬5件: 2, 6, 19, 86, 226 💬
542Capsaicin vapor1件: Capsaicin1件: Capsaicin 💬 1件: TRPV1 💬 2件: Inflammatory mediator regulation of TRP channels, Neuroactive ligand-receptor interaction 💬1件: 6 💬
543Capsules containing: carbidopa (25 mg), levodopa (100 mg), entacapone (200 mg)3件: Carbidopa,
Entacapone,
Levodopa
3件: Levodopa ,
Carbidopa ,
Entacapone 💬
7件: COMT,
DDC,
DRD1,
DRD2,
DRD3,
DRD4,
DRD5 💬
18件: Alcoholism, Amphetamine addiction, Calcium signaling pathway, Cocaine addiction, Dopaminergic synapse, Gap junction, Hormone signaling, Morphine addiction, Neuroactive ligand signaling, Neuroactive ligand-receptor interaction, Parkinson disease, Phenylalanine metabolism, Rap1 signaling pathway, Serotonergic synapse, Steroid hormone biosynthesis, Tryptophan metabolism, Tyrosine metabolism, cAMP signaling pathway 💬1件: 6 💬
544Carbamazepine1件: Carbamazepine1件: Carbamazepine 💬 6件: SCN1A,
SCN2A,
SCN3A,
SCN5A,
SCN8A,
SCN9A 💬
5件: Adrenergic signaling in cardiomyocytes, Cadherin signaling, Dopaminergic synapse, IgSF CAM signaling, Taste transduction 💬6件: 6, 13, 137, 145, 158, 231 💬
545CARBIDOPA1件: Carbidopa1件: Carbidopa 💬 1件: DDC 💬 8件: Alcoholism, Amphetamine addiction, Cocaine addiction, Dopaminergic synapse, Phenylalanine metabolism, Serotonergic synapse, Tryptophan metabolism, Tyrosine metabolism 💬7件: 6, 13, 17, 90, 140, 164, 201 💬
546CARBIDOPA (CD)1件: Carbidopa1件: Carbidopa 💬 1件: DDC 💬 8件: Alcoholism, Amphetamine addiction, Cocaine addiction, Dopaminergic synapse, Phenylalanine metabolism, Serotonergic synapse, Tryptophan metabolism, Tyrosine metabolism 💬1件: 6 💬
547CARBIDOPA (FU)1件: Carbidopa1件: Carbidopa 💬 1件: DDC 💬 8件: Alcoholism, Amphetamine addiction, Cocaine addiction, Dopaminergic synapse, Phenylalanine metabolism, Serotonergic synapse, Tryptophan metabolism, Tyrosine metabolism 💬1件: 6 💬
548Carbidopa 20 mg1件: Carbidopa1件: Carbidopa 💬 1件: DDC 💬 8件: Alcoholism, Amphetamine addiction, Cocaine addiction, Dopaminergic synapse, Phenylalanine metabolism, Serotonergic synapse, Tryptophan metabolism, Tyrosine metabolism 💬1件: 6 💬
549Carbidopa 200mg oral dose1件: Carbidopa1件: Carbidopa 💬 1件: DDC 💬 8件: Alcoholism, Amphetamine addiction, Cocaine addiction, Dopaminergic synapse, Phenylalanine metabolism, Serotonergic synapse, Tryptophan metabolism, Tyrosine metabolism 💬2件: 6, 17 💬
550Carbidopa 25/Levodopa 100Mg Tab2件: Carbidopa,
Levodopa
2件: Levodopa ,
Carbidopa 💬
6件: DDC,
DRD1,
DRD2,
DRD3,
DRD4,
DRD5 💬
17件: Alcoholism, Amphetamine addiction, Calcium signaling pathway, Cocaine addiction, Dopaminergic synapse, Gap junction, Hormone signaling, Morphine addiction, Neuroactive ligand signaling, Neuroactive ligand-receptor interaction, Parkinson disease, Phenylalanine metabolism, Rap1 signaling pathway, Serotonergic synapse, Tryptophan metabolism, Tyrosine metabolism, cAMP signaling pathway 💬1件: 6 💬
551Carbidopa 27.5 mg1件: Carbidopa1件: Carbidopa 💬 1件: DDC 💬 8件: Alcoholism, Amphetamine addiction, Cocaine addiction, Dopaminergic synapse, Phenylalanine metabolism, Serotonergic synapse, Tryptophan metabolism, Tyrosine metabolism 💬1件: 6 💬
552Carbidopa 65 mg capsule1件: Carbidopa1件: Carbidopa 💬 1件: DDC 💬 8件: Alcoholism, Amphetamine addiction, Cocaine addiction, Dopaminergic synapse, Phenylalanine metabolism, Serotonergic synapse, Tryptophan metabolism, Tyrosine metabolism 💬1件: 6 💬
553Carbidopa and Levodopa Controlled Release Tablets2件: Carbidopa,
Levodopa
2件: Levodopa ,
Carbidopa 💬
6件: DDC,
DRD1,
DRD2,
DRD3,
DRD4,
DRD5 💬
17件: Alcoholism, Amphetamine addiction, Calcium signaling pathway, Cocaine addiction, Dopaminergic synapse, Gap junction, Hormone signaling, Morphine addiction, Neuroactive ligand signaling, Neuroactive ligand-receptor interaction, Parkinson disease, Phenylalanine metabolism, Rap1 signaling pathway, Serotonergic synapse, Tryptophan metabolism, Tyrosine metabolism, cAMP signaling pathway 💬1件: 6 💬
554Carbidopa and Levodopa Tablets, USP2件: Carbidopa,
Levodopa
2件: Levodopa ,
Carbidopa 💬
6件: DDC,
DRD1,
DRD2,
DRD3,
DRD4,
DRD5 💬
17件: Alcoholism, Amphetamine addiction, Calcium signaling pathway, Cocaine addiction, Dopaminergic synapse, Gap junction, Hormone signaling, Morphine addiction, Neuroactive ligand signaling, Neuroactive ligand-receptor interaction, Parkinson disease, Phenylalanine metabolism, Rap1 signaling pathway, Serotonergic synapse, Tryptophan metabolism, Tyrosine metabolism, cAMP signaling pathway 💬1件: 6 💬
555CARBIDOPA ANIDRA1件: Carbidopa1件: Carbidopa 💬 1件: DDC 💬 8件: Alcoholism, Amphetamine addiction, Cocaine addiction, Dopaminergic synapse, Phenylalanine metabolism, Serotonergic synapse, Tryptophan metabolism, Tyrosine metabolism 💬1件: 6 💬
556CARBIDOPA FU1件: Carbidopa1件: Carbidopa 💬 1件: DDC 💬 8件: Alcoholism, Amphetamine addiction, Cocaine addiction, Dopaminergic synapse, Phenylalanine metabolism, Serotonergic synapse, Tryptophan metabolism, Tyrosine metabolism 💬1件: 6 💬
557CARBIDOPA INN1件: Carbidopa1件: Carbidopa 💬 1件: DDC 💬 8件: Alcoholism, Amphetamine addiction, Cocaine addiction, Dopaminergic synapse, Phenylalanine metabolism, Serotonergic synapse, Tryptophan metabolism, Tyrosine metabolism 💬1件: 6 💬
558CARBIDOPA LEVODOPA2件: Carbidopa,
Levodopa
2件: Levodopa ,
Carbidopa 💬
6件: DDC,
DRD1,
DRD2,
DRD3,
DRD4,
DRD5 💬
17件: Alcoholism, Amphetamine addiction, Calcium signaling pathway, Cocaine addiction, Dopaminergic synapse, Gap junction, Hormone signaling, Morphine addiction, Neuroactive ligand signaling, Neuroactive ligand-receptor interaction, Parkinson disease, Phenylalanine metabolism, Rap1 signaling pathway, Serotonergic synapse, Tryptophan metabolism, Tyrosine metabolism, cAMP signaling pathway 💬1件: 6 💬
559CARBIDOPA MONOHYDRATE1件: Carbidopa1件: Carbidopa 💬 1件: DDC 💬 8件: Alcoholism, Amphetamine addiction, Cocaine addiction, Dopaminergic synapse, Phenylalanine metabolism, Serotonergic synapse, Tryptophan metabolism, Tyrosine metabolism 💬1件: 6 💬
560Carbidopa Pill1件: Carbidopa1件: Carbidopa 💬 1件: DDC 💬 8件: Alcoholism, Amphetamine addiction, Cocaine addiction, Dopaminergic synapse, Phenylalanine metabolism, Serotonergic synapse, Tryptophan metabolism, Tyrosine metabolism 💬1件: 6 💬
561Carbidopa, levodopa, entacapone3件: Carbidopa,
Entacapone,
Levodopa
3件: Levodopa ,
Carbidopa ,
Entacapone 💬
7件: COMT,
DDC,
DRD1,
DRD2,
DRD3,
DRD4,
DRD5 💬
18件: Alcoholism, Amphetamine addiction, Calcium signaling pathway, Cocaine addiction, Dopaminergic synapse, Gap junction, Hormone signaling, Morphine addiction, Neuroactive ligand signaling, Neuroactive ligand-receptor interaction, Parkinson disease, Phenylalanine metabolism, Rap1 signaling pathway, Serotonergic synapse, Steroid hormone biosynthesis, Tryptophan metabolism, Tyrosine metabolism, cAMP signaling pathway 💬1件: 6 💬
562Carbidopa- Levodopa2件: Carbidopa,
Levodopa
2件: Levodopa ,
Carbidopa 💬
6件: DDC,
DRD1,
DRD2,
DRD3,
DRD4,
DRD5 💬
17件: Alcoholism, Amphetamine addiction, Calcium signaling pathway, Cocaine addiction, Dopaminergic synapse, Gap junction, Hormone signaling, Morphine addiction, Neuroactive ligand signaling, Neuroactive ligand-receptor interaction, Parkinson disease, Phenylalanine metabolism, Rap1 signaling pathway, Serotonergic synapse, Tryptophan metabolism, Tyrosine metabolism, cAMP signaling pathway 💬1件: 6 💬
563Carbidopa-4'-Monophosphate1件: Carbidopa1件: Carbidopa 💬 1件: DDC 💬 8件: Alcoholism, Amphetamine addiction, Cocaine addiction, Dopaminergic synapse, Phenylalanine metabolism, Serotonergic synapse, Tryptophan metabolism, Tyrosine metabolism 💬1件: 6 💬
564Carbidopa-Levodopa2件: Carbidopa,
Levodopa
2件: Levodopa ,
Carbidopa 💬
6件: DDC,
DRD1,
DRD2,
DRD3,
DRD4,
DRD5 💬
17件: Alcoholism, Amphetamine addiction, Calcium signaling pathway, Cocaine addiction, Dopaminergic synapse, Gap junction, Hormone signaling, Morphine addiction, Neuroactive ligand signaling, Neuroactive ligand-receptor interaction, Parkinson disease, Phenylalanine metabolism, Rap1 signaling pathway, Serotonergic synapse, Tryptophan metabolism, Tyrosine metabolism, cAMP signaling pathway 💬1件: 6 💬
565Carbidopa-Levodopa 25 Mg-100 Mg Oral Tablet2件: Carbidopa,
Levodopa
2件: Levodopa ,
Carbidopa 💬
6件: DDC,
DRD1,
DRD2,
DRD3,
DRD4,
DRD5 💬
17件: Alcoholism, Amphetamine addiction, Calcium signaling pathway, Cocaine addiction, Dopaminergic synapse, Gap junction, Hormone signaling, Morphine addiction, Neuroactive ligand signaling, Neuroactive ligand-receptor interaction, Parkinson disease, Phenylalanine metabolism, Rap1 signaling pathway, Serotonergic synapse, Tryptophan metabolism, Tyrosine metabolism, cAMP signaling pathway 💬1件: 6 💬
566Carbidopa/l-dopa1件: Carbidopa1件: Carbidopa 💬 1件: DDC 💬 8件: Alcoholism, Amphetamine addiction, Cocaine addiction, Dopaminergic synapse, Phenylalanine metabolism, Serotonergic synapse, Tryptophan metabolism, Tyrosine metabolism 💬1件: 6 💬
567Carbidopa/l-dopa/entacapone2件: Carbidopa,
Entacapone
2件: Carbidopa ,
Entacapone 💬
2件: COMT,
DDC 💬
9件: Alcoholism, Amphetamine addiction, Cocaine addiction, Dopaminergic synapse, Phenylalanine metabolism, Serotonergic synapse, Steroid hormone biosynthesis, Tryptophan metabolism, Tyrosine metabolism 💬1件: 6 💬
568Carbidopa/levodopa2件: Carbidopa,
Levodopa
2件: Levodopa ,
Carbidopa 💬
6件: DDC,
DRD1,
DRD2,
DRD3,
DRD4,
DRD5 💬
17件: Alcoholism, Amphetamine addiction, Calcium signaling pathway, Cocaine addiction, Dopaminergic synapse, Gap junction, Hormone signaling, Morphine addiction, Neuroactive ligand signaling, Neuroactive ligand-receptor interaction, Parkinson disease, Phenylalanine metabolism, Rap1 signaling pathway, Serotonergic synapse, Tryptophan metabolism, Tyrosine metabolism, cAMP signaling pathway 💬1件: 6 💬
569Carbidopa/levodopa, as prescribed by treating physician2件: Carbidopa,
Levodopa
2件: Levodopa ,
Carbidopa 💬
6件: DDC,
DRD1,
DRD2,
DRD3,
DRD4,
DRD5 💬
17件: Alcoholism, Amphetamine addiction, Calcium signaling pathway, Cocaine addiction, Dopaminergic synapse, Gap junction, Hormone signaling, Morphine addiction, Neuroactive ligand signaling, Neuroactive ligand-receptor interaction, Parkinson disease, Phenylalanine metabolism, Rap1 signaling pathway, Serotonergic synapse, Tryptophan metabolism, Tyrosine metabolism, cAMP signaling pathway 💬1件: 6 💬
570Carbidopa/Levodopa, immediate release2件: Carbidopa,
Levodopa
2件: Levodopa ,
Carbidopa 💬
6件: DDC,
DRD1,
DRD2,
DRD3,
DRD4,
DRD5 💬
17件: Alcoholism, Amphetamine addiction, Calcium signaling pathway, Cocaine addiction, Dopaminergic synapse, Gap junction, Hormone signaling, Morphine addiction, Neuroactive ligand signaling, Neuroactive ligand-receptor interaction, Parkinson disease, Phenylalanine metabolism, Rap1 signaling pathway, Serotonergic synapse, Tryptophan metabolism, Tyrosine metabolism, cAMP signaling pathway 💬1件: 6 💬
571Carbidopa/Levodopa/Entacapone3件: Carbidopa,
Entacapone,
Levodopa
3件: Levodopa ,
Carbidopa ,
Entacapone 💬
7件: COMT,
DDC,
DRD1,
DRD2,
DRD3,
DRD4,
DRD5 💬
18件: Alcoholism, Amphetamine addiction, Calcium signaling pathway, Cocaine addiction, Dopaminergic synapse, Gap junction, Hormone signaling, Morphine addiction, Neuroactive ligand signaling, Neuroactive ligand-receptor interaction, Parkinson disease, Phenylalanine metabolism, Rap1 signaling pathway, Serotonergic synapse, Steroid hormone biosynthesis, Tryptophan metabolism, Tyrosine metabolism, cAMP signaling pathway 💬1件: 6 💬
572Carbidopamonohydraat----1件: 6 💬
573CARBODOPA LEVADOPA----1件: 6 💬
574Carbodopa/levadopa----1件: 6 💬
575Carbon Fiber Ankle Foot Orthosis (AFO)----1件: 6 💬
576Carbon-14 BIA 28-61561件: BIA---1件: 6 💬
577Cardiac monitoring----1件: 6 💬
578Carfentanil1件: Carfentanil2件: Carfentanil citrate ,
Carfentanil 💬
1件: OPRM1 💬 5件: Estrogen signaling pathway, Hormone signaling, Morphine addiction, Neuroactive ligand signaling, Neuroactive ligand-receptor interaction 💬1件: 6 💬
579Carnosine1件: Carnosine---2件: 6, 13 💬
580Carnosine supplementation1件: Carnosine---1件: 6 💬
581Carvedilol1件: Carvedilol2件: Carvedilol ,
Carvedilol phosphate 💬
5件: ADRA1A,
ADRA1B,
ADRA1D,
ADRB1,
ADRB2 💬
15件: AMPK signaling pathway, Adrenergic signaling in cardiomyocytes, Calcium signaling pathway, Chemical carcinogenesis - receptor activation, Dilated cardiomyopathy, Gap junction, Hormone signaling, Neuroactive ligand signaling, Neuroactive ligand-receptor interaction, Regulation of lipolysis in adipocytes, Renin secretion, Salivary secretion, Vascular smooth muscle contraction, cAMP signaling pathway, cGMP-PKG signaling pathway 💬7件: 6, 46, 57, 58, 86, 113, 210 💬
582Catapres ampoules----1件: 6 💬
583CD-LD CR----1件: 6 💬
584CD-LD IR----1件: 6 💬
585CDNF----1件: 6 💬
586Ceftriaxone1件: Ceftriaxone2件: Ceftriaxone sodium ,
Ceftriaxone 💬
--4件: 2, 6, 97, 299 💬
587CELECOXIB1件: Celecoxib1件: Celecoxib 💬 1件: PTGS2 💬 22件: Alzheimer disease, Arachidonic acid metabolism, C-type lectin receptor signaling pathway, Chemical carcinogenesis - DNA adducts, Efferocytosis, Human cytomegalovirus infection, Human papillomavirus infection, IL-17 signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Leishmaniasis, MicroRNAs in cancer, NF-kappa B signaling pathway, Ovarian steroidogenesis, Oxytocin signaling pathway, Pathways in cancer, Pathways of neurodegeneration - multiple diseases, Regulation of lipolysis in adipocytes, Retrograde endocannabinoid signaling, Serotonergic synapse, Small cell lung cancer, TNF signaling pathway, VEGF signaling pathway 💬14件: 2, 3, 6, 13, 34, 46, 70, 89, 96, 97, 107, 161, 171, 271 💬
588Celecoxib 200mg1件: Celecoxib1件: Celecoxib 💬 1件: PTGS2 💬 22件: Alzheimer disease, Arachidonic acid metabolism, C-type lectin receptor signaling pathway, Chemical carcinogenesis - DNA adducts, Efferocytosis, Human cytomegalovirus infection, Human papillomavirus infection, IL-17 signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Leishmaniasis, MicroRNAs in cancer, NF-kappa B signaling pathway, Ovarian steroidogenesis, Oxytocin signaling pathway, Pathways in cancer, Pathways of neurodegeneration - multiple diseases, Regulation of lipolysis in adipocytes, Retrograde endocannabinoid signaling, Serotonergic synapse, Small cell lung cancer, TNF signaling pathway, VEGF signaling pathway 💬1件: 6 💬
589CEP-13471件: CEP-1347---1件: 6 💬
590CEP-1347 10mg1件: CEP-1347---1件: 6 💬
591CEP-1347 50mg1件: CEP-1347---1件: 6 💬
592CEP1347----1件: 6 💬
593CEP1347 25mg----1件: 6 💬
594CERE-1201件: CERE-120---1件: 6 💬
595CERE-120 (Adeno-Associated Virus Serotype 2 [AAV2]-Neurturin [NTN])1件: CERE-120---1件: 6 💬
596CERE-120: Adeno-Associated Virus Delivery of Neurturin1件: CERE-120---1件: 6 💬
597Cerebral Dopamine Neurotrophic Factor1件: Dopamine2件: Dopamine hydrochloride ,
Dopamine 💬
5件: DRD1,
DRD2,
DRD3,
DRD4,
DRD5 💬
13件: Alcoholism, Amphetamine addiction, Calcium signaling pathway, Cocaine addiction, Dopaminergic synapse, Gap junction, Hormone signaling, Morphine addiction, Neuroactive ligand signaling, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, cAMP signaling pathway 💬1件: 6 💬
598Ceretec----1件: 6 💬
599CERETEC (TM) Estabilizado----1件: 6 💬
600Chamomile1件: Chamomile1件: German chamomile flower 💬 --1件: 6 💬
601Champix----1件: 6 💬
602Chinese herbal medicine treatment----1件: 6 💬
603Chocolate----1件: 6 💬
604Cilostazol1件: Cilostazol1件: Cilostazol 💬 3件: PDE3A,
PDE3B,
TBXA2R 💬
13件: Apelin signaling pathway, Calcium signaling pathway, Glucagon signaling pathway, Insulin signaling pathway, Morphine addiction, Neuroactive ligand-receptor interaction, Platelet activation, Progesterone-mediated oocyte maturation, Purine metabolism, Regulation of lipolysis in adipocytes, Renin secretion, cAMP signaling pathway, cGMP-PKG signaling pathway 💬7件: 6, 13, 46, 48, 51, 70, 124 💬
605CIPRALEX----1件: 6 💬
606Circadin®----1件: 6 💬
607Citalopram1件: Citalopram2件: Citalopram hydrobromide ,
Citalopram 💬
1件: SLC6A4 💬 3件: Neuroactive ligand signaling, Serotonergic synapse, Synaptic vesicle cycle 💬7件: 6, 8, 13, 18, 46, 98, 127 💬
608Citalopram 20mg1件: Citalopram2件: Citalopram hydrobromide ,
Citalopram 💬
1件: SLC6A4 💬 3件: Neuroactive ligand signaling, Serotonergic synapse, Synaptic vesicle cycle 💬1件: 6 💬
609CITICOLIN*1G/4ML IM IV 5 F----1件: 6 💬
610Citicolina 1000 mg/die----1件: 6 💬
611CITICOLINA SODICA----1件: 6 💬
612CJH1 (CLR4001)----1件: 6 💬
613Clarithromycin1件: Clarithromycin1件: Clarithromycin 💬 --10件: 6, 46, 63, 84, 96, 97, 222, 223, 228, 299 💬
614Clarithromycin (Not used as of 4/2020)1件: Clarithromycin1件: Clarithromycin 💬 --1件: 6 💬
615Clarium 50 mg Retardtabletten----1件: 6 💬
616Clartihromycin, amoxicillin, and omeprazole2件: Amoxicillin,
Omeprazole
6件: Amoxicillin ,
Omeprazole ,
Omeprazole sodium ,
Amoxicillin sodium ,
Omeprazole magnesium ,
Amoxicillin 💬
2件: ATP4A,
ATP4B 💬
3件: Collecting duct acid secretion, Gastric acid secretion, Oxidative phosphorylation 💬1件: 6 💬
617CLE----1件: 6 💬
618Clenbuterol1件: Clenbuterol2件: Clenbuterol hydrochloride ,
Clenbuterol 💬
1件: ADRB2 💬 11件: Adrenergic signaling in cardiomyocytes, Calcium signaling pathway, Chemical carcinogenesis - receptor activation, Hormone signaling, Neuroactive ligand signaling, Neuroactive ligand-receptor interaction, Regulation of lipolysis in adipocytes, Renin secretion, Salivary secretion, cAMP signaling pathway, cGMP-PKG signaling pathway 💬6件: 1, 2, 6, 57, 113, 256 💬
619Clenbuterol HCl1件: Clenbuterol2件: Clenbuterol hydrochloride ,
Clenbuterol 💬
1件: ADRB2 💬 11件: Adrenergic signaling in cardiomyocytes, Calcium signaling pathway, Chemical carcinogenesis - receptor activation, Hormone signaling, Neuroactive ligand signaling, Neuroactive ligand-receptor interaction, Regulation of lipolysis in adipocytes, Renin secretion, Salivary secretion, cAMP signaling pathway, cGMP-PKG signaling pathway 💬1件: 6 💬
620CLENBUTEROL HYDROCHLORIDE1件: Clenbuterol2件: Clenbuterol hydrochloride ,
Clenbuterol 💬
1件: ADRB2 💬 11件: Adrenergic signaling in cardiomyocytes, Calcium signaling pathway, Chemical carcinogenesis - receptor activation, Hormone signaling, Neuroactive ligand signaling, Neuroactive ligand-receptor interaction, Regulation of lipolysis in adipocytes, Renin secretion, Salivary secretion, cAMP signaling pathway, cGMP-PKG signaling pathway 💬1件: 6 💬
621Clinical DBS Setting----1件: 6 💬
622Clonazepam1件: Clonazepam1件: Clonazepam 💬 16件: GABRA1,
GABRA2,
GABRA3,
GABRA4,
GABRA5,
GABRA6,
GABRB1,
GABRB2,
GABRB3,
GABRD,
GABRE,
GABRG1,
GABRG2,
GABRG3,
GABRP,
GABRQ 💬
9件: Cadherin signaling, GABAergic synapse, Morphine addiction, Neuroactive ligand signaling, Neuroactive ligand-receptor interaction, Nicotine addiction, Retrograde endocannabinoid signaling, Serotonergic synapse, Taste transduction 💬1件: 6 💬
623Clonidine1件: Clonidine2件: Clonidine ,
Clonidine hydrochloride 💬
3件: ADRA2A,
ADRA2B,
ADRA2C 💬
4件: Hormone signaling, Neuroactive ligand signaling, Neuroactive ligand-receptor interaction, cGMP-PKG signaling pathway 💬3件: 6, 65, 70 💬
624Clonidine hydrochloride1件: Clonidine2件: Clonidine ,
Clonidine hydrochloride 💬
3件: ADRA2A,
ADRA2B,
ADRA2C 💬
4件: Hormone signaling, Neuroactive ligand signaling, Neuroactive ligand-receptor interaction, cGMP-PKG signaling pathway 💬1件: 6 💬
625CLOZAPINE1件: Clozapine1件: Clozapine 💬 11件: ADRA2A,
ADRA2B,
ADRA2C,
DRD4,
HTR2A,
HTR2C,
HTR3A,
HTR3B,
HTR3C,
HTR3D,
HTR3E 💬
10件: Calcium signaling pathway, Dopaminergic synapse, Gap junction, Hormone signaling, Inflammatory mediator regulation of TRP channels, Neuroactive ligand signaling, Neuroactive ligand-receptor interaction, Serotonergic synapse, Taste transduction, cGMP-PKG signaling pathway 💬1件: 6 💬
626Coarse wheat bran2件: Wheat,
Wheat bran
1件: Wheat 💬 --1件: 6 💬
627Cocoa1件: Cocoa---1件: 6 💬
628Coenzym Q10 Nanodispersion----2件: 5, 6 💬
629Coenzym Q10, Ubiquinon, Ubichinon----2件: 5, 6 💬
630Coenzyme Q10----11件: 2, 5, 6, 8, 10, 18, 49, 57, 107, 113, 193 💬
631Coenzyme Q10 Nanodispersion (Nanoquinone)----1件: 6 💬
632Coenzyme Q10 with vitamin E1件: Vitamin E1件: Vitamin E 💬 --1件: 6 💬
633Cogane™ (PYM50028)----1件: 6 💬
634Cohort 1:Nilotinib Oral Capsules (150mg or 300mg)1件: Nilotinib1件: Nilotinib 💬 4件: ABL1,
KIT,
PDGFRA,
PDGFRB 💬
35件: Acute myeloid leukemia, Axon guidance, Breast cancer, Cadherin signaling, Calcium signaling pathway, Cell cycle, Central carbon metabolism in cancer, Chemical carcinogenesis - reactive oxygen species, Choline metabolism in cancer, Chronic myeloid leukemia, Endocytosis, ErbB signaling pathway, Focal adhesion, Gap junction, Glioma, Hematopoietic cell lineage, Human cytomegalovirus infection, Human papillomavirus infection, IgSF CAM signaling, Integrin signaling, JAK-STAT signaling pathway, MAPK signaling pathway, Melanogenesis, Melanoma, MicroRNAs in cancer, Neurotrophin signaling pathway, PI3K-Akt signaling pathway, Pathogenic Escherichia coli infection, Pathways in cancer, Phospholipase D signaling pathway, Prostate cancer, Rap1 signaling pathway, Ras signaling pathway, Regulation of actin cytoskeleton, Viral myocarditis 💬1件: 6 💬
635Cohort 2: Nilotinib Oral Capsules (dose to be determined from Cohort 1)1件: Nilotinib1件: Nilotinib 💬 4件: ABL1,
KIT,
PDGFRA,
PDGFRB 💬
35件: Acute myeloid leukemia, Axon guidance, Breast cancer, Cadherin signaling, Calcium signaling pathway, Cell cycle, Central carbon metabolism in cancer, Chemical carcinogenesis - reactive oxygen species, Choline metabolism in cancer, Chronic myeloid leukemia, Endocytosis, ErbB signaling pathway, Focal adhesion, Gap junction, Glioma, Hematopoietic cell lineage, Human cytomegalovirus infection, Human papillomavirus infection, IgSF CAM signaling, Integrin signaling, JAK-STAT signaling pathway, MAPK signaling pathway, Melanogenesis, Melanoma, MicroRNAs in cancer, Neurotrophin signaling pathway, PI3K-Akt signaling pathway, Pathogenic Escherichia coli infection, Pathways in cancer, Phospholipase D signaling pathway, Prostate cancer, Rap1 signaling pathway, Ras signaling pathway, Regulation of actin cytoskeleton, Viral myocarditis 💬1件: 6 💬
636Collection of biological sample (blood and/or CSF)----2件: 2, 6 💬
637Combination injection of EPO and G-CSF----1件: 6 💬
638Combination Product: Fecal Microbiota Transplant1件: Fecal microbiota---1件: 6 💬
639Combination Product: Human induced pluripotent stem cell-derived dopaminergic progenitors (CT1-DAP001)----1件: 6 💬
640Combination Product: INBRIJA®----1件: 6 💬
641Combination Product: L-dopa 140 mg----1件: 6 💬
642Combination Product: L-dopa 35 mg----1件: 6 💬
643Combination Product: L-dopa 70mg----1件: 6 💬
644Combination Product: L-dopa 70mg/carbidopa 7mg1件: Carbidopa1件: Carbidopa 💬 1件: DDC 💬 8件: Alcoholism, Amphetamine addiction, Cocaine addiction, Dopaminergic synapse, Phenylalanine metabolism, Serotonergic synapse, Tryptophan metabolism, Tyrosine metabolism 💬1件: 6 💬
645Combination Product: Levodopa Cyclops®1件: Levodopa1件: Levodopa 💬 5件: DRD1,
DRD2,
DRD3,
DRD4,
DRD5 💬
13件: Alcoholism, Amphetamine addiction, Calcium signaling pathway, Cocaine addiction, Dopaminergic synapse, Gap junction, Hormone signaling, Morphine addiction, Neuroactive ligand signaling, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, cAMP signaling pathway 💬1件: 6 💬
646Combination Product: ND0612 Solution for SC infusion----1件: 6 💬
647Comparator: carbidopa1件: Carbidopa1件: Carbidopa 💬 1件: DDC 💬 8件: Alcoholism, Amphetamine addiction, Cocaine addiction, Dopaminergic synapse, Phenylalanine metabolism, Serotonergic synapse, Tryptophan metabolism, Tyrosine metabolism 💬1件: 6 💬
648Comparator: levodopa1件: Levodopa1件: Levodopa 💬 5件: DRD1,
DRD2,
DRD3,
DRD4,
DRD5 💬
13件: Alcoholism, Amphetamine addiction, Calcium signaling pathway, Cocaine addiction, Dopaminergic synapse, Gap junction, Hormone signaling, Morphine addiction, Neuroactive ligand signaling, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, cAMP signaling pathway 💬1件: 6 💬
649COMTAN----1件: 6 💬
650COMTAN 200* 60 CPR 200 MG----1件: 6 💬
651COMTAN®----1件: 6 💬
652Comtan®----1件: 6 💬
653Comtess----1件: 6 💬
654Comtess®----1件: 6 💬
655Conscious sedation----1件: 6 💬
656Continuous Apomorphine infusion1件: Apomorphine2件: Apomorphine hydrochloride ,
Apomorphine 💬
2件: DRD1,
DRD2 💬
13件: Alcoholism, Amphetamine addiction, Calcium signaling pathway, Cocaine addiction, Dopaminergic synapse, Gap junction, Hormone signaling, Morphine addiction, Neuroactive ligand signaling, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, cAMP signaling pathway 💬1件: 6 💬
657Continuous intrajejunal infusion of levodopa-carbidopa2件: Carbidopa,
Levodopa
2件: Levodopa ,
Carbidopa 💬
6件: DDC,
DRD1,
DRD2,
DRD3,
DRD4,
DRD5 💬
17件: Alcoholism, Amphetamine addiction, Calcium signaling pathway, Cocaine addiction, Dopaminergic synapse, Gap junction, Hormone signaling, Morphine addiction, Neuroactive ligand signaling, Neuroactive ligand-receptor interaction, Parkinson disease, Phenylalanine metabolism, Rap1 signaling pathway, Serotonergic synapse, Tryptophan metabolism, Tyrosine metabolism, cAMP signaling pathway 💬1件: 6 💬
658Continuous Release Dopamine Agonists1件: Dopamine2件: Dopamine hydrochloride ,
Dopamine 💬
5件: DRD1,
DRD2,
DRD3,
DRD4,
DRD5 💬
13件: Alcoholism, Amphetamine addiction, Calcium signaling pathway, Cocaine addiction, Dopaminergic synapse, Gap junction, Hormone signaling, Morphine addiction, Neuroactive ligand signaling, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, cAMP signaling pathway 💬1件: 6 💬
659Continuous Subcutaneous Lisuride Infusion1件: Lisuride1件: Lisuride 💬 3件: DRD2,
DRD3,
DRD4 💬
10件: Alcoholism, Cocaine addiction, Dopaminergic synapse, Gap junction, Hormone signaling, Neuroactive ligand signaling, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, cAMP signaling pathway 💬1件: 6 💬
660Control----8件: 2, 6, 46, 51, 90, 97, 168, 299 💬
661Control surgery----1件: 6 💬
662Controlled-release levodopa / carbidopa2件: Carbidopa,
Levodopa
2件: Levodopa ,
Carbidopa 💬
6件: DDC,
DRD1,
DRD2,
DRD3,
DRD4,
DRD5 💬
17件: Alcoholism, Amphetamine addiction, Calcium signaling pathway, Cocaine addiction, Dopaminergic synapse, Gap junction, Hormone signaling, Morphine addiction, Neuroactive ligand signaling, Neuroactive ligand-receptor interaction, Parkinson disease, Phenylalanine metabolism, Rap1 signaling pathway, Serotonergic synapse, Tryptophan metabolism, Tyrosine metabolism, cAMP signaling pathway 💬1件: 6 💬
663Conventional medication----1件: 6 💬
664CoQ10----4件: 5, 6, 8, 96 💬
665CPL500036----1件: 6 💬
666CPL500036 - high dose----1件: 6 💬
667CPL500036 - low dose----1件: 6 💬
668Creatine1件: Creatine---18件: 1, 2, 3, 5, 6, 8, 13, 15, 21, 46, 49, 50, 97, 113, 156, 201, 256, 337 💬
669CREXONT ER----1件: 6 💬
670Crisugabalin1件: Crisugabalin---2件: 6, 13 💬
671Crocin1件: Crocin---1件: 6 💬
672Crocin and Apigenin2件: Apigenin,
Crocin
---1件: 6 💬
673CST-103----1件: 6 💬
674CST-107----1件: 6 💬
675CST-139----1件: 6 💬
676Cu(II)ATSM----2件: 2, 6 💬
677Custom Device----1件: 6 💬
678Customized microinjection device----1件: 6 💬
679CVD00118-E----1件: 6 💬
680CVL-751----1件: 6 💬
681CVN424----1件: 6 💬
682CVN424 150 mg----1件: 6 💬
683CVN424 75 mg----1件: 6 💬
684CVT-301----1件: 6 💬
685CVT-301 (Dose Level 1)----1件: 6 💬
686CVT-301 (Dose Level 2)----1件: 6 💬
687CVT-301 35mg----1件: 6 💬
688CVT-301 50mg----1件: 6 💬
689CVT-301 High Dose----1件: 6 💬
690CVT-301 Low Dose----1件: 6 💬
691CVT-301, LIP----1件: 6 💬
692CVXL-0107----1件: 6 💬
693CX-8998----1件: 6 💬
694CyberKnife----1件: 6 💬
695CYMBALTA----3件: 6, 13, 49 💬
696CYR-064----1件: 6 💬
697Cysteine1件: Cysteine2件: L-Cysteine ,
Cysteine hydrochloride 💬
--13件: 6, 13, 19, 34, 60, 84, 85, 88, 90, 254, 296, 310, 337 💬
698Cystoscopic injection of Botox into the urinary bladder----1件: 6 💬
699D-Serine2件: D-Serine,
Serine
1件: Serine 💬 --1件: 6 💬
700D-serine (~2g/day)2件: D-Serine,
Serine
1件: Serine 💬 --1件: 6 💬
701DA-9701----1件: 6 💬
702DA-9805 45mg----1件: 6 💬
703DA-9805 90mg----1件: 6 💬
704DAAOI-P----1件: 6 💬
705Dacepton 5 mg/ml----1件: 6 💬
706Dacepton 5 mg/ml infuusioneste, liuos----1件: 6 💬
707Daily ingestion of Lactobacillus plantarum PS1281件: Lactobacillus plantarum---1件: 6 💬
708Dapagliflozin1件: Dapagliflozin1件: Dapagliflozin 💬 --16件: 6, 19, 28, 40, 41, 49, 57, 66, 67, 86, 88, 97, 210, 215, 218, 222 💬
709Dapansutrile1件: Dapansutrile1件: Dapansutrile 💬 --1件: 6 💬
710Daridorexant1件: Daridorexant2件: Daridorexant ,
Daridorexant hydrochloride 💬
2件: HCRTR1,
HCRTR2 💬
2件: Hormone signaling, Neuroactive ligand-receptor interaction 💬1件: 6 💬
711Darifenacin1件: Darifenacin2件: Darifenacin hydrobromide ,
Darifenacin 💬
1件: CHRM3 💬 12件: Alzheimer disease, Calcium signaling pathway, Cholinergic synapse, Gastric acid secretion, Insulin secretion, Neuroactive ligand signaling, Neuroactive ligand-receptor interaction, Pancreatic secretion, Pathways of neurodegeneration - multiple diseases, Regulation of actin cytoskeleton, Salivary secretion, Taste transduction 💬4件: 2, 6, 13, 26 💬
712Dark chocolate (85% cocoa)1件: Cocoa---1件: 6 💬
713DaTSCAN----3件: 2, 5, 6 💬
714DaTSCAN 74 MBq/ml solution for injection----1件: 6 💬
715DATscan and SPECT imaging----1件: 6 💬
716DaTSCAN™----1件: 6 💬
717DBS Setting Maximizing Prefrontal Activation----1件: 6 💬
718DBS Setting Minimizing Prefrontal Activation----1件: 6 💬
719DC158AM----1件: 6 💬
720Deanol1件: Deanol1件: Deanol 💬 --1件: 6 💬
721Deanol pyroglutamate1件: Deanol1件: Deanol 💬 --1件: 6 💬
722DEBRUMYL----1件: 6 💬
723Deep Brain Stimulation----5件: 5, 6, 7, 8, 17 💬
724DEFERIPRONE1件: Deferiprone1件: Deferiprone 💬 --7件: 2, 6, 18, 121, 122, 139, 233 💬
725Deferiprone (Ferriprox)1件: Deferiprone1件: Deferiprone 💬 --2件: 6, 139 💬
726Deferiprone 20mg1件: Deferiprone1件: Deferiprone 💬 --1件: 6 💬
727Deferiprone 30mg1件: Deferiprone1件: Deferiprone 💬 --1件: 6 💬
728Deferiprone 600 mg delayed release tablet1件: Deferiprone1件: Deferiprone 💬 --1件: 6 💬
729Deferiprone DR1件: Deferiprone1件: Deferiprone 💬 --2件: 2, 6 💬
730Desmopressin1件: Desmopressin2件: Desmopressin ,
Desmopressin acetate 💬
2件: AVPR2,
F8 💬
5件: Complement and coagulation cascades, Hormone signaling, Neuroactive ligand-receptor interaction, Phospholipase D signaling pathway, Vasopressin-regulated water reabsorption 💬8件: 6, 22, 64, 72, 75, 223, 225, 288 💬
731Desmopressin Acetat1件: Desmopressin2件: Desmopressin ,
Desmopressin acetate 💬
2件: AVPR2,
F8 💬
5件: Complement and coagulation cascades, Hormone signaling, Neuroactive ligand-receptor interaction, Phospholipase D signaling pathway, Vasopressin-regulated water reabsorption 💬1件: 6 💬
732Desmotabs----1件: 6 💬
733Desmotabs® 0,2 mg Tabletten----1件: 6 💬
734Desmotabs® 0,2mg Tabletten----1件: 6 💬
735Determination of drug effects through amantadine cessation1件: Amantadine2件: Amantadine hydrochloride ,
Amantadine 💬
5件: GRIN1,
GRIN2A,
GRIN2B,
GRIN2C,
GRIN2D 💬
21件: Alcoholism, Alzheimer disease, Amphetamine addiction, Amyotrophic lateral sclerosis, Calcium signaling pathway, Circadian entrainment, Cocaine addiction, Dopaminergic synapse, Glutamatergic synapse, Huntington disease, Long-term potentiation, Neuroactive ligand signaling, Neuroactive ligand-receptor interaction, Nicotine addiction, Pathways of neurodegeneration - multiple diseases, Prion disease, Rap1 signaling pathway, Ras signaling pathway, Spinocerebellar ataxia, Systemic lupus erythematosus, cAMP signaling pathway 💬1件: 6 💬
736Dexdor----4件: 2, 4, 6, 70 💬
737DEXMEDETOMIDINA1件: Dexmedetomidine2件: Dexmedetomidine ,
Dexmedetomidine hydrochloride 💬
3件: ADRA2A,
ADRA2B,
ADRA2C 💬
4件: Hormone signaling, Neuroactive ligand signaling, Neuroactive ligand-receptor interaction, cGMP-PKG signaling pathway 💬1件: 6 💬
738DEXMEDETOMIDINE1件: Dexmedetomidine2件: Dexmedetomidine ,
Dexmedetomidine hydrochloride 💬
3件: ADRA2A,
ADRA2B,
ADRA2C 💬
4件: Hormone signaling, Neuroactive ligand signaling, Neuroactive ligand-receptor interaction, cGMP-PKG signaling pathway 💬15件: 2, 4, 6, 21, 22, 34, 46, 70, 107, 113, 171, 212, 215, 226, 280 💬
739Dexmedetomidine Hydrochloride Infusion1件: Dexmedetomidine2件: Dexmedetomidine ,
Dexmedetomidine hydrochloride 💬
3件: ADRA2A,
ADRA2B,
ADRA2C 💬
4件: Hormone signaling, Neuroactive ligand signaling, Neuroactive ligand-receptor interaction, cGMP-PKG signaling pathway 💬1件: 6 💬
740Dextromethorphan1件: Dextromethorphan3件: Dextromethorphan hydrobromide ,
Dextromethorphan ,
Dextromethorphan polistirex 💬
6件: GRIN1,
GRIN2A,
GRIN2B,
GRIN2C,
GRIN2D,
SIGMAR1 💬
21件: Alcoholism, Alzheimer disease, Amphetamine addiction, Amyotrophic lateral sclerosis, Calcium signaling pathway, Circadian entrainment, Cocaine addiction, Dopaminergic synapse, Glutamatergic synapse, Huntington disease, Long-term potentiation, Neuroactive ligand signaling, Neuroactive ligand-receptor interaction, Nicotine addiction, Pathways of neurodegeneration - multiple diseases, Prion disease, Rap1 signaling pathway, Ras signaling pathway, Spinocerebellar ataxia, Systemic lupus erythematosus, cAMP signaling pathway 💬10件: 2, 6, 8, 13, 21, 46, 85, 96, 97, 156 💬
741Diagnostic Test: 123I-MIBG----1件: 6 💬
742Diagnostic Test: [123I] MIBG scintigraphy of the heart----1件: 6 💬
743Diagnostic Test: [18F]-RO6958948----6件: 2, 5, 6, 7, 17, 127 💬
744Diagnostic Test: a-synuclein seeding amplification assays----1件: 6 💬
745Diagnostic Test: Assessment of dynamic EEG features over 48-hour periods across all study aims----1件: 6 💬
746Diagnostic Test: Beam test to predict falls----1件: 6 💬
747Diagnostic Test: Blood samples----4件: 6, 49, 56, 235 💬
748Diagnostic Test: Blood test and clinical examination.----1件: 6 💬
749Diagnostic Test: brain imaging----1件: 6 💬
750Diagnostic Test: Cognitive Battery----1件: 6 💬
751Diagnostic Test: computerized dynamic posturography----1件: 6 💬
752Diagnostic Test: Dopamine transporter PET scan with [18F]FE-PE2I1件: Dopamine2件: Dopamine hydrochloride ,
Dopamine 💬
5件: DRD1,
DRD2,
DRD3,
DRD4,
DRD5 💬
13件: Alcoholism, Amphetamine addiction, Calcium signaling pathway, Cocaine addiction, Dopaminergic synapse, Gap junction, Hormone signaling, Morphine addiction, Neuroactive ligand signaling, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, cAMP signaling pathway 💬1件: 6 💬
753Diagnostic Test: Elecsys (Roche) Abeta42, Ttau and Ptau----6件: 2, 5, 6, 7, 17, 127 💬
754Diagnostic Test: Electroencephalogram----2件: 6, 127 💬
755Diagnostic Test: electromyography----2件: 2, 6 💬
756Diagnostic Test: Ewing's tests----1件: 6 💬
757Diagnostic Test: Examination of vibration perception threshold in fingertips----1件: 6 💬
758Diagnostic Test: FDG-PET----1件: 6 💬
759Diagnostic Test: Fluoro[18F]promethazine1件: Promethazine3件: Promethazine hydrochloride ,
Promethazine ,
Promethazine teoclate 💬
1件: HRH1 💬 4件: Calcium signaling pathway, Inflammatory mediator regulation of TRP channels, Neuroactive ligand signaling, Neuroactive ligand-receptor interaction 💬1件: 6 💬
760Diagnostic Test: Flutemetamol F18 Injection1件: Flutemetamol---6件: 2, 5, 6, 7, 17, 127 💬
761Diagnostic Test: Inertial measurement Unite----1件: 6 💬
762Diagnostic Test: Lumipulse (Fujirebio) Abeta42, Ttau and Ptau----6件: 2, 5, 6, 7, 17, 127 💬
763Diagnostic Test: Magnetic resonance imaging (MRI)----1件: 6 💬
764Diagnostic Test: Measurement of serum level of anti-dementia drug----1件: 6 💬
765Diagnostic Test: Motion Capture system----1件: 6 💬
766Diagnostic Test: Multi modal MRI----1件: 6 💬
767Diagnostic Test: Neuropsycological assesment----1件: 6 💬
768Diagnostic Test: Oral Glucose Tolerance Test----6件: 6, 13, 57, 65, 77, 299 💬
769Diagnostic Test: Plasma biomarkers----1件: 6 💬
770Diagnostic Test: Polar H10 Heart Sensor----1件: 6 💬
771Diagnostic Test: Polysomnography----1件: 6 💬
772Diagnostic Test: Sham Comparator: Controls----1件: 6 💬
773Diagnostic Test: Smell test----1件: 6 💬
774Diagnostic Test: Thermography----1件: 6 💬
775Diagnostic Test: Tilt table test----1件: 6 💬
776Diagnostic Test: Virtual reality----1件: 6 💬
777Different diets----1件: 6 💬
778DIGIPARK MONITOR----1件: 6 💬
779Dihydroergot mesylate----1件: 6 💬
780Dihydroergotine mesylate sustained-release tablets----1件: 6 💬
781Dihydroergotoxine1件: Dihydroergotoxine1件: Dihydroergotoxine 💬 --1件: 6 💬
782Dipivefrin1件: Dipivefrin2件: Dipivefrin hydrochloride ,
Dipivefrin 💬
9件: ADRA1A,
ADRA1B,
ADRA1D,
ADRA2A,
ADRA2B,
ADRA2C,
ADRB1,
ADRB2,
ADRB3 💬
16件: AMPK signaling pathway, Adrenergic signaling in cardiomyocytes, Calcium signaling pathway, Chemical carcinogenesis - receptor activation, Dilated cardiomyopathy, Gap junction, Hormone signaling, Neuroactive ligand signaling, Neuroactive ligand-receptor interaction, Regulation of lipolysis in adipocytes, Renin secretion, Salivary secretion, Thermogenesis, Vascular smooth muscle contraction, cAMP signaling pathway, cGMP-PKG signaling pathway 💬1件: 6 💬
783Dipraglurant1件: Dipraglurant---1件: 6 💬
784Ditropan elixir----1件: 6 💬
785DM-1992----1件: 6 💬
786DNL151----1件: 6 💬
787DNL151, DN0001575, DN1575----1件: 6 💬
788DNL201----1件: 6 💬
789DNS-7801 (high dose)----1件: 6 💬
790DNS-7801 (low-dose)----1件: 6 💬
791Docosahexaenoic Acid (DHA)----3件: 6, 94, 299 💬
792Domperidone1件: Domperidone2件: Domperidone ,
Domperidone maleate 💬
1件: DRD2 💬 10件: Alcoholism, Cocaine addiction, Dopaminergic synapse, Gap junction, Hormone signaling, Neuroactive ligand signaling, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, cAMP signaling pathway 💬5件: 6, 13, 17, 51, 230 💬
793Domperidone (drug)1件: Domperidone2件: Domperidone ,
Domperidone maleate 💬
1件: DRD2 💬 10件: Alcoholism, Cocaine addiction, Dopaminergic synapse, Gap junction, Hormone signaling, Neuroactive ligand signaling, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, cAMP signaling pathway 💬1件: 6 💬
794Dompéridone----1件: 6 💬
795Donepezil1件: Donepezil2件: Donepezil hydrochloride ,
Donepezil 💬
1件: ACHE 💬 3件: Cholinergic synapse, Glycerophospholipid metabolism, Neuroactive ligand signaling 💬8件: 5, 6, 13, 46, 124, 127, 156, 206 💬
796Donepezil (Aricept)1件: Donepezil2件: Donepezil hydrochloride ,
Donepezil 💬
1件: ACHE 💬 3件: Cholinergic synapse, Glycerophospholipid metabolism, Neuroactive ligand signaling 💬1件: 6 💬
797Donepezil Hydrochloride1件: Donepezil2件: Donepezil hydrochloride ,
Donepezil 💬
1件: ACHE 💬 3件: Cholinergic synapse, Glycerophospholipid metabolism, Neuroactive ligand signaling 💬3件: 6, 124, 156 💬
798Donepezil Sandoz1件: Donepezil2件: Donepezil hydrochloride ,
Donepezil 💬
1件: ACHE 💬 3件: Cholinergic synapse, Glycerophospholipid metabolism, Neuroactive ligand signaling 💬1件: 6 💬
799Dopacell----1件: 6 💬
800DopaFuse Delivery System----1件: 6 💬
801Dopamine1件: Dopamine2件: Dopamine hydrochloride ,
Dopamine 💬
5件: DRD1,
DRD2,
DRD3,
DRD4,
DRD5 💬
13件: Alcoholism, Amphetamine addiction, Calcium signaling pathway, Cocaine addiction, Dopaminergic synapse, Gap junction, Hormone signaling, Morphine addiction, Neuroactive ligand signaling, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, cAMP signaling pathway 💬5件: 6, 7, 17, 74, 77 💬
802Dopamine Agent1件: Dopamine2件: Dopamine hydrochloride ,
Dopamine 💬
5件: DRD1,
DRD2,
DRD3,
DRD4,
DRD5 💬
13件: Alcoholism, Amphetamine addiction, Calcium signaling pathway, Cocaine addiction, Dopaminergic synapse, Gap junction, Hormone signaling, Morphine addiction, Neuroactive ligand signaling, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, cAMP signaling pathway 💬1件: 6 💬
803Dopamine Agonists (pramipexole, ropirinole)2件: Dopamine,
Pramipexole
4件: Pramipexole dihydrochloride ,
Dopamine hydrochloride ,
Pramipexole ,
Dopamine 💬
5件: DRD1,
DRD2,
DRD3,
DRD4,
DRD5 💬
13件: Alcoholism, Amphetamine addiction, Calcium signaling pathway, Cocaine addiction, Dopaminergic synapse, Gap junction, Hormone signaling, Morphine addiction, Neuroactive ligand signaling, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, cAMP signaling pathway 💬1件: 6 💬
804Dopaminergic Agonist + Apomorphine1件: Apomorphine2件: Apomorphine hydrochloride ,
Apomorphine 💬
2件: DRD1,
DRD2 💬
13件: Alcoholism, Amphetamine addiction, Calcium signaling pathway, Cocaine addiction, Dopaminergic synapse, Gap junction, Hormone signaling, Morphine addiction, Neuroactive ligand signaling, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, cAMP signaling pathway 💬1件: 6 💬
805Dopaminergic Agonists----1件: 6 💬
806Dopaminergic medication----1件: 6 💬
807Doxepin1件: Doxepin2件: Doxepin hydrochloride ,
Doxepin 💬
3件: HRH1,
SLC6A2,
SLC6A4 💬
6件: Calcium signaling pathway, Inflammatory mediator regulation of TRP channels, Neuroactive ligand signaling, Neuroactive ligand-receptor interaction, Serotonergic synapse, Synaptic vesicle cycle 💬1件: 6 💬
808Doxepin and Zopiclone2件: Doxepin,
Zopiclone
3件: Doxepin hydrochloride ,
Zopiclone ,
Doxepin 💬
19件: GABRA1,
GABRA2,
GABRA3,
GABRA4,
GABRA5,
GABRA6,
GABRB1,
GABRB2,
GABRB3,
GABRD,
GABRE,
GABRG1,
GABRG2,
GABRG3,
GABRP,
GABRQ,
HRH1,
SLC6A2,
SLC6A4 💬
12件: Cadherin signaling, Calcium signaling pathway, GABAergic synapse, Inflammatory mediator regulation of TRP channels, Morphine addiction, Neuroactive ligand signaling, Neuroactive ligand-receptor interaction, Nicotine addiction, Retrograde endocannabinoid signaling, Serotonergic synapse, Synaptic vesicle cycle, Taste transduction 💬1件: 6 💬
809DPA-714 Metabolite Analysis----1件: 6 💬
810DPA-714-PET/MRI----1件: 6 💬
811Droxidopa1件: Droxidopa1件: Droxidopa 💬 9件: ADRA1A,
ADRA1B,
ADRA1D,
ADRA2A,
ADRA2B,
ADRA2C,
ADRB1,
ADRB2,
ADRB3 💬
16件: AMPK signaling pathway, Adrenergic signaling in cardiomyocytes, Calcium signaling pathway, Chemical carcinogenesis - receptor activation, Dilated cardiomyopathy, Gap junction, Hormone signaling, Neuroactive ligand signaling, Neuroactive ligand-receptor interaction, Regulation of lipolysis in adipocytes, Renin secretion, Salivary secretion, Thermogenesis, Vascular smooth muscle contraction, cAMP signaling pathway, cGMP-PKG signaling pathway 💬5件: 5, 6, 17, 169, 170 💬
812Droxidopa 100 MG [Northera]1件: Droxidopa1件: Droxidopa 💬 9件: ADRA1A,
ADRA1B,
ADRA1D,
ADRA2A,
ADRA2B,
ADRA2C,
ADRB1,
ADRB2,
ADRB3 💬
16件: AMPK signaling pathway, Adrenergic signaling in cardiomyocytes, Calcium signaling pathway, Chemical carcinogenesis - receptor activation, Dilated cardiomyopathy, Gap junction, Hormone signaling, Neuroactive ligand signaling, Neuroactive ligand-receptor interaction, Regulation of lipolysis in adipocytes, Renin secretion, Salivary secretion, Thermogenesis, Vascular smooth muscle contraction, cAMP signaling pathway, cGMP-PKG signaling pathway 💬1件: 6 💬
813DSP-9632P 27.5 mg----1件: 6 💬
814DSP-9632P 55.0 mg----1件: 6 💬
815DSP-9632P 82.5 mg----1件: 6 💬
816Duloxetine1件: Duloxetine2件: Duloxetine hydrochloride ,
Duloxetine 💬
2件: SLC6A2,
SLC6A4 💬
3件: Neuroactive ligand signaling, Serotonergic synapse, Synaptic vesicle cycle 💬3件: 6, 13, 97 💬
817Duloxetine hydrochloride1件: Duloxetine2件: Duloxetine hydrochloride ,
Duloxetine 💬
2件: SLC6A2,
SLC6A4 💬
3件: Neuroactive ligand signaling, Serotonergic synapse, Synaptic vesicle cycle 💬1件: 6 💬
818DUODOPA----1件: 6 💬
819Duodopa gel intestinale----1件: 6 💬
820Duodopa intestinal gel----1件: 6 💬
821Duodopa intestinalgel----1件: 6 💬
822Duodopa LD/CD 20/5 mg/mL----1件: 6 💬
823Duodopa, 20 mg/ml + 5 mg/ml, intestinal gel----1件: 6 💬
824Duodopa, levodopa 20 mg/ml + carbidopa 5 mg/ml, intestinal gel2件: Carbidopa,
Levodopa
2件: Levodopa ,
Carbidopa 💬
6件: DDC,
DRD1,
DRD2,
DRD3,
DRD4,
DRD5 💬
17件: Alcoholism, Amphetamine addiction, Calcium signaling pathway, Cocaine addiction, Dopaminergic synapse, Gap junction, Hormone signaling, Morphine addiction, Neuroactive ligand signaling, Neuroactive ligand-receptor interaction, Parkinson disease, Phenylalanine metabolism, Rap1 signaling pathway, Serotonergic synapse, Tryptophan metabolism, Tyrosine metabolism, cAMP signaling pathway 💬1件: 6 💬
825DUODOPA®Intestinal Gel----1件: 6 💬
826Dynacirc CR (Isradipine)1件: Isradipine1件: Isradipine 💬 4件: CACNA1C,
CACNA1D,
CACNA1F,
CACNA1S 💬
37件: Adrenergic signaling in cardiomyocytes, Aldosterone synthesis and secretion, Alzheimer disease, Amphetamine addiction, Arrhythmogenic right ventricular cardiomyopathy, Calcium signaling pathway, Carbohydrate digestion and absorption, Cardiac muscle contraction, Cellular senescence, Chemical carcinogenesis - receptor activation, Cholinergic synapse, Circadian entrainment, Cortisol synthesis and secretion, Cushing syndrome, Dilated cardiomyopathy, Dopaminergic synapse, GABAergic synapse, Glutamatergic synapse, GnRH secretion, GnRH signaling pathway, Growth hormone synthesis, secretion and action, Hypertrophic cardiomyopathy, Insulin secretion, Long-term potentiation, MAPK signaling pathway, Oxytocin signaling pathway, Pathways of neurodegeneration - multiple diseases, Prion disease, Renin secretion, Retrograde endocannabinoid signaling, Serotonergic synapse, Taste transduction, Tight junction, Type II diabetes mellitus, Vascular smooth muscle contraction, cAMP signaling pathway, cGMP-PKG signaling pathway 💬1件: 6 💬
827E2007----2件: 6, 144 💬
828E2027----1件: 6 💬
829EBIXA----3件: 2, 6, 13 💬
830EBIXA®----1件: 6 💬
831EC5026 oral tablet----2件: 6, 70 💬
832EDARAVONE1件: Edaravone1件: Edaravone 💬 --3件: 2, 6, 22 💬
833ELC200----1件: 6 💬
834Electroacupuncture----2件: 6, 70 💬
835Electrolyte Beverage----1件: 6 💬
836Eliprodil1件: Eliprodil---1件: 6 💬
837Elobixibat1件: Elobixibat1件: Elobixibat 💬 1件: SLC10A2 💬 1件: Bile secretion 💬1件: 6 💬
838ELTOPRAZINE1件: Eltoprazine---1件: 6 💬
839Eltoprazine HCl1件: Eltoprazine---1件: 6 💬
840Eltoprazine Hydrochloride1件: Eltoprazine---1件: 6 💬
841Embryonic dopamine cell implant surgery1件: Dopamine2件: Dopamine hydrochloride ,
Dopamine 💬
5件: DRD1,
DRD2,
DRD3,
DRD4,
DRD5 💬
13件: Alcoholism, Amphetamine addiction, Calcium signaling pathway, Cocaine addiction, Dopaminergic synapse, Gap junction, Hormone signaling, Morphine addiction, Neuroactive ligand signaling, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, cAMP signaling pathway 💬1件: 6 💬
842EMD 128130----2件: 6, 156 💬
843EMD128130----1件: 6 💬
844EN----1件: 6 💬
845ENA713----2件: 6, 13 💬
846ENA713B----1件: 6 💬
847ENERGI-F705 Tablets----1件: 6 💬
848EnFuse----1件: 6 💬
849ENT-01----1件: 6 💬
850Entacapon----1件: 6 💬
851ENTACAPONA----1件: 6 💬
852ENTACAPONE1件: Entacapone1件: Entacapone 💬 1件: COMT 💬 3件: Dopaminergic synapse, Steroid hormone biosynthesis, Tyrosine metabolism 💬2件: 6, 17 💬
853Entacapone 400mg oral dose1件: Entacapone1件: Entacapone 💬 1件: COMT 💬 3件: Dopaminergic synapse, Steroid hormone biosynthesis, Tyrosine metabolism 💬2件: 6, 17 💬
854Entacapone and carbidopa2件: Carbidopa,
Entacapone
2件: Carbidopa ,
Entacapone 💬
2件: COMT,
DDC 💬
9件: Alcoholism, Amphetamine addiction, Cocaine addiction, Dopaminergic synapse, Phenylalanine metabolism, Serotonergic synapse, Steroid hormone biosynthesis, Tryptophan metabolism, Tyrosine metabolism 💬1件: 6 💬
855ENTACAPONE INN1件: Entacapone1件: Entacapone 💬 1件: COMT 💬 3件: Dopaminergic synapse, Steroid hormone biosynthesis, Tyrosine metabolism 💬1件: 6 💬
856Entecapone----1件: 6 💬
857EPI-5891件: EPI-589---2件: 2, 6 💬
858EPI-743 200mg----1件: 6 💬
859EPI-743 400mg----1件: 6 💬
860Equfina----1件: 6 💬
861Equfina 50 mg----1件: 6 💬
862ER CD-LD----1件: 6 💬
863ER tablet 100 mg AZD3241----1件: 6 💬
864ER tablet 25 mg AZD3241----1件: 6 💬
865Eradication of Helcobacter Pylori----1件: 6 💬
866Eradication therapy for H.pylori infection----1件: 6 💬
867Eradication therapy for Helicobacter pylori----1件: 6 💬
868Eril®----2件: 2, 6 💬
869Erythromycin1件: Erythromycin7件: Erythromycin ,
Erythromycin estolate ,
Erythromycin ethylsuccinate ,
Erythromycin lactobionate ,
Erythromycin stearate ,
Erythromycin gluceptate ,
Erythromycin thiocyanate 💬
--6件: 2, 6, 36, 164, 228, 291 💬
870ERYTHROPOIETIN1件: Erythropoietin4件: Epoetin alfa ,
Epoetin epsilon ,
Epoetin theta ,
Epoetin zeta 💬
1件: EPOR 💬 7件: Cytokine-cytokine receptor interaction, Efferocytosis, Hematopoietic cell lineage, Hormone signaling, JAK-STAT signaling pathway, PI3K-Akt signaling pathway, Pathways in cancer 💬11件: 2, 6, 13, 18, 22, 47, 61, 63, 70, 95, 96 💬
871Erythropoietin human recombinant (EPOrh)1件: Erythropoietin4件: Epoetin alfa ,
Epoetin epsilon ,
Epoetin theta ,
Epoetin zeta 💬
1件: EPOR 💬 7件: Cytokine-cytokine receptor interaction, Efferocytosis, Hematopoietic cell lineage, Hormone signaling, JAK-STAT signaling pathway, PI3K-Akt signaling pathway, Pathways in cancer 💬1件: 6 💬
872Escitalopram1件: Escitalopram2件: Escitalopram oxalate ,
Escitalopram 💬
1件: SLC6A4 💬 3件: Neuroactive ligand signaling, Serotonergic synapse, Synaptic vesicle cycle 💬5件: 2, 6, 13, 46, 77 💬
873Escitalopram oxalate1件: Escitalopram2件: Escitalopram oxalate ,
Escitalopram 💬
1件: SLC6A4 💬 3件: Neuroactive ligand signaling, Serotonergic synapse, Synaptic vesicle cycle 💬1件: 6 💬
874ESKETAMINE1件: Esketamine2件: Esketamine ,
Esketamine hydrochloride 💬
5件: GRIN1,
GRIN2A,
GRIN2B,
GRIN2C,
GRIN2D 💬
21件: Alcoholism, Alzheimer disease, Amphetamine addiction, Amyotrophic lateral sclerosis, Calcium signaling pathway, Circadian entrainment, Cocaine addiction, Dopaminergic synapse, Glutamatergic synapse, Huntington disease, Long-term potentiation, Neuroactive ligand signaling, Neuroactive ligand-receptor interaction, Nicotine addiction, Pathways of neurodegeneration - multiple diseases, Prion disease, Rap1 signaling pathway, Ras signaling pathway, Spinocerebellar ataxia, Systemic lupus erythematosus, cAMP signaling pathway 💬7件: 2, 4, 6, 70, 96, 97, 156 💬
875Esomeprazole1件: Esomeprazole5件: Esomeprazole magnesium ,
Esomeprazole sodium ,
Esomeprazole ,
Esomeprazole strontium ,
Esomeprazole magnesium dihydrate 💬
2件: ATP4A,
ATP4B 💬
3件: Collecting duct acid secretion, Gastric acid secretion, Oxidative phosphorylation 💬10件: 6, 13, 46, 86, 98, 107, 113, 234, 298, 299 💬
876Eszopiclone1件: Eszopiclone1件: Eszopiclone 💬 16件: GABRA1,
GABRA2,
GABRA3,
GABRA4,
GABRA5,
GABRA6,
GABRB1,
GABRB2,
GABRB3,
GABRD,
GABRE,
GABRG1,
GABRG2,
GABRG3,
GABRP,
GABRQ 💬
9件: Cadherin signaling, GABAergic synapse, Morphine addiction, Neuroactive ligand signaling, Neuroactive ligand-receptor interaction, Nicotine addiction, Retrograde endocannabinoid signaling, Serotonergic synapse, Taste transduction 💬3件: 6, 13, 46 💬
877ETHNODYNE VISIO----1件: 6 💬
878Ethylmethylcarbamic acid 3-[(1S)-1-(dimethylamino)ethyl]phenyl ester (**See other 2 names below)----1件: 6 💬
879Etomidate1件: Etomidate1件: Etomidate 💬 1件: GABRA1 💬 8件: Cadherin signaling, GABAergic synapse, Morphine addiction, Neuroactive ligand signaling, Neuroactive ligand-receptor interaction, Nicotine addiction, Retrograde endocannabinoid signaling, Taste transduction 💬2件: 6, 11 💬
880Etoricoxib1件: Etoricoxib1件: Etoricoxib 💬 1件: PTGS2 💬 22件: Alzheimer disease, Arachidonic acid metabolism, C-type lectin receptor signaling pathway, Chemical carcinogenesis - DNA adducts, Efferocytosis, Human cytomegalovirus infection, Human papillomavirus infection, IL-17 signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Leishmaniasis, MicroRNAs in cancer, NF-kappa B signaling pathway, Ovarian steroidogenesis, Oxytocin signaling pathway, Pathways in cancer, Pathways of neurodegeneration - multiple diseases, Regulation of lipolysis in adipocytes, Retrograde endocannabinoid signaling, Serotonergic synapse, Small cell lung cancer, TNF signaling pathway, VEGF signaling pathway 💬5件: 6, 46, 70, 165, 271 💬
881Evaluation of mathematical models----1件: 6 💬
882Exablate MRgFUS subthalamotomy----1件: 6 💬
883Exametazime1件: Exametazime1件: Exametazime 💬 --1件: 6 💬
884EXELON----2件: 6, 13 💬
885Exelon 4.6 mg/24 h transdermal patch----1件: 6 💬
886Exelon 9.5 mg/24 h transdermal patch----1件: 6 💬
887Exelon Patch (rivastigmine transdermal system)1件: Rivastigmine2件: Rivastigmine tartrate ,
Rivastigmine 💬
1件: ACHE 💬 3件: Cholinergic synapse, Glycerophospholipid metabolism, Neuroactive ligand signaling 💬1件: 6 💬
888Exelon path transdermal----1件: 6 💬
889Exelon ®----1件: 6 💬
890EXENATIDE1件: Exenatide1件: Exenatide 💬 1件: GLP1R 💬 4件: Hormone signaling, Insulin secretion, Neuroactive ligand-receptor interaction, cAMP signaling pathway 💬6件: 6, 17, 72, 78, 193, 233 💬
891Exenatide 10 micrograms1件: Exenatide1件: Exenatide 💬 1件: GLP1R 💬 4件: Hormone signaling, Insulin secretion, Neuroactive ligand-receptor interaction, cAMP signaling pathway 💬1件: 6 💬
892Exenatide 5 micrograms1件: Exenatide1件: Exenatide 💬 1件: GLP1R 💬 4件: Hormone signaling, Insulin secretion, Neuroactive ligand-receptor interaction, cAMP signaling pathway 💬1件: 6 💬
893Exenatide extended release 2mg (Bydureon)1件: Exenatide1件: Exenatide 💬 1件: GLP1R 💬 4件: Hormone signaling, Insulin secretion, Neuroactive ligand-receptor interaction, cAMP signaling pathway 💬1件: 6 💬
894Exergame----2件: 6, 13 💬
895Exidavnemab1件: Exidavnemab---2件: 6, 17 💬
896EXN-32----1件: 6 💬
897EXN-32 (CARBIDOPA E LEVODOPA)2件: Carbidopa,
Levodopa
2件: Levodopa ,
Carbidopa 💬
6件: DDC,
DRD1,
DRD2,
DRD3,
DRD4,
DRD5 💬
17件: Alcoholism, Amphetamine addiction, Calcium signaling pathway, Cocaine addiction, Dopaminergic synapse, Gap junction, Hormone signaling, Morphine addiction, Neuroactive ligand signaling, Neuroactive ligand-receptor interaction, Parkinson disease, Phenylalanine metabolism, Rap1 signaling pathway, Serotonergic synapse, Tryptophan metabolism, Tyrosine metabolism, cAMP signaling pathway 💬1件: 6 💬
898EXN-44----1件: 6 💬
899EXN-44(LEVODOPA)1件: Levodopa1件: Levodopa 💬 5件: DRD1,
DRD2,
DRD3,
DRD4,
DRD5 💬
13件: Alcoholism, Amphetamine addiction, Calcium signaling pathway, Cocaine addiction, Dopaminergic synapse, Gap junction, Hormone signaling, Morphine addiction, Neuroactive ligand signaling, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, cAMP signaling pathway 💬1件: 6 💬
900Extended Release Melatonin1件: Melatonin1件: Melatonin 💬 2件: MTNR1A,
MTNR1B 💬
2件: Circadian entrainment, Neuroactive ligand-receptor interaction 💬1件: 6 💬
901F-18 FPCIT----1件: 6 💬
902Famotidine1件: Famotidine1件: Famotidine 💬 1件: HRH2 💬 4件: Calcium signaling pathway, Gastric acid secretion, Neuroactive ligand signaling, Neuroactive ligand-receptor interaction 💬7件: 6, 46, 86, 98, 107, 145, 300 💬
903Fasting blood test----1件: 6 💬
904Fasudil1件: Fasudil2件: Fasudil hydrochloride ,
Fasudil 💬
2件: ROCK1,
ROCK2 💬
25件: Adherens junction, Axon guidance, Cadherin signaling, Chemokine signaling pathway, Focal adhesion, Human cytomegalovirus infection, Leukocyte transendothelial migration, Lipid and atherosclerosis, MicroRNAs in cancer, Oxytocin signaling pathway, Pathogenic Escherichia coli infection, Pathways in cancer, Platelet activation, Proteoglycans in cancer, Regulation of actin cytoskeleton, Salmonella infection, Shigellosis, Sphingolipid signaling pathway, TGF-beta signaling pathway, Tight junction, Vascular smooth muscle contraction, Wnt signaling pathway, Yersinia infection, cAMP signaling pathway, cGMP-PKG signaling pathway 💬5件: 2, 5, 6, 7, 51 💬
905FASUDIL HYDROCHLORIDE1件: Fasudil2件: Fasudil hydrochloride ,
Fasudil 💬
2件: ROCK1,
ROCK2 💬
25件: Adherens junction, Axon guidance, Cadherin signaling, Chemokine signaling pathway, Focal adhesion, Human cytomegalovirus infection, Leukocyte transendothelial migration, Lipid and atherosclerosis, MicroRNAs in cancer, Oxytocin signaling pathway, Pathogenic Escherichia coli infection, Pathways in cancer, Platelet activation, Proteoglycans in cancer, Regulation of actin cytoskeleton, Salmonella infection, Shigellosis, Sphingolipid signaling pathway, TGF-beta signaling pathway, Tight junction, Vascular smooth muscle contraction, Wnt signaling pathway, Yersinia infection, cAMP signaling pathway, cGMP-PKG signaling pathway 💬2件: 2, 6 💬
906FB-1011件: FB-101---1件: 6 💬
907FB418----2件: 2, 6 💬
908Febuxostat1件: Febuxostat2件: Febuxostat ,
Febuxostat hydrate 💬
1件: XDH 💬 4件: Caffeine metabolism, Drug metabolism - other enzymes, Peroxisome, Purine metabolism 💬5件: 2, 6, 13, 67, 97 💬
909Fecal microbial transplantation----3件: 6, 96, 97 💬
910Fecal microbiota1件: Fecal microbiota---14件: 2, 6, 13, 49, 63, 66, 93, 94, 96, 97, 99, 222, 271, 298 💬
911Fecal Microbiota Transfer provided by Human Biome Institute1件: Fecal microbiota---1件: 6 💬
912Fecal microbiota transplantation1件: Fecal microbiota---9件: 2, 6, 13, 63, 66, 94, 96, 97, 99 💬
913Ferriprox 500 mg----1件: 6 💬
914Ferrprox (Deferiprone)1件: Deferiprone1件: Deferiprone 💬 --1件: 6 💬
915Fesoterodine1件: Fesoterodine2件: Fesoterodine ,
Fesoterodine fumarate 💬
2件: CHRM2,
CHRM3 💬
14件: Alzheimer disease, Calcium signaling pathway, Cholinergic synapse, Gastric acid secretion, Insulin secretion, Neuroactive ligand signaling, Neuroactive ligand-receptor interaction, PI3K-Akt signaling pathway, Pancreatic secretion, Pathways of neurodegeneration - multiple diseases, Regulation of actin cytoskeleton, Salivary secretion, Taste transduction, cAMP signaling pathway 💬1件: 6 💬
916Fetal porcine cells, Neurocell-PD1件: NeuroCell-PD---1件: 6 💬
917Fexofenadine1件: Fexofenadine2件: Fexofenadine hydrochloride ,
Fexofenadine 💬
1件: HRH1 💬 4件: Calcium signaling pathway, Inflammatory mediator regulation of TRP channels, Neuroactive ligand signaling, Neuroactive ligand-receptor interaction 💬4件: 6, 13, 19, 46 💬
918Filgrastim1件: Filgrastim1件: Filgrastim 💬 1件: CSF3R 💬 5件: Cytokine-cytokine receptor interaction, Hematopoietic cell lineage, JAK-STAT signaling pathway, PI3K-Akt signaling pathway, Pathways in cancer 💬30件: 2, 6, 13, 25, 26, 28, 34, 35, 38, 40, 41, 42, 45, 46, 47, 49, 51, 60, 62, 63, 65, 96, 113, 164, 256, 283, 284, 285, 296, 331 💬
919Finamine tablets----1件: 6 💬
920Finasteride1件: Finasteride1件: Finasteride 💬 1件: SRD5A2 💬 2件: Prostate cancer, Steroid hormone biosynthesis 💬1件: 6 💬
921Fipamezole1件: Fipamezole---2件: 6, 17 💬
922Fipamezole hydrochloride1件: Fipamezole---2件: 6, 17 💬
923Fipamezole hydrochloride 30 mg oral disintegrating tablets1件: Fipamezole---2件: 6, 17 💬
924Fipamezole hydrochloride 60 mg oral disintegrating tablets1件: Fipamezole---2件: 6, 17 💬
925Fipamezole hydrochloride 90 mg oral disintegrating tablets1件: Fipamezole---2件: 6, 17 💬
926Fipamezole ODT1件: Fipamezole---1件: 6 💬
927Fipamezole ODT Cohort 21件: Fipamezole---1件: 6 💬
928Flecainide1件: Flecainide2件: Flecainide acetate ,
Flecainide 💬
6件: SCN1A,
SCN2A,
SCN3A,
SCN5A,
SCN8A,
SCN9A 💬
5件: Adrenergic signaling in cardiomyocytes, Cadherin signaling, Dopaminergic synapse, IgSF CAM signaling, Taste transduction 💬2件: 6, 115 💬
929FLECAINIDE ACETATE2件: Acetate,
Flecainide
2件: Flecainide acetate ,
Flecainide 💬
6件: SCN1A,
SCN2A,
SCN3A,
SCN5A,
SCN8A,
SCN9A 💬
5件: Adrenergic signaling in cardiomyocytes, Cadherin signaling, Dopaminergic synapse, IgSF CAM signaling, Taste transduction 💬1件: 6 💬
930Flecainidum1件: Flecainide2件: Flecainide acetate ,
Flecainide 💬
6件: SCN1A,
SCN2A,
SCN3A,
SCN5A,
SCN8A,
SCN9A 💬
5件: Adrenergic signaling in cardiomyocytes, Cadherin signaling, Dopaminergic synapse, IgSF CAM signaling, Taste transduction 💬1件: 6 💬
931FLORBETABEN (18F)----1件: 6 💬
932Florbetapir F 18----1件: 6 💬
933Fludrocortisone1件: Fludrocortisone2件: Fludrocortisone acetate ,
Fludrocortisone 💬
1件: NR3C2 💬 1件: Aldosterone-regulated sodium reabsorption 💬3件: 6, 17, 81 💬
934Fluid biopsy capsule----1件: 6 💬
935Flumazenil1件: Flumazenil1件: Flumazenil 💬 16件: GABRA1,
GABRA2,
GABRA3,
GABRA4,
GABRA5,
GABRA6,
GABRB1,
GABRB2,
GABRB3,
GABRD,
GABRE,
GABRG1,
GABRG2,
GABRG3,
GABRP,
GABRQ 💬
9件: Cadherin signaling, GABAergic synapse, Morphine addiction, Neuroactive ligand signaling, Neuroactive ligand-receptor interaction, Nicotine addiction, Retrograde endocannabinoid signaling, Serotonergic synapse, Taste transduction 💬5件: 6, 13, 17, 18, 206 💬
936Fluoroscopic swallow evaluation----1件: 6 💬
937Flutemetamol1件: Flutemetamol---6件: 2, 5, 6, 7, 17, 127 💬
938Folic acid1件: Folic acid2件: Folic acid ,
Folate sodium 💬
--9件: 6, 46, 49, 50, 84, 97, 118, 172, 296 💬
939Folic Acid 1 MG1件: Folic acid2件: Folic acid ,
Folate sodium 💬
--1件: 6 💬
940Folic Acid Tablet1件: Folic acid2件: Folic acid ,
Folate sodium 💬
--1件: 6 💬
941Folic Acid, Vitamin B6, Vitamin B121件: Folic acid2件: Folic acid ,
Folate sodium 💬
--1件: 6 💬
942Foliglurax1件: Foliglurax---1件: 6 💬
943Foliglurax 10 mg (treatment A)1件: Foliglurax---1件: 6 💬
944Foliglurax 30 mg (treatment B)1件: Foliglurax---1件: 6 💬
945Fortiral----1件: 6 💬
946Foscarbidopa1件: Foscarbidopa1件: Foscarbidopa 💬 --1件: 6 💬
947Foscarbidopa and Foslevodopa2件: Foscarbidopa,
Foslevodopa
2件: Foslevodopa ,
Foscarbidopa 💬
5件: DRD1,
DRD2,
DRD3,
DRD4,
DRD5 💬
13件: Alcoholism, Amphetamine addiction, Calcium signaling pathway, Cocaine addiction, Dopaminergic synapse, Gap junction, Hormone signaling, Morphine addiction, Neuroactive ligand signaling, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, cAMP signaling pathway 💬1件: 6 💬
948Foslevodopa1件: Foslevodopa1件: Foslevodopa 💬 5件: DRD1,
DRD2,
DRD3,
DRD4,
DRD5 💬
13件: Alcoholism, Amphetamine addiction, Calcium signaling pathway, Cocaine addiction, Dopaminergic synapse, Gap junction, Hormone signaling, Morphine addiction, Neuroactive ligand signaling, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, cAMP signaling pathway 💬1件: 6 💬
949FPFS-1169----1件: 6 💬
950Full-spectrum Cannabidiol (CBD) oil1件: Cannabidiol1件: Cannabidiol 💬 2件: CNR1,
CNR2 💬
4件: Neuroactive ligand-receptor interaction, Rap1 signaling pathway, Retrograde endocannabinoid signaling, Thermogenesis 💬1件: 6 💬
951Functional Magnetic Resonance Imaging----1件: 6 💬
952Furosemide1件: Furosemide1件: Furosemide 💬 1件: SLC12A2 💬 3件: Pancreatic secretion, Salivary secretion, Vibrio cholerae infection 💬5件: 6, 57, 77, 86, 222 💬
953Furosemide Injection1件: Furosemide1件: Furosemide 💬 1件: SLC12A2 💬 3件: Pancreatic secretion, Salivary secretion, Vibrio cholerae infection 💬2件: 6, 222 💬
954Fursultiamine1件: Fursultiamine2件: Fursultiamine ,
Fursultiamine hydrochloride 💬
--2件: 6, 18 💬
955G-CSF1件: Filgrastim1件: Filgrastim 💬 1件: CSF3R 💬 5件: Cytokine-cytokine receptor interaction, Hematopoietic cell lineage, JAK-STAT signaling pathway, PI3K-Akt signaling pathway, Pathways in cancer 💬12件: 6, 11, 13, 51, 60, 61, 63, 65, 85, 96, 284, 285 💬
956GABAPENTIN1件: Gabapentin1件: Gabapentin 💬 5件: CACNA2D1,
CACNA2D2,
CACNA2D3,
CACNA2D4,
SLC6A1 💬
10件: Adrenergic signaling in cardiomyocytes, Arrhythmogenic right ventricular cardiomyopathy, Cardiac muscle contraction, Dilated cardiomyopathy, GABAergic synapse, Hypertrophic cardiomyopathy, MAPK signaling pathway, Neuroactive ligand signaling, Oxytocin signaling pathway, Synaptic vesicle cycle 💬7件: 6, 13, 18, 19, 70, 226, 298 💬
957GABAPENTINA1件: Gabapentin1件: Gabapentin 💬 5件: CACNA2D1,
CACNA2D2,
CACNA2D3,
CACNA2D4,
SLC6A1 💬
10件: Adrenergic signaling in cardiomyocytes, Arrhythmogenic right ventricular cardiomyopathy, Cardiac muscle contraction, Dilated cardiomyopathy, GABAergic synapse, Hypertrophic cardiomyopathy, MAPK signaling pathway, Neuroactive ligand signaling, Oxytocin signaling pathway, Synaptic vesicle cycle 💬1件: 6 💬
958GABAPENTINA KERN PHARMA1件: Gabapentin1件: Gabapentin 💬 5件: CACNA2D1,
CACNA2D2,
CACNA2D3,
CACNA2D4,
SLC6A1 💬
10件: Adrenergic signaling in cardiomyocytes, Arrhythmogenic right ventricular cardiomyopathy, Cardiac muscle contraction, Dilated cardiomyopathy, GABAergic synapse, Hypertrophic cardiomyopathy, MAPK signaling pathway, Neuroactive ligand signaling, Oxytocin signaling pathway, Synaptic vesicle cycle 💬1件: 6 💬
959GALANTAMINE1件: Galantamine2件: Galantamine hydrobromide ,
Galantamine 💬
1件: ACHE 💬 3件: Cholinergic synapse, Glycerophospholipid metabolism, Neuroactive ligand signaling 💬3件: 6, 11, 127 💬
960Galantamine HBr extended-release 8mg capsules (8mg ER).1件: Galantamine2件: Galantamine hydrobromide ,
Galantamine 💬
1件: ACHE 💬 3件: Cholinergic synapse, Glycerophospholipid metabolism, Neuroactive ligand signaling 💬1件: 6 💬
961Galantamine hydrobromide1件: Galantamine2件: Galantamine hydrobromide ,
Galantamine 💬
1件: ACHE 💬 3件: Cholinergic synapse, Glycerophospholipid metabolism, Neuroactive ligand signaling 💬2件: 6, 127 💬
962Gamma- glutamylcysteine----1件: 6 💬
963Ganoderma----1件: 6 💬
964GE180 PET Scan----1件: 6 💬
965Gemfibrozil1件: Gemfibrozil1件: Gemfibrozil 💬 1件: PPARA 💬 10件: Adipocytokine signaling pathway, Alcoholic liver disease, Chemical carcinogenesis - receptor activation, Diabetic cardiomyopathy, Glucagon signaling pathway, Hepatitis C, Insulin resistance, Non-alcoholic fatty liver disease, PPAR signaling pathway, cAMP signaling pathway 💬2件: 6, 13 💬
966Gene therapy----2件: 6, 19 💬
967General anesthesia----1件: 6 💬
968Genetic: AAV-GAD----1件: 6 💬
969Genetic: AAV-GAD High Dose----1件: 6 💬
970Genetic: AAV-GAD Low Dose----1件: 6 💬
971Genetic: AAV-hAADC-2----1件: 6 💬
972Genetic: Adipose-derived stromal vascular fraction cells----1件: 6 💬
973Genetic: APOE genotype----1件: 6 💬
974Genetic: Bilateral surgical infusion of AAV-GAD into the subthalamic nucleus----1件: 6 💬
975Genetic: biomarker identification in Parkinson disease----1件: 6 💬
976Genetic: blood draw----1件: 6 💬
977Genetic: Blood Sampling and DNA collection----1件: 6 💬
978Genetic: CERE-120: AAV2-NTN1件: CERE-120---1件: 6 💬
979Genetic: Cohort1----1件: 6 💬
980Genetic: Cohort2----1件: 6 💬
981Genetic: Convection enhanced delivery/AAV2-GDNF----1件: 6 💬
982Genetic: DNA Analysis----3件: 6, 28, 60 💬
983Genetic: DNA/GeneticTesting----1件: 6 💬
984Genetic: G2019S LRRK2----1件: 6 💬
985Genetic: gene therapy----1件: 6 💬
986Genetic: Genetic: whole genome sequencing----3件: 2, 6, 127 💬
987Genetic: Healthy----1件: 6 💬
988Genetic: Identification of COMT HH, COMT HL or COMT LL genes----1件: 6 💬
989Genetic: Injecting BBM-P002 into the bilateral putamen----1件: 6 💬
990Genetic: KL002 injection solution----1件: 6 💬
991Genetic: Non intervention-Genetic testing----1件: 6 💬
992Genetic: Optional pharmacogenetic assessment----1件: 6 💬
993Genetic: PKD Patients----1件: 6 💬
994Genetic: SHMT1 polymorphism----1件: 6 💬
995Genetic: Skin biopsy----1件: 6 💬
996Genetic: Surgical infusion of AAV-GAD into the subthalamic nucleus----1件: 6 💬
997Genetic: whole exome sequencing----6件: 2, 6, 65, 120, 127, 149 💬
998Genetic: whole genome sequencing----3件: 6, 79, 172 💬
999Genz-682452-AU----3件: 6, 19, 67 💬
1000Glial cell line-derived neurotrophic factor----1件: 6 💬
1001Glial Cell Line-Derived Neurotrophic Factor (GDNF)----1件: 6 💬
1002Glucose----3件: 6, 13, 299 💬
1003Glutathione1件: Glutathione1件: Glutathione 💬 --2件: 6, 299 💬
1004Glycerol Phenylbutyrate1件: Glycerol phenylbutyrate1件: Glycerol phenylbutyrate 💬 --2件: 6, 7 💬
1005Glycopyrrolate----2件: 6, 34 💬
1006GM1----1件: 6 💬
1007GM1 ganglioside----1件: 6 💬
1008GM101----1件: 6 💬
1009GM608----1件: 6 💬
1010GOCOVRI----1件: 6 💬
1011Gold1件: Gold---71件: 2, 5, 6, 11, 13, 17, 19, 21, 22, 28, 34, 35, 46, 49, 50, 53, 54, 56, 57, 58, 60, 63, 64, 65, 66, 68, 71, 75, 76, 77, 79, 84, 85, 86, 88, 91, 93, 95, 96, 97, 98, 107, 113, 127, 137, 158, 162, 167, 171, 193, 206, 215, 218, 222, 223, 224, 226, 227, 228, 230, 235, 271, 291, 294, 296, 298, 299, 310, 318, 331, 340 💬
1012Gold Nanocrystals1件: Gold---3件: 2, 6, 13 💬
1013GPI 1485----1件: 6 💬
1014Grapefruit1件: Grapefruit---5件: 6, 46, 50, 83, 97 💬
1015Green Tea Polyphenols (EGCG/ECG)----1件: 6 💬
1016GRF6021----1件: 6 💬
1017Group AD Anti-PD + Antidepressant----1件: 6 💬
1018Group R Rasagiline1件: Rasagiline3件: Rasagiline mesylate ,
Rasagiline ,
Rasagiline tartrate 💬
1件: MAOB 💬 13件: Alcoholism, Amphetamine addiction, Arginine and proline metabolism, Cocaine addiction, Dopaminergic synapse, Drug metabolism - cytochrome P450, Glycine, serine and threonine metabolism, Histidine metabolism, Parkinson disease, Phenylalanine metabolism, Serotonergic synapse, Tryptophan metabolism, Tyrosine metabolism 💬1件: 6 💬
1019Group R+AD Rasagiline + Antidepressant1件: Rasagiline3件: Rasagiline mesylate ,
Rasagiline ,
Rasagiline tartrate 💬
1件: MAOB 💬 13件: Alcoholism, Amphetamine addiction, Arginine and proline metabolism, Cocaine addiction, Dopaminergic synapse, Drug metabolism - cytochrome P450, Glycine, serine and threonine metabolism, Histidine metabolism, Parkinson disease, Phenylalanine metabolism, Serotonergic synapse, Tryptophan metabolism, Tyrosine metabolism 💬1件: 6 💬
1020GSK962040----1件: 6 💬
1021GSK962040 (25 mg tablet)----1件: 6 💬
1022GT-02287----1件: 6 💬
1023Guar gum1件: Guar gum1件: Guar gum 💬 --1件: 6 💬
1024HA 1A ANTICORPO MONOCLONALE UMANO CLASSE IGM----2件: 6, 49 💬
1025HAESCs----1件: 6 💬
1026HAESCs treatment----1件: 6 💬
1027HB- adMSCs (Hope Biosciences adipose derived mesenchymal stem cells)----1件: 6 💬
1028HB-adMSCs----8件: 2, 4, 6, 13, 14, 46, 49, 113 💬
1029HBI-002----1件: 6 💬
1030Healthy donor-derived FMT capsule----1件: 6 💬
1031HEC122505MsOH----1件: 6 💬
1032Helicobacter pylori eradication therapy----1件: 6 💬
1033Hemoglobin1件: Hemoglobin---3件: 6, 60, 283 💬
1034Heptaminol1件: Heptaminol2件: Heptaminol ,
Heptaminol hydrochloride 💬
--1件: 6 💬
1035Heptaminol hydrochloride1件: Heptaminol2件: Heptaminol ,
Heptaminol hydrochloride 💬
--1件: 6 💬
1036HER-096----1件: 6 💬
1037Herbal Medicinal Mixture (Roucongrong, Heshouwu etc.)----1件: 6 💬
1038Hericium erinaceus mycelium----1件: 6 💬
1039HF0220----1件: 6 💬
1040High dose AFFITOPE® PD03A + Adjuvant----1件: 6 💬
1041High dose ANAVEX2-73----1件: 6 💬
1042High Dose GT-02287----1件: 6 💬
1043High dose levodopa1件: Levodopa1件: Levodopa 💬 5件: DRD1,
DRD2,
DRD3,
DRD4,
DRD5 💬
13件: Alcoholism, Amphetamine addiction, Calcium signaling pathway, Cocaine addiction, Dopaminergic synapse, Gap junction, Hormone signaling, Morphine addiction, Neuroactive ligand signaling, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, cAMP signaling pathway 💬1件: 6 💬
1044High Fiber supplement----1件: 6 💬
1045High Protein. T-Diet plus Range----1件: 6 💬
1046High-Frequency-Only Stimulation----1件: 6 💬
1047HL-400----1件: 6 💬
1048HNC364----1件: 6 💬
1049HNC364 Injectable Suspension----1件: 6 💬
1050Home based balance training----2件: 6, 13 💬
1051HOV-120201件: HOV-12020---2件: 6, 124 💬
1052HRG2010----1件: 6 💬
1053HRG2010 Capsule, Sinemet®, Madopar®----1件: 6 💬
1054HRG2010(I)----1件: 6 💬
1055HRG2010(II)----1件: 6 💬
1056HUC-MSC-sEV-001 nasal drops----3件: 2, 6, 17 💬
1057Human allogeneic induced pluripotent stem cell (iPSC)-derived dopaminergic neural progenitor cell injection----1件: 6 💬
1058Human Amniotic Epithelial Stem Cells----1件: 6 💬
1059Human Dopaminergic Progenitor Cells----2件: 6, 17 💬
1060Human neural stem cell----1件: 6 💬
1061Human Stem Cells----1件: 6 💬
1062Human-derived stromal cells----1件: 6 💬
1063Hydrocortisone1件: Hydrocortisone1件: Hydrocortisone 💬 1件: NR3C1 💬 1件: Neuroactive ligand-receptor interaction 💬10件: 6, 41, 46, 53, 75, 78, 81, 83, 97, 299 💬
1064Hydrocortisone cream1件: Hydrocortisone1件: Hydrocortisone 💬 1件: NR3C1 💬 1件: Neuroactive ligand-receptor interaction 💬1件: 6 💬
1065Hydrocortisone cream 1%1件: Hydrocortisone1件: Hydrocortisone 💬 1件: NR3C1 💬 1件: Neuroactive ligand-receptor interaction 💬1件: 6 💬
1066Hydrocortisone cream 10mg/g FNA Fagron1件: Hydrocortisone1件: Hydrocortisone 💬 1件: NR3C1 💬 1件: Neuroactive ligand-receptor interaction 💬1件: 6 💬
1067Hydrogen1件: Hydrogen---8件: 5, 6, 13, 17, 83, 97, 226, 238 💬
1068Hydrolyzed guar gum1件: Guar gum1件: Guar gum 💬 --1件: 6 💬
1069Hydroxychloroquine1件: Hydroxychloroquine2件: Hydroxychloroquine sulfate ,
Hydroxychloroquine 💬
--29件: 6, 13, 34, 41, 43, 44, 45, 46, 48, 49, 53, 56, 63, 66, 84, 89, 90, 96, 97, 107, 218, 222, 223, 224, 234, 254, 271, 298, 299 💬
1070Hydroxychloroquine (HCQ)1件: Hydroxychloroquine2件: Hydroxychloroquine sulfate ,
Hydroxychloroquine 💬
--2件: 6, 53 💬
1071Hypoestoxide----1件: 6 💬
1072Hypoxic Gas Mixture----1件: 6 💬
1073I-123-5-IA85380----1件: 6 💬
1074IBEROGAST----1件: 6 💬
1075ICA07 therapy----1件: 6 💬
1076Idebenone1件: Idebenone1件: Idebenone 💬 --9件: 6, 8, 13, 17, 18, 21, 113, 115, 302 💬
1077IkT-148009----1件: 6 💬
1078Iloperidone1件: Iloperidone1件: Iloperidone 💬 4件: DRD2,
HTR2A,
HTR2B,
HTR2C 💬
13件: Alcoholism, Calcium signaling pathway, Cocaine addiction, Dopaminergic synapse, Gap junction, Hormone signaling, Inflammatory mediator regulation of TRP channels, Neuroactive ligand signaling, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, Serotonergic synapse, cAMP signaling pathway 💬1件: 6 💬
1079Immediate release carbidopa/levodopa2件: Carbidopa,
Levodopa
2件: Levodopa ,
Carbidopa 💬
6件: DDC,
DRD1,
DRD2,
DRD3,
DRD4,
DRD5 💬
17件: Alcoholism, Amphetamine addiction, Calcium signaling pathway, Cocaine addiction, Dopaminergic synapse, Gap junction, Hormone signaling, Morphine addiction, Neuroactive ligand signaling, Neuroactive ligand-receptor interaction, Parkinson disease, Phenylalanine metabolism, Rap1 signaling pathway, Serotonergic synapse, Tryptophan metabolism, Tyrosine metabolism, cAMP signaling pathway 💬1件: 6 💬
1080Immediate Release carbidopa/levodopa 10/100 mg2件: Carbidopa,
Levodopa
2件: Levodopa ,
Carbidopa 💬
6件: DDC,
DRD1,
DRD2,
DRD3,
DRD4,
DRD5 💬
17件: Alcoholism, Amphetamine addiction, Calcium signaling pathway, Cocaine addiction, Dopaminergic synapse, Gap junction, Hormone signaling, Morphine addiction, Neuroactive ligand signaling, Neuroactive ligand-receptor interaction, Parkinson disease, Phenylalanine metabolism, Rap1 signaling pathway, Serotonergic synapse, Tryptophan metabolism, Tyrosine metabolism, cAMP signaling pathway 💬1件: 6 💬
1081Immediate Release carbidopa/levodopa 25/100 mg2件: Carbidopa,
Levodopa
2件: Levodopa ,
Carbidopa 💬
6件: DDC,
DRD1,
DRD2,
DRD3,
DRD4,
DRD5 💬
17件: Alcoholism, Amphetamine addiction, Calcium signaling pathway, Cocaine addiction, Dopaminergic synapse, Gap junction, Hormone signaling, Morphine addiction, Neuroactive ligand signaling, Neuroactive ligand-receptor interaction, Parkinson disease, Phenylalanine metabolism, Rap1 signaling pathway, Serotonergic synapse, Tryptophan metabolism, Tyrosine metabolism, cAMP signaling pathway 💬1件: 6 💬
1082Immediate Release Melatonin1件: Melatonin1件: Melatonin 💬 2件: MTNR1A,
MTNR1B 💬
2件: Circadian entrainment, Neuroactive ligand-receptor interaction 💬1件: 6 💬
1083Immunosuppressive Regimen----1件: 6 💬
1084Incobotulinum Toxin A----3件: 2, 6, 13 💬
1085IncobotulinumtoxinA----1件: 6 💬
1086IncobotulinumtoxinA (100 Units)----1件: 6 💬
1087IncobotulinumtoxinA (75 Units)----1件: 6 💬
1088Infudopa i.v.----1件: 6 💬
1089Infudopa s.c.----1件: 6 💬
1090Infusion Pump: CADD-Legacy® 1400 Pump----1件: 6 💬
1091Infusions of young plasma----1件: 6 💬
1092Inhaled VR040----1件: 6 💬
1093Injection----2件: 6, 301 💬
1094Injection of apomorphine1件: Apomorphine2件: Apomorphine hydrochloride ,
Apomorphine 💬
2件: DRD1,
DRD2 💬
13件: Alcoholism, Amphetamine addiction, Calcium signaling pathway, Cocaine addiction, Dopaminergic synapse, Gap junction, Hormone signaling, Morphine addiction, Neuroactive ligand signaling, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, cAMP signaling pathway 💬1件: 6 💬
1095Injection of normal saline----1件: 6 💬
1096Injection of Umbilical cord derived MSCs----1件: 6 💬
1097INN not available at this time----1件: 6 💬
1098Inosine1件: Inosine1件: Inosine 💬 --5件: 2, 6, 13, 17, 122 💬
1099INS-GSH----1件: 6 💬
1100Insulin----6件: 6, 13, 46, 75, 77, 299 💬
1101Intervention: Ketamine1件: Ketamine2件: Ketamine hydrochloride ,
Ketamine 💬
5件: GRIN1,
GRIN2A,
GRIN2B,
GRIN2C,
GRIN2D 💬
21件: Alcoholism, Alzheimer disease, Amphetamine addiction, Amyotrophic lateral sclerosis, Calcium signaling pathway, Circadian entrainment, Cocaine addiction, Dopaminergic synapse, Glutamatergic synapse, Huntington disease, Long-term potentiation, Neuroactive ligand signaling, Neuroactive ligand-receptor interaction, Nicotine addiction, Pathways of neurodegeneration - multiple diseases, Prion disease, Rap1 signaling pathway, Ras signaling pathway, Spinocerebellar ataxia, Systemic lupus erythematosus, cAMP signaling pathway 💬1件: 6 💬
1102Intracerebral microinjections----1件: 6 💬
1103Intranasal glutathione - (in)GSH1件: Glutathione1件: Glutathione 💬 --1件: 6 💬
1104Intranasal Insulin----2件: 6, 17 💬
1105Intrathecal (IT)----1件: 6 💬
1106Intravenous----1件: 6 💬
1107Intravenous Infusion----3件: 6, 18, 51 💬
1108Intravenous Levodopa1件: Levodopa1件: Levodopa 💬 5件: DRD1,
DRD2,
DRD3,
DRD4,
DRD5 💬
13件: Alcoholism, Amphetamine addiction, Calcium signaling pathway, Cocaine addiction, Dopaminergic synapse, Gap junction, Hormone signaling, Morphine addiction, Neuroactive ligand signaling, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, cAMP signaling pathway 💬1件: 6 💬
1109Intravesical injection of Botulinum A toxin----2件: 6, 17 💬
1110Inulin1件: Inulin1件: Inulin 💬 --5件: 6, 96, 97, 156, 299 💬
1111Inulin, B-vitamins and vitamin D2件: Inulin,
Vitamin D
1件: Inulin 💬 --1件: 6 💬
1112IODIO IOFLUPANO-123I----1件: 6 💬
1113Ioflupane----1件: 6 💬
1114IOFLUPANE (123I)----1件: 6 💬
1115Ioflupane 123I (DATSCAN®)----1件: 6 💬
1116Ioflupane [123 I]----1件: 6 💬
1117Ioflupane [123I]----1件: 6 💬
1118Ioflupane I 123----1件: 6 💬
1119Ipratropium1件: Ipratropium---2件: 6, 86 💬
1120Ipratropium bromide (drug)1件: Ipratropium---1件: 6 💬
1121IPRONIAZID1件: Iproniazid2件: Iproniazid ,
Iproniazid phosphate 💬
2件: MAOA,
MAOB 💬
13件: Alcoholism, Amphetamine addiction, Arginine and proline metabolism, Cocaine addiction, Dopaminergic synapse, Drug metabolism - cytochrome P450, Glycine, serine and threonine metabolism, Histidine metabolism, Parkinson disease, Phenylalanine metabolism, Serotonergic synapse, Tryptophan metabolism, Tyrosine metabolism 💬1件: 6 💬
1122Ips-nsc cells----1件: 6 💬
1123IPS101A----1件: 6 💬
1124IPT803----1件: 6 💬
1125IPX054 100 mg----1件: 6 💬
1126IPX054 150 mg----1件: 6 💬
1127IPX054 200 mg----1件: 6 💬
1128IPX054 250 mg----1件: 6 💬
1129IPX054 300 mg----1件: 6 💬
1130IPX066----1件: 6 💬
1131IPX066 145 mg----1件: 6 💬
1132IPX066 145 mg LD----1件: 6 💬
1133IPX066 195 mg----1件: 6 💬
1134IPX066 195 mg LD----1件: 6 💬
1135IPX066 245 mg----1件: 6 💬
1136IPX066 245 mg LD----1件: 6 💬
1137IPX066 95 mg----1件: 6 💬
1138IPX066 95 mg LD----1件: 6 💬
1139IPX066-145----1件: 6 💬
1140IPX066-195----1件: 6 💬
1141IPX066-245----1件: 6 💬
1142IPX066-95----1件: 6 💬
1143IPX203----1件: 6 💬
1144IPX203 140 mg----1件: 6 💬
1145IPX203 180 mg----1件: 6 💬
1146IPX203 210 mg----1件: 6 💬
1147IPX203 270 mg----1件: 6 💬
1148IPX203 280 mg----1件: 6 💬
1149IPX203 350 mg----1件: 6 💬
1150IPX203 ER CD-LD----1件: 6 💬
1151IR CD-LD----1件: 6 💬
1152IR CD-LD (carbidopa-levodopa) tablets2件: Carbidopa,
Levodopa
2件: Levodopa ,
Carbidopa 💬
6件: DDC,
DRD1,
DRD2,
DRD3,
DRD4,
DRD5 💬
17件: Alcoholism, Amphetamine addiction, Calcium signaling pathway, Cocaine addiction, Dopaminergic synapse, Gap junction, Hormone signaling, Morphine addiction, Neuroactive ligand signaling, Neuroactive ligand-receptor interaction, Parkinson disease, Phenylalanine metabolism, Rap1 signaling pathway, Serotonergic synapse, Tryptophan metabolism, Tyrosine metabolism, cAMP signaling pathway 💬1件: 6 💬
1153IR LD / CD----1件: 6 💬
1154IR LD/CD----1件: 6 💬
1155IRBD----1件: 6 💬
1156IRL752----1件: 6 💬
1157IRL757----1件: 6 💬
1158IRL790----1件: 6 💬
1159IRX4204----1件: 6 💬
1160ISC-hpNSC----1件: 6 💬
1161Isicom----1件: 6 💬
1162Isoflurane1件: Isoflurane1件: Isoflurane 💬 --1件: 6 💬
1163Isradipine1件: Isradipine1件: Isradipine 💬 4件: CACNA1C,
CACNA1D,
CACNA1F,
CACNA1S 💬
37件: Adrenergic signaling in cardiomyocytes, Aldosterone synthesis and secretion, Alzheimer disease, Amphetamine addiction, Arrhythmogenic right ventricular cardiomyopathy, Calcium signaling pathway, Carbohydrate digestion and absorption, Cardiac muscle contraction, Cellular senescence, Chemical carcinogenesis - receptor activation, Cholinergic synapse, Circadian entrainment, Cortisol synthesis and secretion, Cushing syndrome, Dilated cardiomyopathy, Dopaminergic synapse, GABAergic synapse, Glutamatergic synapse, GnRH secretion, GnRH signaling pathway, Growth hormone synthesis, secretion and action, Hypertrophic cardiomyopathy, Insulin secretion, Long-term potentiation, MAPK signaling pathway, Oxytocin signaling pathway, Pathways of neurodegeneration - multiple diseases, Prion disease, Renin secretion, Retrograde endocannabinoid signaling, Serotonergic synapse, Taste transduction, Tight junction, Type II diabetes mellitus, Vascular smooth muscle contraction, cAMP signaling pathway, cGMP-PKG signaling pathway 💬1件: 6 💬
1164Isradipine CR 10mg1件: Isradipine1件: Isradipine 💬 4件: CACNA1C,
CACNA1D,
CACNA1F,
CACNA1S 💬
37件: Adrenergic signaling in cardiomyocytes, Aldosterone synthesis and secretion, Alzheimer disease, Amphetamine addiction, Arrhythmogenic right ventricular cardiomyopathy, Calcium signaling pathway, Carbohydrate digestion and absorption, Cardiac muscle contraction, Cellular senescence, Chemical carcinogenesis - receptor activation, Cholinergic synapse, Circadian entrainment, Cortisol synthesis and secretion, Cushing syndrome, Dilated cardiomyopathy, Dopaminergic synapse, GABAergic synapse, Glutamatergic synapse, GnRH secretion, GnRH signaling pathway, Growth hormone synthesis, secretion and action, Hypertrophic cardiomyopathy, Insulin secretion, Long-term potentiation, MAPK signaling pathway, Oxytocin signaling pathway, Pathways of neurodegeneration - multiple diseases, Prion disease, Renin secretion, Retrograde endocannabinoid signaling, Serotonergic synapse, Taste transduction, Tight junction, Type II diabetes mellitus, Vascular smooth muscle contraction, cAMP signaling pathway, cGMP-PKG signaling pathway 💬1件: 6 💬
1165Isradipine CR 20mg1件: Isradipine1件: Isradipine 💬 4件: CACNA1C,
CACNA1D,
CACNA1F,
CACNA1S 💬
37件: Adrenergic signaling in cardiomyocytes, Aldosterone synthesis and secretion, Alzheimer disease, Amphetamine addiction, Arrhythmogenic right ventricular cardiomyopathy, Calcium signaling pathway, Carbohydrate digestion and absorption, Cardiac muscle contraction, Cellular senescence, Chemical carcinogenesis - receptor activation, Cholinergic synapse, Circadian entrainment, Cortisol synthesis and secretion, Cushing syndrome, Dilated cardiomyopathy, Dopaminergic synapse, GABAergic synapse, Glutamatergic synapse, GnRH secretion, GnRH signaling pathway, Growth hormone synthesis, secretion and action, Hypertrophic cardiomyopathy, Insulin secretion, Long-term potentiation, MAPK signaling pathway, Oxytocin signaling pathway, Pathways of neurodegeneration - multiple diseases, Prion disease, Renin secretion, Retrograde endocannabinoid signaling, Serotonergic synapse, Taste transduction, Tight junction, Type II diabetes mellitus, Vascular smooth muscle contraction, cAMP signaling pathway, cGMP-PKG signaling pathway 💬1件: 6 💬
1166Isradipine CR 5mg1件: Isradipine1件: Isradipine 💬 4件: CACNA1C,
CACNA1D,
CACNA1F,
CACNA1S 💬
37件: Adrenergic signaling in cardiomyocytes, Aldosterone synthesis and secretion, Alzheimer disease, Amphetamine addiction, Arrhythmogenic right ventricular cardiomyopathy, Calcium signaling pathway, Carbohydrate digestion and absorption, Cardiac muscle contraction, Cellular senescence, Chemical carcinogenesis - receptor activation, Cholinergic synapse, Circadian entrainment, Cortisol synthesis and secretion, Cushing syndrome, Dilated cardiomyopathy, Dopaminergic synapse, GABAergic synapse, Glutamatergic synapse, GnRH secretion, GnRH signaling pathway, Growth hormone synthesis, secretion and action, Hypertrophic cardiomyopathy, Insulin secretion, Long-term potentiation, MAPK signaling pathway, Oxytocin signaling pathway, Pathways of neurodegeneration - multiple diseases, Prion disease, Renin secretion, Retrograde endocannabinoid signaling, Serotonergic synapse, Taste transduction, Tight junction, Type II diabetes mellitus, Vascular smooth muscle contraction, cAMP signaling pathway, cGMP-PKG signaling pathway 💬1件: 6 💬
1167ISTRADEFYLLINE1件: Istradefylline1件: Istradefylline 💬 1件: ADORA2A 💬 8件: Alcoholism, Calcium signaling pathway, Neuroactive ligand signaling, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, Vascular smooth muscle contraction, cAMP signaling pathway 💬1件: 6 💬
1168Istradefylline ( KW-6002)1件: Istradefylline1件: Istradefylline 💬 1件: ADORA2A 💬 8件: Alcoholism, Calcium signaling pathway, Neuroactive ligand signaling, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, Vascular smooth muscle contraction, cAMP signaling pathway 💬1件: 6 💬
1169Istradefylline (KW-6002)1件: Istradefylline1件: Istradefylline 💬 1件: ADORA2A 💬 8件: Alcoholism, Calcium signaling pathway, Neuroactive ligand signaling, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, Vascular smooth muscle contraction, cAMP signaling pathway 💬1件: 6 💬
1170Istradefylline 20 mg1件: Istradefylline1件: Istradefylline 💬 1件: ADORA2A 💬 8件: Alcoholism, Calcium signaling pathway, Neuroactive ligand signaling, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, Vascular smooth muscle contraction, cAMP signaling pathway 💬1件: 6 💬
1171Istradefylline 20 mg or 40 mg1件: Istradefylline1件: Istradefylline 💬 1件: ADORA2A 💬 8件: Alcoholism, Calcium signaling pathway, Neuroactive ligand signaling, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, Vascular smooth muscle contraction, cAMP signaling pathway 💬1件: 6 💬
1172Istradefylline 40 mg1件: Istradefylline1件: Istradefylline 💬 1件: ADORA2A 💬 8件: Alcoholism, Calcium signaling pathway, Neuroactive ligand signaling, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, Vascular smooth muscle contraction, cAMP signaling pathway 💬1件: 6 💬
1173Istradefylline medication1件: Istradefylline1件: Istradefylline 💬 1件: ADORA2A 💬 8件: Alcoholism, Calcium signaling pathway, Neuroactive ligand signaling, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, Vascular smooth muscle contraction, cAMP signaling pathway 💬1件: 6 💬
1174Istradefylline Pill1件: Istradefylline1件: Istradefylline 💬 1件: ADORA2A 💬 8件: Alcoholism, Calcium signaling pathway, Neuroactive ligand signaling, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, Vascular smooth muscle contraction, cAMP signaling pathway 💬1件: 6 💬
1175ITI-214----1件: 6 💬
1176Itraconazole1件: Itraconazole1件: Itraconazole 💬 --13件: 2, 3, 6, 46, 65, 67, 96, 97, 137, 158, 227, 299, 309 💬
1177IV Apomorphine1件: Apomorphine2件: Apomorphine hydrochloride ,
Apomorphine 💬
2件: DRD1,
DRD2 💬
13件: Alcoholism, Amphetamine addiction, Calcium signaling pathway, Cocaine addiction, Dopaminergic synapse, Gap junction, Hormone signaling, Morphine addiction, Neuroactive ligand signaling, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, cAMP signaling pathway 💬1件: 6 💬
1178IV Levodopa1件: Levodopa1件: Levodopa 💬 5件: DRD1,
DRD2,
DRD3,
DRD4,
DRD5 💬
13件: Alcoholism, Amphetamine addiction, Calcium signaling pathway, Cocaine addiction, Dopaminergic synapse, Gap junction, Hormone signaling, Morphine addiction, Neuroactive ligand signaling, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, cAMP signaling pathway 💬1件: 6 💬
1179IZD174----2件: 6, 106 💬
1180J-tube----1件: 6 💬
1181Jejunal extension tube----1件: 6 💬
1182Jejunal extension tube (J-tube)----1件: 6 💬
1183JM-010----1件: 6 💬
1184JM-010 group A----1件: 6 💬
1185JM-010 group B----1件: 6 💬
1186JNJ-31001074----1件: 6 💬
1187JNJ31-31001074----1件: 6 💬
1188JP 1730----1件: 6 💬
1189JP-1730/F01----2件: 6, 17 💬
1190JP-1730/F02----2件: 6, 17 💬
1191JP-1730/F03----2件: 6, 17 💬
1192Juvit D3----1件: 6 💬
1193JX2105----1件: 6 💬
1194JZP-110----1件: 6 💬
1195JZP385----1件: 6 💬
1196K0706----1件: 6 💬
1197KDT-35941件: KDT-3594---1件: 6 💬
1198KETAMINE1件: Ketamine2件: Ketamine hydrochloride ,
Ketamine 💬
5件: GRIN1,
GRIN2A,
GRIN2B,
GRIN2C,
GRIN2D 💬
21件: Alcoholism, Alzheimer disease, Amphetamine addiction, Amyotrophic lateral sclerosis, Calcium signaling pathway, Circadian entrainment, Cocaine addiction, Dopaminergic synapse, Glutamatergic synapse, Huntington disease, Long-term potentiation, Neuroactive ligand signaling, Neuroactive ligand-receptor interaction, Nicotine addiction, Pathways of neurodegeneration - multiple diseases, Prion disease, Rap1 signaling pathway, Ras signaling pathway, Spinocerebellar ataxia, Systemic lupus erythematosus, cAMP signaling pathway 💬6件: 6, 13, 70, 113, 156, 215 💬
1199Ketamine hydrochloride1件: Ketamine2件: Ketamine hydrochloride ,
Ketamine 💬
5件: GRIN1,
GRIN2A,
GRIN2B,
GRIN2C,
GRIN2D 💬
21件: Alcoholism, Alzheimer disease, Amphetamine addiction, Amyotrophic lateral sclerosis, Calcium signaling pathway, Circadian entrainment, Cocaine addiction, Dopaminergic synapse, Glutamatergic synapse, Huntington disease, Long-term potentiation, Neuroactive ligand signaling, Neuroactive ligand-receptor interaction, Nicotine addiction, Pathways of neurodegeneration - multiple diseases, Prion disease, Rap1 signaling pathway, Ras signaling pathway, Spinocerebellar ataxia, Systemic lupus erythematosus, cAMP signaling pathway 💬1件: 6 💬
1200Ketamine Infusion1件: Ketamine2件: Ketamine hydrochloride ,
Ketamine 💬
5件: GRIN1,
GRIN2A,
GRIN2B,
GRIN2C,
GRIN2D 💬
21件: Alcoholism, Alzheimer disease, Amphetamine addiction, Amyotrophic lateral sclerosis, Calcium signaling pathway, Circadian entrainment, Cocaine addiction, Dopaminergic synapse, Glutamatergic synapse, Huntington disease, Long-term potentiation, Neuroactive ligand signaling, Neuroactive ligand-receptor interaction, Nicotine addiction, Pathways of neurodegeneration - multiple diseases, Prion disease, Rap1 signaling pathway, Ras signaling pathway, Spinocerebellar ataxia, Systemic lupus erythematosus, cAMP signaling pathway 💬1件: 6 💬
1201Ketone Ester (R)-3-Hydroxybutyl (R)-3-Hydroxybutyrate----1件: 6 💬
1202Ketone Ester Beverage----1件: 6 💬
1203Ketone ester drink----2件: 6, 344 💬
1204Ketone Ester Elite endurance Nutrition Drink----1件: 6 💬
1205Kinetra and Soletra (neurostimulator, Medtronic)----1件: 6 💬
1206Kinoquinone (proposed)----1件: 6 💬
1207KM-819----2件: 6, 17 💬
1208KP405----1件: 6 💬
1209KW-6002----1件: 6 💬
1210KW-6002 (istradefylline)1件: Istradefylline1件: Istradefylline 💬 1件: ADORA2A 💬 8件: Alcoholism, Calcium signaling pathway, Neuroactive ligand signaling, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, Vascular smooth muscle contraction, cAMP signaling pathway 💬1件: 6 💬
1211KW-63561件: KW-6356---1件: 6 💬
1212KW-6356 High Dose1件: KW-6356---1件: 6 💬
1213KW-6356 Low Dose1件: KW-6356---1件: 6 💬
1214KW-6356 Middle Dose1件: KW-6356---1件: 6 💬
1215KW-6356 X Dose1件: KW-6356---1件: 6 💬
1216KW-6356 Y Dose1件: KW-6356---1件: 6 💬
1217KW-6500----1件: 6 💬
1218L-123 Ioflupane----1件: 6 💬
1219L-3-(3,4-Dihydroxyphenyl)alanine1件: Alanine1件: Alanine 💬 --1件: 6 💬
1220L-DOPA1件: Levodopa1件: Levodopa 💬 5件: DRD1,
DRD2,
DRD3,
DRD4,
DRD5 💬
13件: Alcoholism, Amphetamine addiction, Calcium signaling pathway, Cocaine addiction, Dopaminergic synapse, Gap junction, Hormone signaling, Morphine addiction, Neuroactive ligand signaling, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, cAMP signaling pathway 💬1件: 6 💬
1221L-Dopa/ MODOPAR----1件: 6 💬
1222L-DOPA/DDCI----1件: 6 💬
1223L-DOPS----1件: 6 💬
1224L-tyrosine1件: Tyrosine1件: Tyrosine 💬 --2件: 6, 111 💬
1225Lactobacillus acidophilus1件: Lactobacillus acidophilus1件: Lactomin 💬 --1件: 6 💬
1226Lactobacillus acidophilus 10 billion colony forming unit (CFU) and prebiotic fibers1件: Lactobacillus acidophilus1件: Lactomin 💬 --1件: 6 💬
1227Lactobacillus casei1件: Lactobacillus casei1件: Lactobacillus casei 💬 --3件: 6, 97, 296 💬
1228Lactobacillus casei DG (Enterolactis duo®)1件: Lactobacillus casei1件: Lactobacillus casei 💬 --1件: 6 💬
1229Lactobacillus plantarum1件: Lactobacillus plantarum---3件: 6, 97, 156 💬
1230Lactobacillus plantarum PS1281件: Lactobacillus plantarum---1件: 6 💬
1231Lactose1件: Lactose2件: Anhydrous lactose ,
Lactose hydrate 💬
--8件: 2, 6, 13, 21, 97, 107, 228, 310 💬
1232Lactulose1件: Lactulose1件: Lactulose 💬 --5件: 6, 13, 96, 97, 291 💬
1233LBT-3627----1件: 6 💬
1234LCIG----1件: 6 💬
1235LCIG (Duodopa)----1件: 6 💬
1236LD / BE----1件: 6 💬
1237LD+DDCI----1件: 6 💬
1238LD-DDCI----1件: 6 💬
1239LD/CD----1件: 6 💬
1240LD/CD SC solution----1件: 6 💬
1241Lecanemab1件: Lecanemab1件: Lecanemab 💬 1件: APP 💬 4件: Alzheimer disease, IgSF CAM signaling, Pathways of neurodegeneration - multiple diseases, Serotonergic synapse 💬1件: 6 💬
1242LECIG (levodopa, carbidopa, entacapone intestinal gel)3件: Carbidopa,
Entacapone,
Levodopa
3件: Levodopa ,
Carbidopa ,
Entacapone 💬
7件: COMT,
DDC,
DRD1,
DRD2,
DRD3,
DRD4,
DRD5 💬
18件: Alcoholism, Amphetamine addiction, Calcium signaling pathway, Cocaine addiction, Dopaminergic synapse, Gap junction, Hormone signaling, Morphine addiction, Neuroactive ligand signaling, Neuroactive ligand-receptor interaction, Parkinson disease, Phenylalanine metabolism, Rap1 signaling pathway, Serotonergic synapse, Steroid hormone biosynthesis, Tryptophan metabolism, Tyrosine metabolism, cAMP signaling pathway 💬1件: 6 💬
1243Lemborexant1件: Lemborexant1件: Lemborexant 💬 2件: HCRTR1,
HCRTR2 💬
2件: Hormone signaling, Neuroactive ligand-receptor interaction 💬2件: 6, 127 💬
1244Lenrispodun1件: Lenrispodun1件: Lenrispodun 💬 3件: PDE1A,
PDE1B,
PDE1C 💬
6件: Calcium signaling pathway, Morphine addiction, Olfactory transduction, Purine metabolism, Renin secretion, Taste transduction 💬1件: 6 💬
1245Leptin1件: Leptin---2件: 6, 265 💬
1246Leucine1件: Leucine1件: Leucine 💬 --13件: 5, 6, 7, 18, 19, 65, 96, 97, 127, 280, 283, 284, 299 💬
1247Levetiracetam1件: Levetiracetam1件: Levetiracetam 💬 1件: SV2A 💬 1件: ECM-receptor interaction 💬7件: 2, 4, 6, 13, 34, 149, 307 💬
1248Levodopa1件: Levodopa1件: Levodopa 💬 5件: DRD1,
DRD2,
DRD3,
DRD4,
DRD5 💬
13件: Alcoholism, Amphetamine addiction, Calcium signaling pathway, Cocaine addiction, Dopaminergic synapse, Gap junction, Hormone signaling, Morphine addiction, Neuroactive ligand signaling, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, cAMP signaling pathway 💬8件: 5, 6, 17, 90, 120, 140, 164, 201 💬
1249LEVODOPA (DC.IT) (FU)1件: Levodopa1件: Levodopa 💬 5件: DRD1,
DRD2,
DRD3,
DRD4,
DRD5 💬
13件: Alcoholism, Amphetamine addiction, Calcium signaling pathway, Cocaine addiction, Dopaminergic synapse, Gap junction, Hormone signaling, Morphine addiction, Neuroactive ligand signaling, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, cAMP signaling pathway 💬1件: 6 💬
1250Levodopa (delivered intravenously)1件: Levodopa1件: Levodopa 💬 5件: DRD1,
DRD2,
DRD3,
DRD4,
DRD5 💬
13件: Alcoholism, Amphetamine addiction, Calcium signaling pathway, Cocaine addiction, Dopaminergic synapse, Gap junction, Hormone signaling, Morphine addiction, Neuroactive ligand signaling, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, cAMP signaling pathway 💬1件: 6 💬
1251Levodopa (drug), intraduodenal administration1件: Levodopa1件: Levodopa 💬 5件: DRD1,
DRD2,
DRD3,
DRD4,
DRD5 💬
13件: Alcoholism, Amphetamine addiction, Calcium signaling pathway, Cocaine addiction, Dopaminergic synapse, Gap junction, Hormone signaling, Morphine addiction, Neuroactive ligand signaling, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, cAMP signaling pathway 💬1件: 6 💬
1252Levodopa (L-dopa)1件: Levodopa1件: Levodopa 💬 5件: DRD1,
DRD2,
DRD3,
DRD4,
DRD5 💬
13件: Alcoholism, Amphetamine addiction, Calcium signaling pathway, Cocaine addiction, Dopaminergic synapse, Gap junction, Hormone signaling, Morphine addiction, Neuroactive ligand signaling, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, cAMP signaling pathway 💬1件: 6 💬
1253Levodopa (L-DOPA) + Standard care1件: Levodopa1件: Levodopa 💬 5件: DRD1,
DRD2,
DRD3,
DRD4,
DRD5 💬
13件: Alcoholism, Amphetamine addiction, Calcium signaling pathway, Cocaine addiction, Dopaminergic synapse, Gap junction, Hormone signaling, Morphine addiction, Neuroactive ligand signaling, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, cAMP signaling pathway 💬1件: 6 💬
1254LEVODOPA (LD)1件: Levodopa1件: Levodopa 💬 5件: DRD1,
DRD2,
DRD3,
DRD4,
DRD5 💬
13件: Alcoholism, Amphetamine addiction, Calcium signaling pathway, Cocaine addiction, Dopaminergic synapse, Gap junction, Hormone signaling, Morphine addiction, Neuroactive ligand signaling, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, cAMP signaling pathway 💬1件: 6 💬
1255Levodopa / Benserazid1件: Levodopa1件: Levodopa 💬 5件: DRD1,
DRD2,
DRD3,
DRD4,
DRD5 💬
13件: Alcoholism, Amphetamine addiction, Calcium signaling pathway, Cocaine addiction, Dopaminergic synapse, Gap junction, Hormone signaling, Morphine addiction, Neuroactive ligand signaling, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, cAMP signaling pathway 💬1件: 6 💬
1256LEVODOPA / BENSERAZIDE 200 + 50 MG2件: Benserazide,
Levodopa
3件: Levodopa ,
Benserazide hydrochloride ,
Benserazide 💬
6件: DDC,
DRD1,
DRD2,
DRD3,
DRD4,
DRD5 💬
17件: Alcoholism, Amphetamine addiction, Calcium signaling pathway, Cocaine addiction, Dopaminergic synapse, Gap junction, Hormone signaling, Morphine addiction, Neuroactive ligand signaling, Neuroactive ligand-receptor interaction, Parkinson disease, Phenylalanine metabolism, Rap1 signaling pathway, Serotonergic synapse, Tryptophan metabolism, Tyrosine metabolism, cAMP signaling pathway 💬1件: 6 💬
1257Levodopa / carbidopa solution2件: Carbidopa,
Levodopa
2件: Levodopa ,
Carbidopa 💬
6件: DDC,
DRD1,
DRD2,
DRD3,
DRD4,
DRD5 💬
17件: Alcoholism, Amphetamine addiction, Calcium signaling pathway, Cocaine addiction, Dopaminergic synapse, Gap junction, Hormone signaling, Morphine addiction, Neuroactive ligand signaling, Neuroactive ligand-receptor interaction, Parkinson disease, Phenylalanine metabolism, Rap1 signaling pathway, Serotonergic synapse, Tryptophan metabolism, Tyrosine metabolism, cAMP signaling pathway 💬1件: 6 💬
1258Levodopa 100 mg / benserazide 25 mg2件: Benserazide,
Levodopa
3件: Levodopa ,
Benserazide hydrochloride ,
Benserazide 💬
6件: DDC,
DRD1,
DRD2,
DRD3,
DRD4,
DRD5 💬
17件: Alcoholism, Amphetamine addiction, Calcium signaling pathway, Cocaine addiction, Dopaminergic synapse, Gap junction, Hormone signaling, Morphine addiction, Neuroactive ligand signaling, Neuroactive ligand-receptor interaction, Parkinson disease, Phenylalanine metabolism, Rap1 signaling pathway, Serotonergic synapse, Tryptophan metabolism, Tyrosine metabolism, cAMP signaling pathway 💬1件: 6 💬
1259Levodopa 100 mg A CAP1件: Levodopa1件: Levodopa 💬 5件: DRD1,
DRD2,
DRD3,
DRD4,
DRD5 💬
13件: Alcoholism, Amphetamine addiction, Calcium signaling pathway, Cocaine addiction, Dopaminergic synapse, Gap junction, Hormone signaling, Morphine addiction, Neuroactive ligand signaling, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, cAMP signaling pathway 💬1件: 6 💬
1260Levodopa 125 mg A CAP1件: Levodopa1件: Levodopa 💬 5件: DRD1,
DRD2,
DRD3,
DRD4,
DRD5 💬
13件: Alcoholism, Amphetamine addiction, Calcium signaling pathway, Cocaine addiction, Dopaminergic synapse, Gap junction, Hormone signaling, Morphine addiction, Neuroactive ligand signaling, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, cAMP signaling pathway 💬1件: 6 💬
1261Levodopa 150 mg A CAP1件: Levodopa1件: Levodopa 💬 5件: DRD1,
DRD2,
DRD3,
DRD4,
DRD5 💬
13件: Alcoholism, Amphetamine addiction, Calcium signaling pathway, Cocaine addiction, Dopaminergic synapse, Gap junction, Hormone signaling, Morphine addiction, Neuroactive ligand signaling, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, cAMP signaling pathway 💬1件: 6 💬
1262Levodopa 75 mg A CAP1件: Levodopa1件: Levodopa 💬 5件: DRD1,
DRD2,
DRD3,
DRD4,
DRD5 💬
13件: Alcoholism, Amphetamine addiction, Calcium signaling pathway, Cocaine addiction, Dopaminergic synapse, Gap junction, Hormone signaling, Morphine addiction, Neuroactive ligand signaling, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, cAMP signaling pathway 💬1件: 6 💬
1263Levodopa acute challenge1件: Levodopa1件: Levodopa 💬 5件: DRD1,
DRD2,
DRD3,
DRD4,
DRD5 💬
13件: Alcoholism, Amphetamine addiction, Calcium signaling pathway, Cocaine addiction, Dopaminergic synapse, Gap junction, Hormone signaling, Morphine addiction, Neuroactive ligand signaling, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, cAMP signaling pathway 💬1件: 6 💬
1264Levodopa and carbidopa2件: Carbidopa,
Levodopa
2件: Levodopa ,
Carbidopa 💬
6件: DDC,
DRD1,
DRD2,
DRD3,
DRD4,
DRD5 💬
17件: Alcoholism, Amphetamine addiction, Calcium signaling pathway, Cocaine addiction, Dopaminergic synapse, Gap junction, Hormone signaling, Morphine addiction, Neuroactive ligand signaling, Neuroactive ligand-receptor interaction, Parkinson disease, Phenylalanine metabolism, Rap1 signaling pathway, Serotonergic synapse, Tryptophan metabolism, Tyrosine metabolism, cAMP signaling pathway 💬1件: 6 💬
1265Levodopa and decarboxylase inhibitor1件: Levodopa1件: Levodopa 💬 5件: DRD1,
DRD2,
DRD3,
DRD4,
DRD5 💬
13件: Alcoholism, Amphetamine addiction, Calcium signaling pathway, Cocaine addiction, Dopaminergic synapse, Gap junction, Hormone signaling, Morphine addiction, Neuroactive ligand signaling, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, cAMP signaling pathway 💬1件: 6 💬
1266Levodopa and Domperidone2件: Domperidone,
Levodopa
3件: Levodopa ,
Domperidone ,
Domperidone maleate 💬
5件: DRD1,
DRD2,
DRD3,
DRD4,
DRD5 💬
13件: Alcoholism, Amphetamine addiction, Calcium signaling pathway, Cocaine addiction, Dopaminergic synapse, Gap junction, Hormone signaling, Morphine addiction, Neuroactive ligand signaling, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, cAMP signaling pathway 💬1件: 6 💬
1267Levodopa Benserazide Madopar2件: Benserazide,
Levodopa
3件: Levodopa ,
Benserazide hydrochloride ,
Benserazide 💬
6件: DDC,
DRD1,
DRD2,
DRD3,
DRD4,
DRD5 💬
17件: Alcoholism, Amphetamine addiction, Calcium signaling pathway, Cocaine addiction, Dopaminergic synapse, Gap junction, Hormone signaling, Morphine addiction, Neuroactive ligand signaling, Neuroactive ligand-receptor interaction, Parkinson disease, Phenylalanine metabolism, Rap1 signaling pathway, Serotonergic synapse, Tryptophan metabolism, Tyrosine metabolism, cAMP signaling pathway 💬1件: 6 💬
1268Levodopa Benserazide Teva Italia2件: Benserazide,
Levodopa
3件: Levodopa ,
Benserazide hydrochloride ,
Benserazide 💬
6件: DDC,
DRD1,
DRD2,
DRD3,
DRD4,
DRD5 💬
17件: Alcoholism, Amphetamine addiction, Calcium signaling pathway, Cocaine addiction, Dopaminergic synapse, Gap junction, Hormone signaling, Morphine addiction, Neuroactive ligand signaling, Neuroactive ligand-receptor interaction, Parkinson disease, Phenylalanine metabolism, Rap1 signaling pathway, Serotonergic synapse, Tryptophan metabolism, Tyrosine metabolism, cAMP signaling pathway 💬1件: 6 💬
1269Levodopa Carbidopa2件: Carbidopa,
Levodopa
2件: Levodopa ,
Carbidopa 💬
6件: DDC,
DRD1,
DRD2,
DRD3,
DRD4,
DRD5 💬
17件: Alcoholism, Amphetamine addiction, Calcium signaling pathway, Cocaine addiction, Dopaminergic synapse, Gap junction, Hormone signaling, Morphine addiction, Neuroactive ligand signaling, Neuroactive ligand-receptor interaction, Parkinson disease, Phenylalanine metabolism, Rap1 signaling pathway, Serotonergic synapse, Tryptophan metabolism, Tyrosine metabolism, cAMP signaling pathway 💬1件: 6 💬
1270Levodopa carbidopa (LC) oral encapsulated immediate release (IR) tablets2件: Carbidopa,
Levodopa
2件: Levodopa ,
Carbidopa 💬
6件: DDC,
DRD1,
DRD2,
DRD3,
DRD4,
DRD5 💬
17件: Alcoholism, Amphetamine addiction, Calcium signaling pathway, Cocaine addiction, Dopaminergic synapse, Gap junction, Hormone signaling, Morphine addiction, Neuroactive ligand signaling, Neuroactive ligand-receptor interaction, Parkinson disease, Phenylalanine metabolism, Rap1 signaling pathway, Serotonergic synapse, Tryptophan metabolism, Tyrosine metabolism, cAMP signaling pathway 💬1件: 6 💬
1271Levodopa carbidopa intestinal gel (LCIG)2件: Carbidopa,
Levodopa
2件: Levodopa ,
Carbidopa 💬
6件: DDC,
DRD1,
DRD2,
DRD3,
DRD4,
DRD5 💬
17件: Alcoholism, Amphetamine addiction, Calcium signaling pathway, Cocaine addiction, Dopaminergic synapse, Gap junction, Hormone signaling, Morphine addiction, Neuroactive ligand signaling, Neuroactive ligand-receptor interaction, Parkinson disease, Phenylalanine metabolism, Rap1 signaling pathway, Serotonergic synapse, Tryptophan metabolism, Tyrosine metabolism, cAMP signaling pathway 💬1件: 6 💬
1272Levodopa CR (controlled release)1件: Levodopa1件: Levodopa 💬 5件: DRD1,
DRD2,
DRD3,
DRD4,
DRD5 💬
13件: Alcoholism, Amphetamine addiction, Calcium signaling pathway, Cocaine addiction, Dopaminergic synapse, Gap junction, Hormone signaling, Morphine addiction, Neuroactive ligand signaling, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, cAMP signaling pathway 💬1件: 6 💬
1273Levodopa Cyclops1件: Levodopa1件: Levodopa 💬 5件: DRD1,
DRD2,
DRD3,
DRD4,
DRD5 💬
13件: Alcoholism, Amphetamine addiction, Calcium signaling pathway, Cocaine addiction, Dopaminergic synapse, Gap junction, Hormone signaling, Morphine addiction, Neuroactive ligand signaling, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, cAMP signaling pathway 💬1件: 6 💬
1274LEVODOPA DC.IT FU1件: Levodopa1件: Levodopa 💬 5件: DRD1,
DRD2,
DRD3,
DRD4,
DRD5 💬
13件: Alcoholism, Amphetamine addiction, Calcium signaling pathway, Cocaine addiction, Dopaminergic synapse, Gap junction, Hormone signaling, Morphine addiction, Neuroactive ligand signaling, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, cAMP signaling pathway 💬1件: 6 💬
1275Levodopa dispersible1件: Levodopa1件: Levodopa 💬 5件: DRD1,
DRD2,
DRD3,
DRD4,
DRD5 💬
13件: Alcoholism, Amphetamine addiction, Calcium signaling pathway, Cocaine addiction, Dopaminergic synapse, Gap junction, Hormone signaling, Morphine addiction, Neuroactive ligand signaling, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, cAMP signaling pathway 💬1件: 6 💬
1276Levodopa formulation1件: Levodopa1件: Levodopa 💬 5件: DRD1,
DRD2,
DRD3,
DRD4,
DRD5 💬
13件: Alcoholism, Amphetamine addiction, Calcium signaling pathway, Cocaine addiction, Dopaminergic synapse, Gap junction, Hormone signaling, Morphine addiction, Neuroactive ligand signaling, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, cAMP signaling pathway 💬1件: 6 💬
1277Levodopa infusion1件: Levodopa1件: Levodopa 💬 5件: DRD1,
DRD2,
DRD3,
DRD4,
DRD5 💬
13件: Alcoholism, Amphetamine addiction, Calcium signaling pathway, Cocaine addiction, Dopaminergic synapse, Gap junction, Hormone signaling, Morphine addiction, Neuroactive ligand signaling, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, cAMP signaling pathway 💬1件: 6 💬
1278LEVODOPA INN1件: Levodopa1件: Levodopa 💬 5件: DRD1,
DRD2,
DRD3,
DRD4,
DRD5 💬
13件: Alcoholism, Amphetamine addiction, Calcium signaling pathway, Cocaine addiction, Dopaminergic synapse, Gap junction, Hormone signaling, Morphine addiction, Neuroactive ligand signaling, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, cAMP signaling pathway 💬1件: 6 💬
1279Levodopa MR1件: Levodopa1件: Levodopa 💬 5件: DRD1,
DRD2,
DRD3,
DRD4,
DRD5 💬
13件: Alcoholism, Amphetamine addiction, Calcium signaling pathway, Cocaine addiction, Dopaminergic synapse, Gap junction, Hormone signaling, Morphine addiction, Neuroactive ligand signaling, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, cAMP signaling pathway 💬1件: 6 💬
1280Levodopa powder for inhalation1件: Levodopa1件: Levodopa 💬 5件: DRD1,
DRD2,
DRD3,
DRD4,
DRD5 💬
13件: Alcoholism, Amphetamine addiction, Calcium signaling pathway, Cocaine addiction, Dopaminergic synapse, Gap junction, Hormone signaling, Morphine addiction, Neuroactive ligand signaling, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, cAMP signaling pathway 💬1件: 6 💬
1281Levodopa tablet1件: Levodopa1件: Levodopa 💬 5件: DRD1,
DRD2,
DRD3,
DRD4,
DRD5 💬
13件: Alcoholism, Amphetamine addiction, Calcium signaling pathway, Cocaine addiction, Dopaminergic synapse, Gap junction, Hormone signaling, Morphine addiction, Neuroactive ligand signaling, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, cAMP signaling pathway 💬1件: 6 💬
1282Levodopa, carbidopa, entacapone3件: Carbidopa,
Entacapone,
Levodopa
3件: Levodopa ,
Carbidopa ,
Entacapone 💬
7件: COMT,
DDC,
DRD1,
DRD2,
DRD3,
DRD4,
DRD5 💬
18件: Alcoholism, Amphetamine addiction, Calcium signaling pathway, Cocaine addiction, Dopaminergic synapse, Gap junction, Hormone signaling, Morphine addiction, Neuroactive ligand signaling, Neuroactive ligand-receptor interaction, Parkinson disease, Phenylalanine metabolism, Rap1 signaling pathway, Serotonergic synapse, Steroid hormone biosynthesis, Tryptophan metabolism, Tyrosine metabolism, cAMP signaling pathway 💬1件: 6 💬
1283Levodopa, carbidopa, ODM-1042件: Carbidopa,
Levodopa
2件: Levodopa ,
Carbidopa 💬
6件: DDC,
DRD1,
DRD2,
DRD3,
DRD4,
DRD5 💬
17件: Alcoholism, Amphetamine addiction, Calcium signaling pathway, Cocaine addiction, Dopaminergic synapse, Gap junction, Hormone signaling, Morphine addiction, Neuroactive ligand signaling, Neuroactive ligand-receptor interaction, Parkinson disease, Phenylalanine metabolism, Rap1 signaling pathway, Serotonergic synapse, Tryptophan metabolism, Tyrosine metabolism, cAMP signaling pathway 💬1件: 6 💬
1284Levodopa, decarboxylase inhibitor and COMT inhibitor1件: Levodopa1件: Levodopa 💬 5件: DRD1,
DRD2,
DRD3,
DRD4,
DRD5 💬
13件: Alcoholism, Amphetamine addiction, Calcium signaling pathway, Cocaine addiction, Dopaminergic synapse, Gap junction, Hormone signaling, Morphine addiction, Neuroactive ligand signaling, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, cAMP signaling pathway 💬1件: 6 💬
1285Levodopa-4'-Monophosphate2件: Foslevodopa,
Levodopa
2件: Levodopa ,
Foslevodopa 💬
5件: DRD1,
DRD2,
DRD3,
DRD4,
DRD5 💬
13件: Alcoholism, Amphetamine addiction, Calcium signaling pathway, Cocaine addiction, Dopaminergic synapse, Gap junction, Hormone signaling, Morphine addiction, Neuroactive ligand signaling, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, cAMP signaling pathway 💬1件: 6 💬
1286Levodopa-Carbidopa2件: Carbidopa,
Levodopa
2件: Levodopa ,
Carbidopa 💬
6件: DDC,
DRD1,
DRD2,
DRD3,
DRD4,
DRD5 💬
17件: Alcoholism, Amphetamine addiction, Calcium signaling pathway, Cocaine addiction, Dopaminergic synapse, Gap junction, Hormone signaling, Morphine addiction, Neuroactive ligand signaling, Neuroactive ligand-receptor interaction, Parkinson disease, Phenylalanine metabolism, Rap1 signaling pathway, Serotonergic synapse, Tryptophan metabolism, Tyrosine metabolism, cAMP signaling pathway 💬2件: 6, 90 💬
1287Levodopa-carbidopa (LC) oral encapsulated immediate release (IR) tablets2件: Carbidopa,
Levodopa
2件: Levodopa ,
Carbidopa 💬
6件: DDC,
DRD1,
DRD2,
DRD3,
DRD4,
DRD5 💬
17件: Alcoholism, Amphetamine addiction, Calcium signaling pathway, Cocaine addiction, Dopaminergic synapse, Gap junction, Hormone signaling, Morphine addiction, Neuroactive ligand signaling, Neuroactive ligand-receptor interaction, Parkinson disease, Phenylalanine metabolism, Rap1 signaling pathway, Serotonergic synapse, Tryptophan metabolism, Tyrosine metabolism, cAMP signaling pathway 💬1件: 6 💬
1288Levodopa-Carbidopa Immediate Release2件: Carbidopa,
Levodopa
2件: Levodopa ,
Carbidopa 💬
6件: DDC,
DRD1,
DRD2,
DRD3,
DRD4,
DRD5 💬
17件: Alcoholism, Amphetamine addiction, Calcium signaling pathway, Cocaine addiction, Dopaminergic synapse, Gap junction, Hormone signaling, Morphine addiction, Neuroactive ligand signaling, Neuroactive ligand-receptor interaction, Parkinson disease, Phenylalanine metabolism, Rap1 signaling pathway, Serotonergic synapse, Tryptophan metabolism, Tyrosine metabolism, cAMP signaling pathway 💬1件: 6 💬
1289Levodopa-carbidopa Immediate Release (LC-IR) Tablets2件: Carbidopa,
Levodopa
2件: Levodopa ,
Carbidopa 💬
6件: DDC,
DRD1,
DRD2,
DRD3,
DRD4,
DRD5 💬
17件: Alcoholism, Amphetamine addiction, Calcium signaling pathway, Cocaine addiction, Dopaminergic synapse, Gap junction, Hormone signaling, Morphine addiction, Neuroactive ligand signaling, Neuroactive ligand-receptor interaction, Parkinson disease, Phenylalanine metabolism, Rap1 signaling pathway, Serotonergic synapse, Tryptophan metabolism, Tyrosine metabolism, cAMP signaling pathway 💬1件: 6 💬
1290Levodopa-Carbidopa Intestinal Gel2件: Carbidopa,
Levodopa
2件: Levodopa ,
Carbidopa 💬
6件: DDC,
DRD1,
DRD2,
DRD3,
DRD4,
DRD5 💬
17件: Alcoholism, Amphetamine addiction, Calcium signaling pathway, Cocaine addiction, Dopaminergic synapse, Gap junction, Hormone signaling, Morphine addiction, Neuroactive ligand signaling, Neuroactive ligand-receptor interaction, Parkinson disease, Phenylalanine metabolism, Rap1 signaling pathway, Serotonergic synapse, Tryptophan metabolism, Tyrosine metabolism, cAMP signaling pathway 💬1件: 6 💬
1291Levodopa-Carbidopa Intestinal Gel (LCIG)2件: Carbidopa,
Levodopa
2件: Levodopa ,
Carbidopa 💬
6件: DDC,
DRD1,
DRD2,
DRD3,
DRD4,
DRD5 💬
17件: Alcoholism, Amphetamine addiction, Calcium signaling pathway, Cocaine addiction, Dopaminergic synapse, Gap junction, Hormone signaling, Morphine addiction, Neuroactive ligand signaling, Neuroactive ligand-receptor interaction, Parkinson disease, Phenylalanine metabolism, Rap1 signaling pathway, Serotonergic synapse, Tryptophan metabolism, Tyrosine metabolism, cAMP signaling pathway 💬1件: 6 💬
1292Levodopa-Carbidopa Multilayer Extended Release Tablet2件: Carbidopa,
Levodopa
2件: Levodopa ,
Carbidopa 💬
6件: DDC,
DRD1,
DRD2,
DRD3,
DRD4,
DRD5 💬
17件: Alcoholism, Amphetamine addiction, Calcium signaling pathway, Cocaine addiction, Dopaminergic synapse, Gap junction, Hormone signaling, Morphine addiction, Neuroactive ligand signaling, Neuroactive ligand-receptor interaction, Parkinson disease, Phenylalanine metabolism, Rap1 signaling pathway, Serotonergic synapse, Tryptophan metabolism, Tyrosine metabolism, cAMP signaling pathway 💬1件: 6 💬
1293Levodopa-Carbidopa XL tablet (M)2件: Carbidopa,
Levodopa
2件: Levodopa ,
Carbidopa 💬
6件: DDC,
DRD1,
DRD2,
DRD3,
DRD4,
DRD5 💬
17件: Alcoholism, Amphetamine addiction, Calcium signaling pathway, Cocaine addiction, Dopaminergic synapse, Gap junction, Hormone signaling, Morphine addiction, Neuroactive ligand signaling, Neuroactive ligand-receptor interaction, Parkinson disease, Phenylalanine metabolism, Rap1 signaling pathway, Serotonergic synapse, Tryptophan metabolism, Tyrosine metabolism, cAMP signaling pathway 💬1件: 6 💬
1294Levodopa-carbidopa-entacapone3件: Carbidopa,
Entacapone,
Levodopa
3件: Levodopa ,
Carbidopa ,
Entacapone 💬
7件: COMT,
DDC,
DRD1,
DRD2,
DRD3,
DRD4,
DRD5 💬
18件: Alcoholism, Amphetamine addiction, Calcium signaling pathway, Cocaine addiction, Dopaminergic synapse, Gap junction, Hormone signaling, Morphine addiction, Neuroactive ligand signaling, Neuroactive ligand-receptor interaction, Parkinson disease, Phenylalanine metabolism, Rap1 signaling pathway, Serotonergic synapse, Steroid hormone biosynthesis, Tryptophan metabolism, Tyrosine metabolism, cAMP signaling pathway 💬1件: 6 💬
1295Levodopa/benserazide2件: Benserazide,
Levodopa
3件: Levodopa ,
Benserazide hydrochloride ,
Benserazide 💬
6件: DDC,
DRD1,
DRD2,
DRD3,
DRD4,
DRD5 💬
17件: Alcoholism, Amphetamine addiction, Calcium signaling pathway, Cocaine addiction, Dopaminergic synapse, Gap junction, Hormone signaling, Morphine addiction, Neuroactive ligand signaling, Neuroactive ligand-receptor interaction, Parkinson disease, Phenylalanine metabolism, Rap1 signaling pathway, Serotonergic synapse, Tryptophan metabolism, Tyrosine metabolism, cAMP signaling pathway 💬1件: 6 💬
1296Levodopa/benserazide 100/25 mg2件: Benserazide,
Levodopa
3件: Levodopa ,
Benserazide hydrochloride ,
Benserazide 💬
6件: DDC,
DRD1,
DRD2,
DRD3,
DRD4,
DRD5 💬
17件: Alcoholism, Amphetamine addiction, Calcium signaling pathway, Cocaine addiction, Dopaminergic synapse, Gap junction, Hormone signaling, Morphine addiction, Neuroactive ligand signaling, Neuroactive ligand-receptor interaction, Parkinson disease, Phenylalanine metabolism, Rap1 signaling pathway, Serotonergic synapse, Tryptophan metabolism, Tyrosine metabolism, cAMP signaling pathway 💬1件: 6 💬
1297LEVODOPA/BENZERASIDE1件: Levodopa1件: Levodopa 💬 5件: DRD1,
DRD2,
DRD3,
DRD4,
DRD5 💬
13件: Alcoholism, Amphetamine addiction, Calcium signaling pathway, Cocaine addiction, Dopaminergic synapse, Gap junction, Hormone signaling, Morphine addiction, Neuroactive ligand signaling, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, cAMP signaling pathway 💬1件: 6 💬
1298Levodopa/Benzerazide1件: Levodopa1件: Levodopa 💬 5件: DRD1,
DRD2,
DRD3,
DRD4,
DRD5 💬
13件: Alcoholism, Amphetamine addiction, Calcium signaling pathway, Cocaine addiction, Dopaminergic synapse, Gap junction, Hormone signaling, Morphine addiction, Neuroactive ligand signaling, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, cAMP signaling pathway 💬1件: 6 💬
1299LEVODOPA/CARBIDOPA2件: Carbidopa,
Levodopa
2件: Levodopa ,
Carbidopa 💬
6件: DDC,
DRD1,
DRD2,
DRD3,
DRD4,
DRD5 💬
17件: Alcoholism, Amphetamine addiction, Calcium signaling pathway, Cocaine addiction, Dopaminergic synapse, Gap junction, Hormone signaling, Morphine addiction, Neuroactive ligand signaling, Neuroactive ligand-receptor interaction, Parkinson disease, Phenylalanine metabolism, Rap1 signaling pathway, Serotonergic synapse, Tryptophan metabolism, Tyrosine metabolism, cAMP signaling pathway 💬2件: 6, 164 💬
1300Levodopa/Carbidopa (LD/CD)2件: Carbidopa,
Levodopa
2件: Levodopa ,
Carbidopa 💬
6件: DDC,
DRD1,
DRD2,
DRD3,
DRD4,
DRD5 💬
17件: Alcoholism, Amphetamine addiction, Calcium signaling pathway, Cocaine addiction, Dopaminergic synapse, Gap junction, Hormone signaling, Morphine addiction, Neuroactive ligand signaling, Neuroactive ligand-receptor interaction, Parkinson disease, Phenylalanine metabolism, Rap1 signaling pathway, Serotonergic synapse, Tryptophan metabolism, Tyrosine metabolism, cAMP signaling pathway 💬1件: 6 💬
1301Levodopa/Carbidopa (Sinemet)2件: Carbidopa,
Levodopa
2件: Levodopa ,
Carbidopa 💬
6件: DDC,
DRD1,
DRD2,
DRD3,
DRD4,
DRD5 💬
17件: Alcoholism, Amphetamine addiction, Calcium signaling pathway, Cocaine addiction, Dopaminergic synapse, Gap junction, Hormone signaling, Morphine addiction, Neuroactive ligand signaling, Neuroactive ligand-receptor interaction, Parkinson disease, Phenylalanine metabolism, Rap1 signaling pathway, Serotonergic synapse, Tryptophan metabolism, Tyrosine metabolism, cAMP signaling pathway 💬1件: 6 💬
1302Levodopa/carbidopa 100/252件: Carbidopa,
Levodopa
2件: Levodopa ,
Carbidopa 💬
6件: DDC,
DRD1,
DRD2,
DRD3,
DRD4,
DRD5 💬
17件: Alcoholism, Amphetamine addiction, Calcium signaling pathway, Cocaine addiction, Dopaminergic synapse, Gap junction, Hormone signaling, Morphine addiction, Neuroactive ligand signaling, Neuroactive ligand-receptor interaction, Parkinson disease, Phenylalanine metabolism, Rap1 signaling pathway, Serotonergic synapse, Tryptophan metabolism, Tyrosine metabolism, cAMP signaling pathway 💬1件: 6 💬
1303Levodopa/carbidopa oral formulation A2件: Carbidopa,
Levodopa
2件: Levodopa ,
Carbidopa 💬
6件: DDC,
DRD1,
DRD2,
DRD3,
DRD4,
DRD5 💬
17件: Alcoholism, Amphetamine addiction, Calcium signaling pathway, Cocaine addiction, Dopaminergic synapse, Gap junction, Hormone signaling, Morphine addiction, Neuroactive ligand signaling, Neuroactive ligand-receptor interaction, Parkinson disease, Phenylalanine metabolism, Rap1 signaling pathway, Serotonergic synapse, Tryptophan metabolism, Tyrosine metabolism, cAMP signaling pathway 💬1件: 6 💬
1304Levodopa/carbidopa oral formulation B2件: Carbidopa,
Levodopa
2件: Levodopa ,
Carbidopa 💬
6件: DDC,
DRD1,
DRD2,
DRD3,
DRD4,
DRD5 💬
17件: Alcoholism, Amphetamine addiction, Calcium signaling pathway, Cocaine addiction, Dopaminergic synapse, Gap junction, Hormone signaling, Morphine addiction, Neuroactive ligand signaling, Neuroactive ligand-receptor interaction, Parkinson disease, Phenylalanine metabolism, Rap1 signaling pathway, Serotonergic synapse, Tryptophan metabolism, Tyrosine metabolism, cAMP signaling pathway 💬1件: 6 💬
1305Levodopa/Carbidopa Solution2件: Carbidopa,
Levodopa
2件: Levodopa ,
Carbidopa 💬
6件: DDC,
DRD1,
DRD2,
DRD3,
DRD4,
DRD5 💬
17件: Alcoholism, Amphetamine addiction, Calcium signaling pathway, Cocaine addiction, Dopaminergic synapse, Gap junction, Hormone signaling, Morphine addiction, Neuroactive ligand signaling, Neuroactive ligand-receptor interaction, Parkinson disease, Phenylalanine metabolism, Rap1 signaling pathway, Serotonergic synapse, Tryptophan metabolism, Tyrosine metabolism, cAMP signaling pathway 💬1件: 6 💬
1306Levodopa/carbidopa solution for SC administration2件: Carbidopa,
Levodopa
2件: Levodopa ,
Carbidopa 💬
6件: DDC,
DRD1,
DRD2,
DRD3,
DRD4,
DRD5 💬
17件: Alcoholism, Amphetamine addiction, Calcium signaling pathway, Cocaine addiction, Dopaminergic synapse, Gap junction, Hormone signaling, Morphine addiction, Neuroactive ligand signaling, Neuroactive ligand-receptor interaction, Parkinson disease, Phenylalanine metabolism, Rap1 signaling pathway, Serotonergic synapse, Tryptophan metabolism, Tyrosine metabolism, cAMP signaling pathway 💬1件: 6 💬
1307Levodopa/Carbidopa(200mg/50mg)2件: Carbidopa,
Levodopa
2件: Levodopa ,
Carbidopa 💬
6件: DDC,
DRD1,
DRD2,
DRD3,
DRD4,
DRD5 💬
17件: Alcoholism, Amphetamine addiction, Calcium signaling pathway, Cocaine addiction, Dopaminergic synapse, Gap junction, Hormone signaling, Morphine addiction, Neuroactive ligand signaling, Neuroactive ligand-receptor interaction, Parkinson disease, Phenylalanine metabolism, Rap1 signaling pathway, Serotonergic synapse, Tryptophan metabolism, Tyrosine metabolism, cAMP signaling pathway 💬1件: 6 💬
1308Levodopa/carbidopa/entacapone3件: Carbidopa,
Entacapone,
Levodopa
3件: Levodopa ,
Carbidopa ,
Entacapone 💬
7件: COMT,
DDC,
DRD1,
DRD2,
DRD3,
DRD4,
DRD5 💬
18件: Alcoholism, Amphetamine addiction, Calcium signaling pathway, Cocaine addiction, Dopaminergic synapse, Gap junction, Hormone signaling, Morphine addiction, Neuroactive ligand signaling, Neuroactive ligand-receptor interaction, Parkinson disease, Phenylalanine metabolism, Rap1 signaling pathway, Serotonergic synapse, Steroid hormone biosynthesis, Tryptophan metabolism, Tyrosine metabolism, cAMP signaling pathway 💬1件: 6 💬
1309Levodopa/DDCI1件: Levodopa1件: Levodopa 💬 5件: DRD1,
DRD2,
DRD3,
DRD4,
DRD5 💬
13件: Alcoholism, Amphetamine addiction, Calcium signaling pathway, Cocaine addiction, Dopaminergic synapse, Gap junction, Hormone signaling, Morphine addiction, Neuroactive ligand signaling, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, cAMP signaling pathway 💬1件: 6 💬
1310Levodopa/dopa decarboxylase inhibitor1件: Levodopa1件: Levodopa 💬 5件: DRD1,
DRD2,
DRD3,
DRD4,
DRD5 💬
13件: Alcoholism, Amphetamine addiction, Calcium signaling pathway, Cocaine addiction, Dopaminergic synapse, Gap junction, Hormone signaling, Morphine addiction, Neuroactive ligand signaling, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, cAMP signaling pathway 💬1件: 6 💬
1311Liatermin1件: Liatermin1件: Liatermin 💬 --1件: 6 💬
1312Liatermin (r-metHuGDNF)1件: Liatermin1件: Liatermin 💬 --1件: 6 💬
1313Lidocaine1件: Lidocaine3件: Lidocaine ,
Lidocaine hydrochloride ,
Lidocaine hydrochloride monohydrate 💬
6件: SCN1A,
SCN2A,
SCN3A,
SCN5A,
SCN8A,
SCN9A 💬
5件: Adrenergic signaling in cardiomyocytes, Cadherin signaling, Dopaminergic synapse, IgSF CAM signaling, Taste transduction 💬14件: 6, 13, 22, 34, 46, 51, 70, 86, 107, 168, 226, 231, 256, 298 💬
1314Lidocaine hydrochloride1件: Lidocaine3件: Lidocaine ,
Lidocaine hydrochloride ,
Lidocaine hydrochloride monohydrate 💬
6件: SCN1A,
SCN2A,
SCN3A,
SCN5A,
SCN8A,
SCN9A 💬
5件: Adrenergic signaling in cardiomyocytes, Cadherin signaling, Dopaminergic synapse, IgSF CAM signaling, Taste transduction 💬1件: 6 💬
1315Light box ( Litebook company)----1件: 6 💬
1316Light box (Litebook company)----1件: 6 💬
1317Linaclotide1件: Linaclotide2件: Linaclotide acetate ,
Linaclotide 💬
1件: GUCY2C 💬 2件: Hormone signaling, Purine metabolism 💬3件: 6, 97, 299 💬
1318Lingzhi (Ganoderma)----1件: 6 💬
1319Lipopolysaccharide----1件: 6 💬
1320Liquigen MCT oil----1件: 6 💬
1321Liraglutide1件: Liraglutide1件: Liraglutide 💬 1件: GLP1R 💬 4件: Hormone signaling, Insulin secretion, Neuroactive ligand-receptor interaction, cAMP signaling pathway 💬5件: 6, 13, 75, 77, 193 💬
1322Lisparin----1件: 6 💬
1323LISURIDE1件: Lisuride1件: Lisuride 💬 3件: DRD2,
DRD3,
DRD4 💬
10件: Alcoholism, Cocaine addiction, Dopaminergic synapse, Gap junction, Hormone signaling, Neuroactive ligand signaling, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, cAMP signaling pathway 💬2件: 6, 86 💬
1324Lisuride Hydrogenmaleate1件: Lisuride1件: Lisuride 💬 3件: DRD2,
DRD3,
DRD4 💬
10件: Alcoholism, Cocaine addiction, Dopaminergic synapse, Gap junction, Hormone signaling, Neuroactive ligand signaling, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, cAMP signaling pathway 💬1件: 6 💬
1325Lisuride Transdermal System1件: Lisuride1件: Lisuride 💬 3件: DRD2,
DRD3,
DRD4 💬
10件: Alcoholism, Cocaine addiction, Dopaminergic synapse, Gap junction, Hormone signaling, Neuroactive ligand signaling, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, cAMP signaling pathway 💬1件: 6 💬
1326Lisuride TTS1件: Lisuride1件: Lisuride 💬 3件: DRD2,
DRD3,
DRD4 💬
10件: Alcoholism, Cocaine addiction, Dopaminergic synapse, Gap junction, Hormone signaling, Neuroactive ligand signaling, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, cAMP signaling pathway 💬1件: 6 💬
1327Lisuride TTS 10cm²1件: Lisuride1件: Lisuride 💬 3件: DRD2,
DRD3,
DRD4 💬
10件: Alcoholism, Cocaine addiction, Dopaminergic synapse, Gap junction, Hormone signaling, Neuroactive ligand signaling, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, cAMP signaling pathway 💬1件: 6 💬
1328Lisuride TTS 20cm²1件: Lisuride1件: Lisuride 💬 3件: DRD2,
DRD3,
DRD4 💬
10件: Alcoholism, Cocaine addiction, Dopaminergic synapse, Gap junction, Hormone signaling, Neuroactive ligand signaling, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, cAMP signaling pathway 💬1件: 6 💬
1329Lithium----5件: 2, 5, 6, 7, 8 💬
1330Lithium aspartate----1件: 6 💬
1331Live Combined Bifidobacterium,Lactobacillus and Enterococcus Capsules----1件: 6 💬
1332Lixisenatide1件: Lixisenatide1件: Lixisenatide 💬 1件: GLP1R 💬 4件: Hormone signaling, Insulin secretion, Neuroactive ligand-receptor interaction, cAMP signaling pathway 💬1件: 6 💬
1333Local Anesthesia (lidocaine hydrochloride)1件: Lidocaine3件: Lidocaine ,
Lidocaine hydrochloride ,
Lidocaine hydrochloride monohydrate 💬
6件: SCN1A,
SCN2A,
SCN3A,
SCN5A,
SCN8A,
SCN9A 💬
5件: Adrenergic signaling in cardiomyocytes, Cadherin signaling, Dopaminergic synapse, IgSF CAM signaling, Taste transduction 💬1件: 6 💬
1334Local Trade Name, 2mg----1件: 6 💬
1335Local Trade Name, 4mg----1件: 6 💬
1336Local Trade Name, 8mg----1件: 6 💬
1337LODALÈS®----1件: 6 💬
1338Lovastatin1件: Lovastatin1件: Lovastatin 💬 1件: HMGCR 💬 3件: AMPK signaling pathway, Bile secretion, Terpenoid backbone biosynthesis 💬11件: 6, 34, 46, 79, 156, 160, 195, 206, 263, 280, 310 💬
1339Low dose AFFITOPE® PD03A + Adjuvant----1件: 6 💬
1340Low Dose GT-02287----1件: 6 💬
1341Low dose levodopa1件: Levodopa1件: Levodopa 💬 5件: DRD1,
DRD2,
DRD3,
DRD4,
DRD5 💬
13件: Alcoholism, Amphetamine addiction, Calcium signaling pathway, Cocaine addiction, Dopaminergic synapse, Gap junction, Hormone signaling, Morphine addiction, Neuroactive ligand signaling, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, cAMP signaling pathway 💬1件: 6 💬
1342Low-Frequency-Only Stimulation----1件: 6 💬
1343Lu 00-800----1件: 6 💬
1344Lu AF28996----1件: 6 💬
1345Lu AF82422----2件: 6, 17 💬
1346LUBIPROSTONE1件: Lubiprostone1件: Lubiprostone 💬 1件: CLCN2 💬 1件: Mineral absorption 💬5件: 6, 13, 97, 290, 299 💬
1347Lumbar puncture----9件: 2, 6, 13, 14, 19, 96, 97, 127, 201 💬
1348LY03003----1件: 6 💬
1349LY03003 ( Rotigotine, extended-release microspheres)1件: Rotigotine1件: Rotigotine 💬 1件: DRD2 💬 10件: Alcoholism, Cocaine addiction, Dopaminergic synapse, Gap junction, Hormone signaling, Neuroactive ligand signaling, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, cAMP signaling pathway 💬1件: 6 💬
1350LY03003 (rotigotine extended release microspheres for intramuscular [IM] injection)1件: Rotigotine1件: Rotigotine 💬 1件: DRD2 💬 10件: Alcoholism, Cocaine addiction, Dopaminergic synapse, Gap junction, Hormone signaling, Neuroactive ligand signaling, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, cAMP signaling pathway 💬1件: 6 💬
1351LY03003( the name of rotigotine)1件: Rotigotine1件: Rotigotine 💬 1件: DRD2 💬 10件: Alcoholism, Cocaine addiction, Dopaminergic synapse, Gap junction, Hormone signaling, Neuroactive ligand signaling, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, cAMP signaling pathway 💬1件: 6 💬
1352LY03003(Rotigotine,extended-release microspheres)1件: Rotigotine1件: Rotigotine 💬 1件: DRD2 💬 10件: Alcoholism, Cocaine addiction, Dopaminergic synapse, Gap junction, Hormone signaling, Neuroactive ligand signaling, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, cAMP signaling pathway 💬1件: 6 💬
1353LY03009 F1----1件: 6 💬
1354LY03009 F2----1件: 6 💬
1355LY03009 F3----1件: 6 💬
1356LY03009 F4----1件: 6 💬
1357LY03017----1件: 6 💬
1358LY300164----1件: 6 💬
1359LY3154207----1件: 6 💬
1360LY38849611件: LY3884961---2件: 6, 19 💬
1361LY3962681----1件: 6 💬
1362LY4006896----1件: 6 💬
1363Madopar----1件: 6 💬
1364Madopar 125 mg T, tablets----1件: 6 💬
1365Madopar 125 mg, orodispersible tablet----1件: 6 💬
1366Madopar 200+50 mg----1件: 6 💬
1367Madopar LT----1件: 6 💬
1368Madopar monotherapy----1件: 6 💬
1369Madopar Tab. 125 or Perkin Tab. 25-100mg----1件: 6 💬
1370Madopar® 125----1件: 6 💬
1371Madopar® 125 mg T Tablets Levodopa 100 mg Benserazide 25 mg (as benserazide hydrochloride)2件: Benserazide,
Levodopa
3件: Levodopa ,
Benserazide hydrochloride ,
Benserazide 💬
6件: DDC,
DRD1,
DRD2,
DRD3,
DRD4,
DRD5 💬
17件: Alcoholism, Amphetamine addiction, Calcium signaling pathway, Cocaine addiction, Dopaminergic synapse, Gap junction, Hormone signaling, Morphine addiction, Neuroactive ligand signaling, Neuroactive ligand-receptor interaction, Parkinson disease, Phenylalanine metabolism, Rap1 signaling pathway, Serotonergic synapse, Tryptophan metabolism, Tyrosine metabolism, cAMP signaling pathway 💬1件: 6 💬
1372Madopar® 250----1件: 6 💬
1373Madopar® HBS----1件: 6 💬
1374Madopar® HBS 125----1件: 6 💬
1375Magnesium1件: Magnesium---23件: 3, 6, 11, 13, 15, 46, 64, 70, 71, 93, 97, 113, 166, 225, 234, 235, 256, 284, 291, 296, 297, 298, 340 💬
1376Magnesium oxide2件: Magnesium,
Magnesium oxide
1件: Magnesium oxide 💬 --4件: 6, 113, 166, 291 💬
1377Magnetic Resonance Imaging----10件: 6, 13, 19, 22, 28, 34, 65, 205, 285, 299 💬
1378Maltodextrin1件: Maltodextrin1件: Maltodextrin 💬 --4件: 6, 13, 96, 97 💬
1379Mannitol1件: Mannitol1件: Mannitol 💬 --8件: 6, 13, 21, 28, 60, 96, 113, 299 💬
1380MANTADIX----1件: 6 💬
1381Marketed Pramipexole ER1件: Pramipexole2件: Pramipexole dihydrochloride ,
Pramipexole 💬
3件: DRD2,
DRD3,
DRD4 💬
10件: Alcoholism, Cocaine addiction, Dopaminergic synapse, Gap junction, Hormone signaling, Neuroactive ligand signaling, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, cAMP signaling pathway 💬1件: 6 💬
1382MARS----1件: 6 💬
1383MASITINIB1件: Masitinib1件: Masitinib 💬 1件: KIT 💬 11件: Acute myeloid leukemia, Breast cancer, Central carbon metabolism in cancer, Hematopoietic cell lineage, MAPK signaling pathway, Melanogenesis, PI3K-Akt signaling pathway, Pathways in cancer, Phospholipase D signaling pathway, Rap1 signaling pathway, Ras signaling pathway 💬6件: 2, 5, 6, 13, 46, 96 💬
1384MASITINIB MESYLATE1件: Masitinib1件: Masitinib 💬 1件: KIT 💬 11件: Acute myeloid leukemia, Breast cancer, Central carbon metabolism in cancer, Hematopoietic cell lineage, MAPK signaling pathway, Melanogenesis, PI3K-Akt signaling pathway, Pathways in cancer, Phospholipase D signaling pathway, Rap1 signaling pathway, Ras signaling pathway 💬6件: 2, 5, 6, 13, 46, 96 💬
1385Massage with a spiky ball----1件: 6 💬
1386Mavoglurant1件: Mavoglurant---2件: 6, 206 💬
1387MC1----3件: 6, 13, 46 💬
1388MED ON plus----1件: 6 💬
1389MEDI1341----1件: 6 💬
1390Medical Cannabis1件: Medical Cannabis1件: Cannabis 💬 --3件: 6, 96, 97 💬
1391Mediterranean diet supplemented with medium-chain triglyceride oil----1件: 6 💬
1392Melatonin1件: Melatonin1件: Melatonin 💬 2件: MTNR1A,
MTNR1B 💬
2件: Circadian entrainment, Neuroactive ligand-receptor interaction 💬18件: 2, 6, 8, 13, 37, 46, 49, 72, 78, 86, 90, 96, 97, 145, 149, 159, 202, 265 💬
1393MELATONIN (MELATL07959)1件: Melatonin1件: Melatonin 💬 2件: MTNR1A,
MTNR1B 💬
2件: Circadian entrainment, Neuroactive ligand-receptor interaction 💬1件: 6 💬
1394Melatonin PR1件: Melatonin1件: Melatonin 💬 2件: MTNR1A,
MTNR1B 💬
2件: Circadian entrainment, Neuroactive ligand-receptor interaction 💬1件: 6 💬
1395Melatonin(Circadin®)1件: Melatonin1件: Melatonin 💬 2件: MTNR1A,
MTNR1B 💬
2件: Circadian entrainment, Neuroactive ligand-receptor interaction 💬1件: 6 💬
1396Melevodopa1件: Melevodopa1件: Melevodopa 💬 --1件: 6 💬
1397Melevodopa and decarboxylase inhibitor1件: Melevodopa1件: Melevodopa 💬 --1件: 6 💬
1398Melperon----1件: 6 💬
1399Melperone1件: Melperone2件: Melperone ,
Melperone hydrochloride 💬
1件: DRD2 💬 10件: Alcoholism, Cocaine addiction, Dopaminergic synapse, Gap junction, Hormone signaling, Neuroactive ligand signaling, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, cAMP signaling pathway 💬1件: 6 💬
1400Melperone HCl1件: Melperone2件: Melperone ,
Melperone hydrochloride 💬
1件: DRD2 💬 10件: Alcoholism, Cocaine addiction, Dopaminergic synapse, Gap junction, Hormone signaling, Neuroactive ligand signaling, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, cAMP signaling pathway 💬1件: 6 💬
1401Memantin Orion----1件: 6 💬
1402Memantine1件: Memantine2件: Memantine hydrochloride ,
Memantine 💬
5件: GRIN1,
GRIN2A,
GRIN2B,
GRIN2C,
GRIN2D 💬
21件: Alcoholism, Alzheimer disease, Amphetamine addiction, Amyotrophic lateral sclerosis, Calcium signaling pathway, Circadian entrainment, Cocaine addiction, Dopaminergic synapse, Glutamatergic synapse, Huntington disease, Long-term potentiation, Neuroactive ligand signaling, Neuroactive ligand-receptor interaction, Nicotine addiction, Pathways of neurodegeneration - multiple diseases, Prion disease, Rap1 signaling pathway, Ras signaling pathway, Spinocerebellar ataxia, Systemic lupus erythematosus, cAMP signaling pathway 💬8件: 2, 6, 8, 13, 49, 127, 205, 206 💬
1403Memantine (drug)1件: Memantine2件: Memantine hydrochloride ,
Memantine 💬
5件: GRIN1,
GRIN2A,
GRIN2B,
GRIN2C,
GRIN2D 💬
21件: Alcoholism, Alzheimer disease, Amphetamine addiction, Amyotrophic lateral sclerosis, Calcium signaling pathway, Circadian entrainment, Cocaine addiction, Dopaminergic synapse, Glutamatergic synapse, Huntington disease, Long-term potentiation, Neuroactive ligand signaling, Neuroactive ligand-receptor interaction, Nicotine addiction, Pathways of neurodegeneration - multiple diseases, Prion disease, Rap1 signaling pathway, Ras signaling pathway, Spinocerebellar ataxia, Systemic lupus erythematosus, cAMP signaling pathway 💬1件: 6 💬
1404MEMANTINE HYDROCHLORIDE1件: Memantine2件: Memantine hydrochloride ,
Memantine 💬
5件: GRIN1,
GRIN2A,
GRIN2B,
GRIN2C,
GRIN2D 💬
21件: Alcoholism, Alzheimer disease, Amphetamine addiction, Amyotrophic lateral sclerosis, Calcium signaling pathway, Circadian entrainment, Cocaine addiction, Dopaminergic synapse, Glutamatergic synapse, Huntington disease, Long-term potentiation, Neuroactive ligand signaling, Neuroactive ligand-receptor interaction, Nicotine addiction, Pathways of neurodegeneration - multiple diseases, Prion disease, Rap1 signaling pathway, Ras signaling pathway, Spinocerebellar ataxia, Systemic lupus erythematosus, cAMP signaling pathway 💬3件: 2, 6, 127 💬
1405Menthol gloves and socks----1件: 6 💬
1406Mesdopetam1件: Mesdopetam---1件: 6 💬
1407Mesdopetam (IRL790)1件: Mesdopetam---1件: 6 💬
1408Mesencephalic Neuronal Precursor Cells----1件: 6 💬
1409Mesenchymal stem cells----16件: 2, 6, 13, 20, 46, 49, 50, 51, 60, 96, 107, 222, 271, 274, 298, 299 💬
1410Mestinon----3件: 3, 6, 11 💬
1411Metformin1件: Metformin2件: Metformin hydrochloride ,
Metformin 💬
2件: PRKAA1,
PRKAA2 💬
20件: AMPK signaling pathway, Adipocytokine signaling pathway, Alcoholic liver disease, Apelin signaling pathway, Autophagy - animal, Circadian rhythm, Fluid shear stress and atherosclerosis, FoxO signaling pathway, Glucagon signaling pathway, Hypertrophic cardiomyopathy, Insulin resistance, Insulin signaling pathway, Longevity regulating pathway, Longevity regulating pathway - multiple species, Non-alcoholic fatty liver disease, Oxytocin signaling pathway, PI3K-Akt signaling pathway, Thermogenesis, Tight junction, mTOR signaling pathway 💬31件: 2, 6, 8, 13, 46, 49, 60, 65, 66, 67, 74, 75, 77, 81, 84, 85, 86, 97, 113, 127, 158, 206, 218, 222, 225, 233, 265, 285, 298, 299, 301 💬
1412Methylphenidate1件: Methylphenidate2件: Methylphenidate hydrochloride ,
Methylphenidate 💬
2件: SLC6A2,
SLC6A3 💬
8件: Alcoholism, Amphetamine addiction, Cocaine addiction, Dopaminergic synapse, Neuroactive ligand signaling, Parkinson disease, Pathways of neurodegeneration - multiple diseases, Synaptic vesicle cycle 💬7件: 6, 13, 34, 84, 113, 179, 206 💬
1413Methylphenidate (MPD)1件: Methylphenidate2件: Methylphenidate hydrochloride ,
Methylphenidate 💬
2件: SLC6A2,
SLC6A3 💬
8件: Alcoholism, Amphetamine addiction, Cocaine addiction, Dopaminergic synapse, Neuroactive ligand signaling, Parkinson disease, Pathways of neurodegeneration - multiple diseases, Synaptic vesicle cycle 💬1件: 6 💬
1414METHYLPHENIDATE HYDROCHLORIDE1件: Methylphenidate2件: Methylphenidate hydrochloride ,
Methylphenidate 💬
2件: SLC6A2,
SLC6A3 💬
8件: Alcoholism, Amphetamine addiction, Cocaine addiction, Dopaminergic synapse, Neuroactive ligand signaling, Parkinson disease, Pathways of neurodegeneration - multiple diseases, Synaptic vesicle cycle 💬2件: 6, 13 💬
1415Methylprednisolone1件: Methylprednisolone2件: Methylprednisolone ,
Methylprednisolone acetate 💬
1件: NR3C1 💬 1件: Neuroactive ligand-receptor interaction 💬51件: 2, 6, 11, 13, 14, 18, 19, 25, 26, 35, 38, 39, 40, 41, 42, 43, 44, 45, 46, 49, 50, 51, 60, 62, 63, 64, 65, 66, 83, 84, 85, 86, 93, 95, 96, 97, 111, 127, 145, 162, 164, 211, 222, 223, 224, 271, 283, 284, 285, 296, 300 💬
1416Mg++----1件: 6 💬
1417Mid dose ANAVEX2-73----1件: 6 💬
1418Midazolam1件: Midazolam3件: Midazolam ,
Midazolam hydrochloride ,
Midazolam maleate 💬
16件: GABRA1,
GABRA2,
GABRA3,
GABRA4,
GABRA5,
GABRA6,
GABRB1,
GABRB2,
GABRB3,
GABRD,
GABRE,
GABRG1,
GABRG2,
GABRG3,
GABRP,
GABRQ 💬
9件: Cadherin signaling, GABAergic synapse, Morphine addiction, Neuroactive ligand signaling, Neuroactive ligand-receptor interaction, Nicotine addiction, Retrograde endocannabinoid signaling, Serotonergic synapse, Taste transduction 💬14件: 2, 3, 6, 13, 21, 46, 67, 70, 96, 97, 231, 272, 298, 299 💬
1419Midodrine1件: Midodrine2件: Midodrine hydrochloride ,
Midodrine 💬
3件: ADRA1A,
ADRA1B,
ADRA1D 💬
9件: AMPK signaling pathway, Adrenergic signaling in cardiomyocytes, Calcium signaling pathway, Hormone signaling, Neuroactive ligand signaling, Neuroactive ligand-receptor interaction, Salivary secretion, Vascular smooth muscle contraction, cGMP-PKG signaling pathway 💬3件: 6, 17, 58 💬
1420Minocycline1件: Minocycline2件: Minocycline hydrochloride ,
Minocycline 💬
--14件: 2, 6, 8, 13, 46, 85, 90, 94, 97, 162, 201, 206, 280, 299 💬
1421Minodronic acid1件: Minodronic acid---4件: 6, 46, 93, 95 💬
1422Minzasolmin1件: Minzasolmin1件: Minzasolmin 💬 1件: SNCA 💬 3件: Alzheimer disease, Parkinson disease, Pathways of neurodegeneration - multiple diseases 💬1件: 6 💬
1423Minzasolmin (UCB0599)1件: Minzasolmin1件: Minzasolmin 💬 1件: SNCA 💬 3件: Alzheimer disease, Parkinson disease, Pathways of neurodegeneration - multiple diseases 💬1件: 6 💬
1424Mirabegron1件: Mirabegron1件: Mirabegron 💬 1件: ADRB3 💬 9件: Calcium signaling pathway, Chemical carcinogenesis - receptor activation, Hormone signaling, Neuroactive ligand-receptor interaction, Regulation of lipolysis in adipocytes, Renin secretion, Salivary secretion, Thermogenesis, cGMP-PKG signaling pathway 💬4件: 6, 13, 53, 226 💬
1425Mirapex----1件: 6 💬
1426Mirapex (pramipexole)1件: Pramipexole2件: Pramipexole dihydrochloride ,
Pramipexole 💬
3件: DRD2,
DRD3,
DRD4 💬
10件: Alcoholism, Cocaine addiction, Dopaminergic synapse, Gap junction, Hormone signaling, Neuroactive ligand signaling, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, cAMP signaling pathway 💬1件: 6 💬
1427Mirapex ER----1件: 6 💬
1428Mirapex LA----1件: 6 💬
1429Mirapexin----1件: 6 💬
1430Mirapexin / Sifrol----1件: 6 💬
1431Mirapexin extended release various strengths----1件: 6 💬
1432MIRAPEXIN*30CPR 0,7MG----1件: 6 💬
1433Mirapexin/Sifrol----1件: 6 💬
1434Mirtazapine1件: Mirtazapine1件: Mirtazapine 💬 11件: ADRA2A,
ADRA2B,
ADRA2C,
HTR2A,
HTR2B,
HTR2C,
HTR3A,
HTR3B,
HTR3C,
HTR3D,
HTR3E 💬
9件: Calcium signaling pathway, Gap junction, Hormone signaling, Inflammatory mediator regulation of TRP channels, Neuroactive ligand signaling, Neuroactive ligand-receptor interaction, Serotonergic synapse, Taste transduction, cGMP-PKG signaling pathway 💬4件: 6, 85, 97, 156 💬
1435Mirtazapine 15 MG1件: Mirtazapine1件: Mirtazapine 💬 11件: ADRA2A,
ADRA2B,
ADRA2C,
HTR2A,
HTR2B,
HTR2C,
HTR3A,
HTR3B,
HTR3C,
HTR3D,
HTR3E 💬
9件: Calcium signaling pathway, Gap junction, Hormone signaling, Inflammatory mediator regulation of TRP channels, Neuroactive ligand signaling, Neuroactive ligand-receptor interaction, Serotonergic synapse, Taste transduction, cGMP-PKG signaling pathway 💬1件: 6 💬
1436MitoQ----3件: 2, 6, 97 💬
1437MK0657----1件: 6 💬
1438MOCLOBEMIDE1件: Moclobemide1件: Moclobemide 💬 1件: MAOA 💬 13件: Alcoholism, Amphetamine addiction, Arginine and proline metabolism, Cocaine addiction, Dopaminergic synapse, Drug metabolism - cytochrome P450, Glycine, serine and threonine metabolism, Histidine metabolism, Parkinson disease, Phenylalanine metabolism, Serotonergic synapse, Tryptophan metabolism, Tyrosine metabolism 💬1件: 6 💬
1439MODAFINIL1件: Modafinil1件: Modafinil 💬